TW202500672A - Protein polyurethane alloy membranes - Google Patents
Protein polyurethane alloy membranes Download PDFInfo
- Publication number
- TW202500672A TW202500672A TW113122885A TW113122885A TW202500672A TW 202500672 A TW202500672 A TW 202500672A TW 113122885 A TW113122885 A TW 113122885A TW 113122885 A TW113122885 A TW 113122885A TW 202500672 A TW202500672 A TW 202500672A
- Authority
- TW
- Taiwan
- Prior art keywords
- protein
- polyurethane
- membrane
- textile
- measured according
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 382
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 381
- 229920002635 polyurethane Polymers 0.000 title claims abstract description 363
- 239000004814 polyurethane Substances 0.000 title claims abstract description 363
- 239000012528 membrane Substances 0.000 title claims abstract description 156
- 239000000956 alloy Substances 0.000 title abstract 4
- 229910045601 alloy Inorganic materials 0.000 title abstract 4
- 229920003009 polyurethane dispersion Polymers 0.000 claims abstract description 82
- 238000012360 testing method Methods 0.000 claims abstract description 62
- 230000002706 hydrostatic effect Effects 0.000 claims abstract description 52
- 239000000203 mixture Substances 0.000 claims description 325
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 152
- 239000004753 textile Substances 0.000 claims description 109
- 239000003431 cross linking reagent Substances 0.000 claims description 89
- 230000035699 permeability Effects 0.000 claims description 89
- 238000009472 formulation Methods 0.000 claims description 85
- 230000005484 gravity Effects 0.000 claims description 45
- 239000007787 solid Substances 0.000 claims description 43
- 125000001931 aliphatic group Chemical group 0.000 claims description 37
- 238000000576 coating method Methods 0.000 claims description 31
- 239000011248 coating agent Substances 0.000 claims description 30
- 229920000728 polyester Polymers 0.000 claims description 24
- 239000000980 acid dye Substances 0.000 claims description 22
- 239000000853 adhesive Substances 0.000 claims description 22
- 230000001070 adhesive effect Effects 0.000 claims description 22
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 21
- 229920000570 polyether Polymers 0.000 claims description 21
- 229940071440 soy protein isolate Drugs 0.000 claims description 20
- 239000000985 reactive dye Substances 0.000 claims description 18
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims description 17
- 239000002243 precursor Substances 0.000 claims description 17
- 239000005871 repellent Substances 0.000 claims description 17
- 239000012948 isocyanate Substances 0.000 claims description 16
- 150000002513 isocyanates Chemical class 0.000 claims description 14
- 239000007921 spray Substances 0.000 claims description 13
- 229920000877 Melamine resin Polymers 0.000 claims description 12
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 claims description 12
- 230000002940 repellent Effects 0.000 claims description 12
- 239000004593 Epoxy Substances 0.000 claims description 11
- 150000001718 carbodiimides Chemical class 0.000 claims description 11
- 239000002518 antifoaming agent Substances 0.000 claims description 9
- 238000005299 abrasion Methods 0.000 claims description 8
- 230000002378 acidificating effect Effects 0.000 claims description 8
- FJQXCDYVZAHXNS-UHFFFAOYSA-N methadone hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 FJQXCDYVZAHXNS-UHFFFAOYSA-N 0.000 claims description 8
- 239000002480 mineral oil Substances 0.000 claims description 3
- 235000010446 mineral oil Nutrition 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 43
- 239000000463 material Substances 0.000 abstract description 36
- 239000004971 Cross linker Substances 0.000 abstract description 18
- 235000018102 proteins Nutrition 0.000 description 356
- 239000010410 layer Substances 0.000 description 92
- 229920001436 collagen Polymers 0.000 description 66
- 108010035532 Collagen Proteins 0.000 description 61
- 102000008186 Collagen Human genes 0.000 description 61
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
- 239000000243 solution Substances 0.000 description 26
- 239000007864 aqueous solution Substances 0.000 description 25
- 239000000975 dye Substances 0.000 description 19
- 239000012790 adhesive layer Substances 0.000 description 18
- 238000002156 mixing Methods 0.000 description 17
- 239000012634 fragment Substances 0.000 description 16
- 239000002245 particle Substances 0.000 description 16
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 14
- 239000004472 Lysine Substances 0.000 description 14
- 150000001413 amino acids Chemical class 0.000 description 14
- 239000000758 substrate Substances 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 108010084695 Pea Proteins Proteins 0.000 description 12
- 238000001035 drying Methods 0.000 description 12
- 235000019702 pea protein Nutrition 0.000 description 12
- SJEYSFABYSGQBG-UHFFFAOYSA-M Patent blue Chemical compound [Na+].C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=CC=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1 SJEYSFABYSGQBG-UHFFFAOYSA-M 0.000 description 11
- -1 azo acid dyes Chemical compound 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000004417 polycarbonate Substances 0.000 description 10
- 229920000515 polycarbonate Polymers 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 229920005862 polyol Polymers 0.000 description 9
- 150000003077 polyols Chemical class 0.000 description 9
- 238000003475 lamination Methods 0.000 description 8
- 239000006254 rheological additive Substances 0.000 description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 7
- 108010010803 Gelatin Proteins 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 7
- 239000004677 Nylon Substances 0.000 description 7
- 239000002202 Polyethylene glycol Substances 0.000 description 7
- 108010073771 Soybean Proteins Proteins 0.000 description 7
- 102000007544 Whey Proteins Human genes 0.000 description 7
- 108010046377 Whey Proteins Proteins 0.000 description 7
- 229940098773 bovine serum albumin Drugs 0.000 description 7
- 238000007872 degassing Methods 0.000 description 7
- 239000000835 fiber Substances 0.000 description 7
- 239000008273 gelatin Substances 0.000 description 7
- 229920000159 gelatin Polymers 0.000 description 7
- 235000019322 gelatine Nutrition 0.000 description 7
- 235000011852 gelatine desserts Nutrition 0.000 description 7
- 229920001778 nylon Polymers 0.000 description 7
- 229920001223 polyethylene glycol Polymers 0.000 description 7
- 229940001941 soy protein Drugs 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 244000037433 Pongamia pinnata Species 0.000 description 6
- 235000004599 Pongamia pinnata Nutrition 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 239000003086 colorant Substances 0.000 description 6
- 238000004925 denaturation Methods 0.000 description 6
- 230000036425 denaturation Effects 0.000 description 6
- 238000010348 incorporation Methods 0.000 description 6
- 239000003607 modifier Substances 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 239000000049 pigment Substances 0.000 description 6
- 239000000651 prodrug Substances 0.000 description 6
- 229940002612 prodrug Drugs 0.000 description 6
- 235000017060 Arachis glabrata Nutrition 0.000 description 5
- 244000105624 Arachis hypogaea Species 0.000 description 5
- 235000010777 Arachis hypogaea Nutrition 0.000 description 5
- 235000018262 Arachis monticola Nutrition 0.000 description 5
- 102000011632 Caseins Human genes 0.000 description 5
- 108010076119 Caseins Proteins 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 229920002334 Spandex Polymers 0.000 description 5
- 230000001143 conditioned effect Effects 0.000 description 5
- 239000013530 defoamer Substances 0.000 description 5
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical class C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 5
- 230000007613 environmental effect Effects 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 239000004744 fabric Substances 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 239000008267 milk Substances 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 235000020232 peanut Nutrition 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
- 239000002028 Biomass Substances 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 4
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 4
- 239000005862 Whey Substances 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 239000000908 ammonium hydroxide Substances 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- 150000002009 diols Chemical class 0.000 description 4
- 239000003063 flame retardant Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 229920006264 polyurethane film Polymers 0.000 description 4
- 238000007764 slot die coating Methods 0.000 description 4
- 239000004759 spandex Substances 0.000 description 4
- 230000003068 static effect Effects 0.000 description 4
- 210000003371 toe Anatomy 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 108010059892 Cellulase Proteins 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 229920002873 Polyethylenimine Polymers 0.000 description 3
- 239000012670 alkaline solution Substances 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 229940121375 antifungal agent Drugs 0.000 description 3
- 239000004599 antimicrobial Substances 0.000 description 3
- 230000000386 athletic effect Effects 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 150000004696 coordination complex Chemical class 0.000 description 3
- 238000000113 differential scanning calorimetry Methods 0.000 description 3
- 239000000982 direct dye Substances 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hcl hcl Chemical compound Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 3
- 239000008240 homogeneous mixture Substances 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 3
- 229940011051 isopropyl acetate Drugs 0.000 description 3
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 3
- 239000010985 leather Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920002994 synthetic fiber Polymers 0.000 description 3
- 235000021119 whey protein Nutrition 0.000 description 3
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 2
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 239000004262 Ethyl gallate Substances 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 2
- 239000004831 Hot glue Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000005058 Isophorone diisocyanate Substances 0.000 description 2
- 240000006240 Linum usitatissimum Species 0.000 description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 description 2
- 108010058846 Ovalbumin Proteins 0.000 description 2
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 2
- 229920000297 Rayon Polymers 0.000 description 2
- 239000004823 Reactive adhesive Substances 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 241000499912 Trichoderma reesei Species 0.000 description 2
- GTTSNKDQDACYLV-UHFFFAOYSA-N Trihydroxybutane Chemical compound CCCC(O)(O)O GTTSNKDQDACYLV-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 239000012963 UV stabilizer Substances 0.000 description 2
- 238000010306 acid treatment Methods 0.000 description 2
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 2
- 150000004056 anthraquinones Chemical class 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 229920003235 aromatic polyamide Polymers 0.000 description 2
- 150000001541 aziridines Chemical class 0.000 description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 2
- 235000009120 camo Nutrition 0.000 description 2
- 229940106157 cellulase Drugs 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000005607 chanvre indien Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 238000007766 curtain coating Methods 0.000 description 2
- 238000005034 decoration Methods 0.000 description 2
- 239000002274 desiccant Substances 0.000 description 2
- 125000005442 diisocyanate group Chemical group 0.000 description 2
- 238000011978 dissolution method Methods 0.000 description 2
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 239000011487 hemp Substances 0.000 description 2
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 2
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000004005 microsphere Substances 0.000 description 2
- 102000035118 modified proteins Human genes 0.000 description 2
- 108091005573 modified proteins Proteins 0.000 description 2
- 150000002903 organophosphorus compounds Chemical class 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920005906 polyester polyol Polymers 0.000 description 2
- 229920000223 polyglycerol Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000000988 sulfur dye Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 239000000984 vat dye Substances 0.000 description 2
- UIYCHXAGWOYNNA-UHFFFAOYSA-N vinyl sulfide Chemical compound C=CSC=C UIYCHXAGWOYNNA-UHFFFAOYSA-N 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- JEBWAOITKHXCBF-BEAPMJEYSA-N (3s,3ar,6r,6ar)-3,6-bis(oxiran-2-ylmethoxy)-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound O([C@@H]1[C@H]2OC[C@H]([C@H]2OC1)OCC1OC1)CC1CO1 JEBWAOITKHXCBF-BEAPMJEYSA-N 0.000 description 1
- PVPBBTJXIKFICP-UHFFFAOYSA-N (7-aminophenothiazin-3-ylidene)azanium;chloride Chemical compound [Cl-].C1=CC(=[NH2+])C=C2SC3=CC(N)=CC=C3N=C21 PVPBBTJXIKFICP-UHFFFAOYSA-N 0.000 description 1
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 1
- IVIDDMGBRCPGLJ-UHFFFAOYSA-N 2,3-bis(oxiran-2-ylmethoxy)propan-1-ol Chemical compound C1OC1COC(CO)COCC1CO1 IVIDDMGBRCPGLJ-UHFFFAOYSA-N 0.000 description 1
- OZDGMOYKSFPLSE-UHFFFAOYSA-N 2-Methylaziridine Chemical compound CC1CN1 OZDGMOYKSFPLSE-UHFFFAOYSA-N 0.000 description 1
- SYEWHONLFGZGLK-UHFFFAOYSA-N 2-[1,3-bis(oxiran-2-ylmethoxy)propan-2-yloxymethyl]oxirane Chemical compound C1OC1COCC(OCC1OC1)COCC1CO1 SYEWHONLFGZGLK-UHFFFAOYSA-N 0.000 description 1
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 1
- PLDLPVSQYMQDBL-UHFFFAOYSA-N 2-[[3-(oxiran-2-ylmethoxy)-2,2-bis(oxiran-2-ylmethoxymethyl)propoxy]methyl]oxirane Chemical compound C1OC1COCC(COCC1OC1)(COCC1OC1)COCC1CO1 PLDLPVSQYMQDBL-UHFFFAOYSA-N 0.000 description 1
- UUODQIKUTGWMPT-UHFFFAOYSA-N 2-fluoro-5-(trifluoromethyl)pyridine Chemical compound FC1=CC=C(C(F)(F)F)C=N1 UUODQIKUTGWMPT-UHFFFAOYSA-N 0.000 description 1
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 1
- AXKLSEHRUHRCIJ-UHFFFAOYSA-N 3,3-bis(hydroxymethyl)butane-1,1,1,4-tetrol Chemical compound OCC(CO)(CO)CC(O)(O)O AXKLSEHRUHRCIJ-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- RZVHIXYEVGDQDX-UHFFFAOYSA-N 9,10-anthraquinone Chemical group C1=CC=C2C(=O)C3=CC=CC=C3C(=O)C2=C1 RZVHIXYEVGDQDX-UHFFFAOYSA-N 0.000 description 1
- 229920002972 Acrylic fiber Polymers 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 229920002749 Bacterial cellulose Polymers 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 241001674044 Blattodea Species 0.000 description 1
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical compound C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 description 1
- 229920000049 Carbon (fiber) Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 239000004908 Emulsion polymer Substances 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical class C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 240000000797 Hibiscus cannabinus Species 0.000 description 1
- 101000875027 Homo sapiens Collagen alpha-1(X) chain Proteins 0.000 description 1
- 101001062093 Homo sapiens RNA-binding protein 15 Proteins 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 229920000433 Lyocell Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 229930182559 Natural dye Natural products 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 101710161300 Protein peanut Proteins 0.000 description 1
- 102100029244 RNA-binding protein 15 Human genes 0.000 description 1
- 101710137510 Saimiri transformation-associated protein Proteins 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 229920001872 Spider silk Polymers 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 108010077465 Tropocollagen Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- LNWBFIVSTXCJJG-UHFFFAOYSA-N [diisocyanato(phenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(N=C=O)(N=C=O)C1=CC=CC=C1 LNWBFIVSTXCJJG-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 210000001361 achilles tendon Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 238000003916 acid precipitation Methods 0.000 description 1
- 229920003232 aliphatic polyester Polymers 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000000077 angora Anatomy 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000004760 aramid Substances 0.000 description 1
- 239000005016 bacterial cellulose Substances 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 238000009739 binding Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000004917 carbon fiber Substances 0.000 description 1
- 210000000085 cashmere Anatomy 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000011026 diafiltration Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- 238000004512 die casting Methods 0.000 description 1
- 238000001938 differential scanning calorimetry curve Methods 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- KIQKWYUGPPFMBV-UHFFFAOYSA-N diisocyanatomethane Chemical compound O=C=NCN=C=O KIQKWYUGPPFMBV-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000009820 dry lamination Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000004751 flashspun nonwoven Substances 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 238000009408 flooring Methods 0.000 description 1
- 238000005188 flotation Methods 0.000 description 1
- 229910003472 fullerene Inorganic materials 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 238000007756 gravure coating Methods 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 102000044123 human COL10A1 Human genes 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000007759 kiss coating Methods 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000005226 mechanical processes and functions Effects 0.000 description 1
- 239000004750 melt-blown nonwoven Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000000978 natural dye Substances 0.000 description 1
- 229940092253 ovalbumin Drugs 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000005056 polyisocyanate Substances 0.000 description 1
- 229920001228 polyisocyanate Polymers 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000000164 protein isolation Methods 0.000 description 1
- 238000001799 protein solubilization Methods 0.000 description 1
- 230000007925 protein solubilization Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 239000004749 staple nonwoven Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 1
- 210000002105 tongue Anatomy 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 238000009816 wet lamination Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L75/00—Compositions of polyureas or polyurethanes; Compositions of derivatives of such polymers
- C08L75/04—Polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D175/00—Coating compositions based on polyureas or polyurethanes; Coating compositions based on derivatives of such polymers
- C09D175/04—Polyurethanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Polyurethanes Or Polyureas (AREA)
Abstract
Description
相關申請案之交互參照Cross-reference to related applications
與本申請書一起提交之XML檔案中以電子方式提交之序列表(名稱:4431_111TW02_SeqListing_ST26.xml;檔案大小:2,497位元組;及創建日期:2024年6月17日)之內容以全文引用方式併入本文中。The contents of the sequence listing submitted electronically in the XML file submitted with this application (name: 4431_111TW02_SeqListing_ST26.xml; file size: 2,497 bytes; and creation date: June 17, 2024) are incorporated herein by reference in their entirety.
本揭露關於用於紡織物材料之膜。在一些實施例中,該膜可應用於紡織物材料以用於製造各種物品,例如織物、衣服、時尚配件、或室內裝潢。The present disclosure relates to films for use in textile materials. In some embodiments, the films can be applied to textile materials for use in making various articles, such as fabrics, clothing, fashion accessories, or interior decoration.
紡織物或織物材料,包括天然材料(例如,棉花)、合成材料(例如,氨綸及聚酯)、及複合紡織物(包括天然及合成材料),係應用於包括家具業及服裝業等諸多行業。此等紡織物或織物材料可經塗佈或處理以賦予一或多種所欲之特性或性質。對於改善紡織物材料之特性及性能,以及改善此等材料之製造程序,仍然有持續的需求。Textile or woven materials, including natural materials (e.g., cotton), synthetic materials (e.g., spandex and polyester), and composite textiles (including both natural and synthetic materials), are used in a variety of industries, including the furniture and apparel industries. These textile or woven materials may be coated or treated to impart one or more desired characteristics or properties. There remains a continuing need to improve the properties and performance of textile materials, as well as to improve the processes for manufacturing these materials.
本揭露提供具有包含高透氣性、高防水性、或兩者之蛋白質聚胺甲酸酯混摻物之膜。如本文中所述之一或多種蛋白質及一或多種水性聚胺甲酸酯分散液之獨特組合,可形成對於各種紡織物材料具有所欲之透氣性及防水特性的薄膜(例如具有厚度小於50微米之膜)。The present disclosure provides films having protein polyurethane blends that have high air permeability, high water resistance, or both. The unique combination of one or more proteins and one or more aqueous polyurethane dispersions as described herein can form films (e.g., films having a thickness of less than 50 microns) having desired air permeability and water resistance properties for a variety of textile materials.
本揭露之第一實施例(1)涉及一種包含蛋白質聚胺甲酸酯混摻物之膜,其包含:溶解於由水性聚胺甲酸酯分散液製備之聚胺甲酸酯中之蛋白質、交聯劑,且厚度在約5微米至約200微米之範圍內;其中,該蛋白質聚胺甲酸酯混摻物具有根據JIS L 1092靜水壓法測試所測量之大於3,000 mm的H 2O之防水性及根據JIS L 1099 B1所測量之大於3,000 g/m 2/24hr之透氣性。 The first embodiment (1) of the present disclosure relates to a membrane comprising a protein polyurethane blend, comprising: a protein dissolved in a polyurethane prepared from an aqueous polyurethane dispersion, a crosslinking agent, and having a thickness ranging from about 5 microns to about 200 microns; wherein the protein polyurethane blend has a water resistance of greater than 3,000 mm H 2 O measured by the hydrostatic pressure test according to JIS L 1092 and an air permeability of greater than 3,000 g/m 2 /24hr measured according to JIS L 1099 B1.
在第二實施例(2)中,根據第一實施例(1)之交聯劑係選自由下列所組成之群組:環氧交聯劑、氮丙啶交聯劑、異氰酸酯交聯劑、碳二亞胺交聯劑、三聚氰胺交聯劑、及其組合。In the second embodiment (2), the crosslinking agent according to the first embodiment (1) is selected from the group consisting of epoxy crosslinking agents, aziridine crosslinking agents, isocyanate crosslinking agents, carbodiimide crosslinking agents, melamine crosslinking agents, and combinations thereof.
在第三實施例(3)中,根據第一實施例(1)或第二實施例(2)之蛋白質聚胺甲酸酯混摻物進一步包含第二聚胺甲酸酯。In the third embodiment (3), the protein polyurethane mixture according to the first embodiment (1) or the second embodiment (2) further comprises a second polyurethane.
在第四實施例(4)中,蛋白質係溶解於第三實施例(3)之第二聚胺甲酸酯中。In the fourth embodiment (4), the protein is dissolved in the second polyurethane of the third embodiment (3).
在第五實施例(5)中,根據實施例(1)至(4)中任一者之膜具有大於或等於約5 g/m 2之乾重。 In a fifth embodiment (5), the film according to any one of embodiments (1) to (4) has a dry weight greater than or equal to about 5 g/ m2 .
在第六實施例(6)中,根據實施例(1)至(5)中任一者之蛋白質聚胺甲酸酯混摻物具有根據JIS L 1099 B1所測量之大於5,000 g/m 2/24hr之透氣性。 In the sixth embodiment (6), the protein polyurethane blend according to any one of embodiments (1) to (5) has an air permeability of more than 5,000 g/m 2 /24hr measured according to JIS L 1099 B1.
在第七實施例(7)中,根據實施例(1)至(5)中任一者之蛋白質聚胺甲酸酯混摻物具有根據JIS L 1099 A1所測量之大於3,000 g/m 2/24hr之透氣性。 In the seventh embodiment (7), the protein polyurethane blend according to any one of embodiments (1) to (5) has an air permeability of more than 3,000 g/m 2 /24hr measured according to JIS L 1099 A1.
在第八實施例(8)中,根據實施例(1)至(5)中任一者之蛋白質聚胺甲酸酯混摻物具有根據ASTM E 96 B所測量之大於250 g/m 2/24hr之透氣性。 In the eighth embodiment (8), the protein polyurethane blend according to any one of embodiments (1) to (5) has an air permeability measured according to ASTM E 96 B of greater than 250 g/m 2 /24hr.
在第九實施例(9)中,根據實施例(1)至(8)中任一者之蛋白質聚胺甲酸酯混摻物具有根據JIS L 1092所測量之大於10,000 mm的H 2O之防水性。 In the ninth embodiment (9), the protein polyurethane blend according to any one of embodiments (1) to (8) has a water repellency of greater than 10,000 mm H 2 O measured according to JIS L 1092.
在第十實施例(10)中,根據實施例(1)至(9)中任一者之蛋白質聚胺甲酸酯混摻物包含大於或等於約5 wt%的該蛋白質。In a tenth embodiment (10), the protein-polyurethane blend according to any one of embodiments (1) to (9) comprises greater than or equal to about 5 wt % of the protein.
在第十一實施例(11)中,根據實施例(1)至(10)中任一者之聚胺甲酸酯包含如根據ASTM D6866所測量之大於或等於約15%之生物含量。In an eleventh embodiment (11), the polyurethane according to any one of embodiments (1) to (10) comprises a biocontent greater than or equal to about 15% as measured according to ASTM D6866.
在第十二實施例(12)中,根據實施例(1)至(11)中任一者之蛋白質聚胺甲酸酯混摻物包含如根據ASTM D6866所測量之大於或等於約35%之生物含量。In a twelfth embodiment (12), the protein polyurethane blend according to any one of embodiments (1) to (11) comprises a biocontent greater than or equal to about 35% as measured according to ASTM D6866.
在第十三實施例(13)中,根據實施例(1)至(12)中任一者之蛋白質聚胺甲酸酯混摻物係用酸性或反應性染料染色。In the thirteenth embodiment (13), the protein polyurethane blend according to any one of embodiments (1) to (12) is dyed with an acidic or reactive dye.
在第十四實施例(14)中,根據實施例(1)至(13)中任一者之膜係無孔或微孔的。In a fourteenth embodiment (14), the membrane according to any one of embodiments (1) to (13) is non-porous or microporous.
在第十五實施例(15)中,根據實施例(1)至(14)中任一者之膜係用防潑水整理劑處理且包含如根據AATCC 22所測量之大於或等於約70之防潑水性噴霧等級。In a fifteenth embodiment (15), the film according to any one of embodiments (1) to (14) is treated with a water repellent finish and comprises a water repellency spray rating of greater than or equal to about 70 as measured according to AATCC 22.
在第十六實施例(16)中,根據實施例(1)至(14)中任一者之膜係用聚胺甲酸酯整理劑處理且包含如根據AATCC 22所測量之大於或等於約70之防潑水性噴霧等級。In a sixteenth embodiment (16), a film according to any one of embodiments (1) to (14) is treated with a polyurethane finish and comprises a water repellency spray rating of greater than or equal to about 70 as measured according to AATCC 22.
在第十七實施例(17)中,根據實施例(1)至(14)中任一者之膜具有如根據用9 kPa荷重之馬丁代爾磨耗測試(Martindale Abrasion Test)所測量之大於或等於約20,000次循環的馬丁代爾乾磨耗(dry Martindale abrasion)。In the seventeenth embodiment (17), the film according to any one of embodiments (1) to (14) has a dry Martindale abrasion of greater than or equal to about 20,000 cycles as measured according to the Martindale Abrasion Test with a 9 kPa load.
在第十八實施例(18)中,根據實施例(1)至(17)中任一者之蛋白質係大豆分離蛋白質(soy protein isolate)。In the eighteenth embodiment (18), the protein according to any one of embodiments (1) to (17) is soy protein isolate.
在第十九實施例(19)中,根據實施例(1)至(18)中任一者之水性聚胺甲酸酯分散液,當在蛋白質及交聯劑不存在之情況下固化時,具有如藉由JIS L 1092靜水壓法測試(hydrostatic pressure method test)所測量之大於10,000 mm的H 2O之防水性。 In the nineteenth embodiment (19), the aqueous polyurethane dispersion according to any one of embodiments (1) to (18), when cured in the absence of a protein and a crosslinking agent, has a water resistance of greater than 10,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure method test.
在第二十實施例(20)中,根據實施例(1)至(18)中任一者之水性聚胺甲酸酯分散液包含具有約35%之固體含量及約1.02 g/mL之比重之基於水性脂族聚醚之聚胺甲酸酯;具有約30%之固體含量及約1.1 g/mL之比重之非離子型脂族聚碳酸酯-聚醚聚胺甲酸酯分散液;具有約32%之固體含量、1.03 g/mL之比重、及約200 mPa.s之布氏黏度(Brookfield viscosity)之水性脂族非離子型聚胺甲酸酯分散液;具有約50%之固體含量、1.1 g/mL之比重、小於或等於1200 mPa.s之布氏黏度、如根據ASTM D6866所測量之約50%之生物含量、30 MPa之拉伸強度、及1000%之斷裂伸長率之水性脂族陰離子型聚酯聚胺甲酸酯分散液;具有約50%之固體含量、1.1 g/mL之比重、小於或等於1200 mPa.s之布氏黏度、如根據ASTM D6866所測量之約56%之生物含量、12 Mpa之拉伸強度、及800%之斷裂伸長率之水性脂族陰離子型聚酯聚胺甲酸酯分散液、或其組合。In the twentieth embodiment (20), the aqueous polyurethane dispersion according to any one of embodiments (1) to (18) comprises an aqueous aliphatic polyether-based polyurethane having a solid content of about 35% and a specific gravity of about 1.02 g/mL; a nonionic aliphatic polycarbonate-polyether polyurethane dispersion having a solid content of about 30% and a specific gravity of about 1.1 g/mL; an aqueous aliphatic nonionic polyurethane dispersion having a solid content of about 32%, a specific gravity of 1.03 g/mL, and a Brookfield viscosity of about 200 mPa.s; an aqueous aliphatic nonionic polyurethane dispersion having a solid content of about 50%, a specific gravity of 1.1 g/mL, a Brookfield viscosity of less than or equal to 1200 mPa.s, a biocontent of about 50% as measured according to ASTM D6866, a specific gravity of 30 An aqueous aliphatic anionic polyester polyurethane dispersion having a tensile strength of about 12 MPa, and an elongation at break of 1000%; an aqueous aliphatic anionic polyester polyurethane dispersion having a solids content of about 50%, a specific gravity of 1.1 g/mL, a Brookfield viscosity of less than or equal to 1200 mPa.s, a biocontent of about 56% as measured according to ASTM D6866, a tensile strength of 12 MPa, and an elongation at break of 800%, or a combination thereof.
本揭露之第二十一實施例(21)涉及前驅物配方,其包含:水;蛋白質;水性聚胺甲酸酯分散液;及一或多種交聯劑,其以相對於該配方中之水、蛋白質、及水性聚胺甲酸酯分散液之總重量之約0.1 wt%至約5 wt%之範圍內的重量百分比存在。The twenty-first embodiment (21) of the present disclosure relates to a precursor formulation comprising: water; protein; aqueous polyurethane dispersion; and one or more crosslinking agents, which are present in a weight percentage ranging from about 0.1 wt % to about 5 wt % relative to the total weight of water, protein, and aqueous polyurethane dispersion in the formulation.
在第二十二實施例(22)中,將第二十一實施例(21)之蛋白質溶解於聚胺甲酸酯分散液之聚胺甲酸酯中。In the twenty-second embodiment (22), the protein of the twenty-first embodiment (21) is dissolved in the polyurethane of the polyurethane dispersion.
在第二十三實施例(23)中,根據第二十一實施例(21)或第二十二實施例(22)之一或多種交聯劑係選自由下列所組成之群組:環氧交聯劑、氮丙啶交聯劑、異氰酸酯交聯劑、碳二亞胺交聯劑、三聚氰胺交聯劑、及其組合。In the twenty-third embodiment (23), one or more crosslinking agents according to the twenty-first embodiment (21) or the twenty-second embodiment (22) are selected from the group consisting of epoxy crosslinking agents, aziridine crosslinking agents, isocyanate crosslinking agents, carbodiimide crosslinking agents, melamine crosslinking agents, and combinations thereof.
在第二十四實施例(24)中,根據實施例(21)至(23)中任一者之配方進一步包含酸性染料或反應性染料。In the twenty-fourth embodiment (24), the formulation according to any one of embodiments (21) to (23) further comprises an acid dye or a reactive dye.
在第二十五實施例(25)中,根據實施例(21)至(24)中任一者之配方進一步包含消泡劑或防沫劑。In the twenty-fifth embodiment (25), the formulation according to any one of embodiments (21) to (24) further comprises a defoaming agent or an antifoaming agent.
在第二十六實施例(26)中,根據第二十五實施例(25)之消泡劑係基於礦物油之消泡劑。In the twenty-sixth embodiment (26), the defoaming agent according to the twenty-fifth embodiment (25) is a defoaming agent based on mineral oil.
在第二十七實施例(27)中,根據實施例(21)至(26)中任一者之水性聚胺甲酸酯分散液,當在蛋白質及交聯劑不存在之情況下固化時,具有如藉由JIS L 1092靜水壓法測試所測量之大於3,000 mm的H 2O之防水性。 In the twenty-seventh embodiment (27), the aqueous polyurethane dispersion according to any one of embodiments (21) to (26), when cured in the absence of a protein and a crosslinking agent, has a water resistance of greater than 3,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test.
在第二十八實施例(28)中,根據實施例(21)至(26)中任一者之水性聚胺甲酸酯分散液包含具有約35%之固體含量及約1.02 g/mL之比重之基於水性脂族聚醚之聚胺甲酸酯;具有約30%之固體含量及約1.1 g/mL之比重之非離子型脂族聚碳酸酯-聚醚聚胺甲酸酯分散液;具有約32%之固體含量、1.03 g/mL之比重、及約200 mPa.s之布氏黏度之水性脂族非離子型聚胺甲酸酯分散液;具有約50%之固體含量、1.1 g/mL之比重、小於或等於1200 mPa.s之布氏黏度、如根據ASTM D6866所測量之約50%之生物含量、30 MPa之拉伸強度、及1000%之斷裂伸長率之水性脂族陰離子型聚酯聚胺甲酸酯分散液;具有約50%之固體含量、1.1 g/mL之比重、小於或等於1200 mPa.s之布氏黏度、如根據ASTM D6866所測量之約56%之生物含量、12 Mpa之拉伸強度、及800%之斷裂伸長率之水性脂族陰離子型聚酯聚胺甲酸酯分散液、或其組合。In the twenty-eighth embodiment (28), the aqueous polyurethane dispersion according to any one of embodiments (21) to (26) comprises an aqueous aliphatic polyether-based polyurethane having a solid content of about 35% and a specific gravity of about 1.02 g/mL; a non-ionic aliphatic polycarbonate-polyether polyurethane dispersion having a solid content of about 30% and a specific gravity of about 1.1 g/mL; an aqueous aliphatic non-ionic polyurethane dispersion having a solid content of about 32%, a specific gravity of 1.03 g/mL, and a Brookfield viscosity of about 200 mPa.s; an aqueous aliphatic non-ionic polyurethane dispersion having a solid content of about 50%, a specific gravity of 1.1 g/mL, a Brookfield viscosity of less than or equal to 1200 mPa.s, a biocontent of about 50% as measured according to ASTM D6866, a specific gravity of 30 An aqueous aliphatic anionic polyester polyurethane dispersion having a tensile strength of about 12 MPa, and an elongation at break of 1000%; an aqueous aliphatic anionic polyester polyurethane dispersion having a solids content of about 50%, a specific gravity of 1.1 g/mL, a Brookfield viscosity of less than or equal to 1200 mPa.s, a biocontent of about 56% as measured according to ASTM D6866, a tensile strength of 12 MPa, and an elongation at break of 800%, or a combination thereof.
本揭露之第二十九實施例(29)涉及一種物品,其包含:一紡織物;及根據實施例(1)至(20)中任一者之一膜,其附接至該紡織物。The twenty-ninth embodiment (29) of the present disclosure relates to an article comprising: a textile; and a film according to any one of embodiments (1) to (20), attached to the textile.
在第三十實施例(30)中,根據第二十九實施例(29)之膜係用黏著劑附接至該紡織物。In the thirtieth embodiment (30), the film according to the twenty-ninth embodiment (29) is attached to the textile with an adhesive.
在第三十一實施例(31)中,根據第二十九實施例(29)或第三十實施例(30)之紡織物包含第一紡織物層及第二紡織物層,且該膜經設置在該第一紡織物層及該第二紡織物層之間。In the thirty-first embodiment (31), the textile according to the twenty-ninth embodiment (29) or the thirtieth embodiment (30) includes a first textile layer and a second textile layer, and the film is disposed between the first textile layer and the second textile layer.
在第三十二實施例(32)中,根據第二十九實施例(29)或第三十實施例(30)之膜經附接至該紡織物之一外部表面。In the thirty-second embodiment (32), the film according to the twenty-ninth embodiment (29) or the thirtieth embodiment (30) is attached to an outer surface of the textile.
本揭露之第三十三實施例(33)涉及一種物品,其包含:一紡織物;及一塗層,其包含根據實施例(21)至(28)中任一項之配方,該塗層經附接至該紡織物。The thirty-third embodiment (33) of the present disclosure relates to an article comprising: a textile; and a coating comprising the formulation according to any one of embodiments (21) to (28), the coating being attached to the textile.
在第三十四實施例(34)中,根據第三十三實施例(33)之塗層經直接附接至該紡織物之一表面。In the thirty-fourth embodiment (34), the coating according to the thirty-third embodiment (33) is directly attached to one surface of the textile.
在第三十五實施例(35)中,根據第三十三實施例(33)或第三十四實施例(34)之塗層經附接至該紡織物之一正面表面。In the thirty-fifth embodiment (35), the coating according to the thirty-third embodiment (33) or the thirty-fourth embodiment (34) is attached to a front surface of the textile.
在第三十六實施例(36)中,根據實施例(33)至(35)中任一者之塗層經附接至該紡織物之一背面表面。In the thirty-sixth embodiment (36), the coating according to any one of embodiments (33) to (35) is attached to a back surface of the textile.
在第三十七實施例(37)中,根據實施例(33)至(36)中任一者之物品係用酸性染料、反應性染料、或其組合染色。In the thirty-seventh embodiment (37), the article according to any one of embodiments (33) to (36) is dyed with an acid dye, a reactive dye, or a combination thereof.
在第三十八實施例(38)中,根據第三十七實施例(37)之紡織物係用酸性染料、反應性染料、或其組合染色。In the thirty-eighth embodiment (38), the textile according to the thirty-seventh embodiment (37) is dyed with an acid dye, a reactive dye, or a combination thereof.
在第三十九實施例(39)中,根據第三十七實施例(37)或第三十八實施例(38)之塗層係用酸性染料、反應性染料、或其組合染色。In the thirty-ninth embodiment (39), the coating according to the thirty-seventh embodiment (37) or the thirty-eighth embodiment (38) is dyed with an acid dye, a reactive dye, or a combination thereof.
除非明顯矛盾或上下文另有明確指示,否則不定冠詞「一(a)」、「一(an)」及「該(the)」包括複數所指的對象。The indefinite articles “a”, “an” and “the” include plural referents unless clearly contradicted or the context clearly indicates otherwise.
用語「包含(comprising)」及「包括(including)」係末端開放性過渡片語。在過渡片語「包括」或「包括」之後的元件列表係一非排他性列表,使得亦可存在列表中具體記載的彼等之外的元件。片語「基本上由......所組成(consisting essentially of)」係將一組件的組成物限制至指定的材料及不會對組件的基本及新穎特性產生實質影響的材料。片語「由......所組成(consisting of)」係將一組件的組成物限制至指定的材料,且排除任何未指定的材料。The terms "comprising" and "including" are open-ended transition phrases. The list of elements following the transition phrase "comprising" or "including" is a non-exclusive list such that there may be elements other than those specifically recited in the list. The phrase "consisting essentially of" limits the composition of a component to the specified materials and materials that do not materially affect the basic and novel properties of the component. The phrase "consisting of" limits the composition of a component to the specified materials and excludes any unspecified materials.
當本文記載包含上限值及下限值的數值範圍時,除非在具體情況下另有說明,否則該範圍係亦欲包括其端值及在該範圍內之所有整數及分數。本揭露或申請專利範圍無意欲受限於當界定一範圍時所記載的特定值。此外,當一量、濃度、或其他值或參數係以一範圍、一或多個範圍、或以具有上限值及下限值的列表給出時,此應理解為具體揭示由任何範圍上限(或上限值)與任何範圍下限(或下限值)的任何一對所形成的所有範圍,無論此種成對是否係分開揭示。最後,當用語「約(about)」係用於描述一數值或一範圍的一端點時,本揭露應理解為包括所提及的特定值或端值。無論一數值或一範圍的端點係否記載「約」,該數值或一範圍的端點係意欲包括兩個實施例:一個由「約」修飾,及另一個不由「約」修飾。When a numerical range including an upper limit and a lower limit is recorded herein, unless otherwise specified in a specific case, the range is intended to include its end value and all integers and fractions within the range. The disclosure or patent application scope is not intended to be limited to the specific values recorded when defining a range. In addition, when an amount, concentration, or other value or parameter is given as a range, one or more ranges, or as a list with an upper limit and a lower limit, it should be understood to specifically disclose all ranges formed by any pair of any range upper limit (or upper limit value) and any range lower limit (or lower limit value), regardless of whether such pairing is disclosed separately. Finally, when the term "about" is used to describe a numerical value or an end point of a range, the disclosure should be understood to include the specific value or end value mentioned. Regardless of whether a value or an end-point of a range is expressed as "about," the value or the end-point of a range is intended to include two embodiments: one modified by "about" and the other not modified by "about."
如本文中所使用,用語「約」指的是在所述之值的±10%內的值。例如,「約3 MPa」包括在2.7 MPa及3.3 MPa之間的任何數字以及端點(亦即,2.7及3.3)。儘管如此,若列出百分比,且該百分比的值不能超過100%(例如,100 wt%或99 wt%)的話,則「約」無法修飾該百分比而包括超過100%的值。。As used herein, the term "about" refers to values within ±10% of the stated value. For example, "about 3 MPa" includes any number between 2.7 MPa and 3.3 MPa as well as the endpoints (i.e., 2.7 and 3.3). However, if a percentage is listed and the value of the percentage cannot exceed 100% (e.g., 100 wt% or 99 wt%), "about" cannot modify the percentage to include values exceeding 100%. .
如本文中所使用,第一組分(例如膜、混摻物、或紡織物)經描述為「附接至」第二組分意指該等組分係藉由在兩個組分之間的直接接觸及附接或經由一或多個中間黏著劑層而彼此附接。一中間黏著劑層可係用於將一第一組分附接至一第二組分之任何層。As used herein, a first component (e.g., a film, a blend, or a textile) is described as being "attached to" a second component means that the components are attached to each other by direct contact and attachment between the two components or through one or more intermediate adhesive layers. An intermediate adhesive layer can be any layer used to attach a first component to a second component.
如本文中所使用,片語「設置在......上(disposed on)」意指將一第一組分與一第二部分直接接觸。「設置在」一第二組分上之一第一組分可經沉積、形成、放置、或以其他方式直接施加到第二組分上。換言之,若一第一組分經設置在一第二組分上,則在該第一組分及該第二組分之間沒有組分。As used herein, the phrase "disposed on" means that a first component is in direct contact with a second component. A first component "disposed on" a second component may be deposited, formed, placed, or otherwise applied directly to the second component. In other words, if a first component is disposed on a second component, there are no components between the first component and the second component.
如本文中所使用,片語「設置在......上方(disposed over)」意指在一第一組分與一第二組分之間可存在或可不存在其他組分(例如膜或紡織物)。As used herein, the phrase “disposed over” means that other components (eg, films or textiles) may or may not be present between a first component and a second component.
如本文中所使用,「基於生物之聚胺甲酸酯(bio-based polyurethane)」係其中多元醇(諸如二醇)及二酸(如琥珀酸)之建構嵌段係衍生自生物材料(諸如玉米澱粉)的聚胺甲酸酯。As used herein, "bio-based polyurethane" is a polyurethane in which the building blocks of polyols (such as diols) and diacids (such as succinic acid) are derived from biomaterials (such as corn starch).
如本文中所使用,用語「實質上不含(substantially free of)」係指組分係以不超過約0.1 wt%的可檢測量存在。As used herein, the term "substantially free of" means that a component is present in a detectable amount of no more than about 0.1 wt%.
如本文中所使用,用語「不含(free of)」係指一組分係不存在於一摻合物或材料(例如,蛋白質聚胺甲酸酯混摻物)中,即使是微量的。As used herein, the term "free of" means that a component is not present in a blend or material (eg, a protein polyurethane blend), even in trace amounts.
如本文中所使用,「膠原蛋白(collagen)」係指至少28種不同的天然存在之膠原蛋白類型之家族,包括但不限於膠原蛋白類型I、II、III、IV、V、VI、VII、VIII、IX、X、XI、XII、XIII、XIV、XV、XVI、XVII、XVIII、XIX、及XX。如本文中所使用之用語膠原蛋白(collagen)亦指使用重組技術所製備之膠原蛋白,亦即重組膠原蛋白。用語「膠原蛋白」包括膠原蛋白、膠原蛋白片段、類膠原蛋白、三螺旋膠原蛋白、α鏈、單體、明膠、三聚體及其組合。膠原蛋白及類膠原蛋白蛋白質之重組表現在所屬技術領域中係已知的(參見例如Bell, EP 1232182B1, Bovine collagen and method for producing recombinant gelatin;Olsen等人之美國專利第6,428,978號及VanHeerde等人之美國專利第8,188,230號,該等專利以全文引用方式併入本文中)。除非另有說明,否則無論是天然存在之還是使用重組技術製備之任何類型之膠原蛋白均可用於本文中所述之任何實施例中。儘管如此,在一些實施例中,本文所述之膠原蛋白可使用牛第I型膠原蛋白來製備。膠原蛋白的特徵在於重複的胺基酸三聯體-(Gly-XY)n-,使得膠原蛋白中大約三分之一的胺基酸殘基係甘胺酸。X經常係脯胺酸,且Y經常係羥脯胺酸。因此,膠原蛋白之結構可由三個不同長度之相互纏繞的肽鏈所組成。不同的動物可產生具有膠原蛋白之不同胺基酸組成物,其可導致不同的特性。As used herein, "collagen" refers to a family of at least 28 different naturally occurring collagen types, including but not limited to collagen types I, II, III, IV, V, VI, VII, VIII, IX, X, XI, XII, XIII, XIV, XV, XVI, XVII, XVIII, XIX, and XX. As used herein, the term collagen also refers to collagen prepared using recombinant technology, i.e., recombinant collagen. The term "collagen" includes collagen, collagen fragments, collagenoids, triple helical collagen, alpha chains, monomers, gelatin, trimers, and combinations thereof. The recombinant expression of collagen and collagen-like proteins is known in the art (see, e.g., Bell, EP 1232182B1, Bovine collagen and method for producing recombinant gelatin; U.S. Patent No. 6,428,978 to Olsen et al. and U.S. Patent No. 8,188,230 to VanHeerde et al., which are incorporated herein by reference in their entirety). Unless otherwise specified, any type of collagen, whether naturally occurring or prepared using recombinant techniques, can be used in any of the embodiments described herein. Nevertheless, in some embodiments, the collagen described herein can be prepared using bovine type I collagen. Collagen is characterized by repeated amino acid triplets - (Gly-XY)n-, such that about one-third of the amino acid residues in collagen are glycine. X is often proline, and Y is often hydroxyproline. Therefore, the structure of collagen can be composed of three intertwined peptide chains of different lengths. Different animals can produce collagen with different amino acid compositions, which can lead to different properties.
在一些實施例中,可對膠原蛋白進行化學改質,以促進在水中的溶解度。In some embodiments, collagen can be chemically modified to improve solubility in water.
任何類型的之膠原蛋白、截短之膠原蛋白、未經修飾或經轉譯後修飾之膠原蛋白、或經胺基酸序列修飾之膠原蛋白均可用作蛋白質聚胺甲酸酯混摻物之一部分。Any type of collagen, truncated collagen, unmodified or translationally modified collagen, or collagen with amino acid sequence modifications can be used as part of the protein polyurethane blend.
在一些實施例中,膠原蛋白可係植物系膠原蛋白。例如,膠原蛋白可係由CollPlant所製造之植物系膠原蛋白。In some embodiments, the collagen can be plant-based collagen. For example, the collagen can be plant-based collagen produced by CollPlant.
在一些實施例中,一重組膠原蛋白可包含能夠形成原膠原蛋白(tropocollagen)(三聚體膠原蛋白(trimeric collagen))的一天然膠原蛋白分子的胺基酸序列的一膠原蛋白片段。重組膠原蛋白亦可包含一改質的膠原蛋白或截短的膠原蛋白,其具有與天然膠原蛋白胺基酸序列(或與它的一纖絲(fibril)形成區域、或與實質上包含[Gly-X-Y]n的一鏈段)至少70%、80%、90%、95%、96%、97%、98%、或99%相同或相似的胺基酸序列。在一些實施例中,膠原蛋白片段可係一天然膠原蛋白之一50 kDa部分。天然膠原蛋白序列包括由登錄號NP_001029211.1、NP_776945.1、及NP_001070299.1所述之CollAl、CollA2、及Col3Al之胺基酸序列,該等胺基酸序列係以引用方式併入本文中。在一些實施例中,膠原蛋白片段可係人類膠原蛋白α-1(III) (Col3A1; Uniprot # P02461, Entrez Gene ID # 1281)之一部分。在一些實施例中,膠原蛋白片段可係如SEQ ID NO: 1所示之胺基酸序列。在一些實施例中,膠原蛋白片段包含與SEQ ID NO: 1具有至少80%序列同一性之胺基序列。包含與SEQ ID NO: 1至少80%序列同一性之例示蛋白質係揭示於PCT/US2022/027016中,該揭露內容係以引用方式併入本文中。In some embodiments, a recombinant collagen may comprise a collagen fragment having an amino acid sequence of a natural collagen molecule capable of forming tropocollagen (trimeric collagen). The recombinant collagen may also comprise a modified collagen or a truncated collagen having an amino acid sequence that is at least 70%, 80%, 90%, 95%, 96%, 97%, 98%, or 99% identical or similar to the amino acid sequence of natural collagen (or to a fibril-forming region thereof, or to a chain segment substantially comprising [Gly-X-Y]n). In some embodiments, the collagen fragment may be a 50 kDa portion of a natural collagen. The natural collagen sequence includes the amino acid sequences of CollA1, CollA2, and Col3A1 described by accession numbers NP_001029211.1, NP_776945.1, and NP_001070299.1, which are incorporated herein by reference. In some embodiments, the collagen fragment may be a portion of human collagen α-1 (III) (Col3A1; Uniprot # P02461, Entrez Gene ID # 1281). In some embodiments, the collagen fragment may be an amino acid sequence as shown in SEQ ID NO: 1. In some embodiments, the collagen fragment comprises an amino sequence having at least 80% sequence identity to SEQ ID NO: 1. Exemplary proteins comprising at least 80% sequence identity to SEQ ID NO: 1 are disclosed in PCT/US2022/027016, the disclosure of which is incorporated herein by reference.
產生重組膠原蛋白及重組膠原片段之方法在所屬技術領域中係已知的。例如,美國公開號2019/0002893、2019/0040400、2019/0093116、及2019/0092838提供用於產生膠原蛋白及膠原片段之方法,該等方法可用於產生本文中所揭示之重組膠原蛋白及重組膠原片段。此等四個公開內容係以全文引用方式併入本文中。Methods for producing recombinant collagen and recombinant collagen fragments are known in the art. For example, U.S. Publication Nos. 2019/0002893, 2019/0040400, 2019/0093116, and 2019/0092838 provide methods for producing collagen and collagen fragments, which can be used to produce the recombinant collagen and recombinant collagen fragments disclosed herein. These four disclosures are incorporated herein by reference in their entirety.
本文中所述之用於膜之蛋白質聚胺甲酸酯混摻物可包含當摻合時僅與聚胺甲酸酯之複數個相中之一個相、或與複數個聚胺甲酸酯混溶的蛋白質。例如,在一些實施例中,蛋白質聚胺甲酸酯混摻物可包括僅與聚胺甲酸酯之硬相、或與具有硬相及軟相兩者之複數個聚胺甲酸酯混溶的蛋白質。在特定實施例中,蛋白質聚胺甲酸酯混摻物可包含僅溶解於一或多種聚胺甲酸酯之硬相中之一或多種蛋白質。本文中所述之蛋白質聚胺甲酸酯混摻物可不含或實質上不含分散在聚胺甲酸酯中呈粒子形式之蛋白質。例如,在一些實施例中,蛋白質聚胺甲酸酯混摻物可不含或實質上不含具有大於1微米(µm)之平均直徑之蛋白質粒子。The protein polyurethane blends for membranes described herein may include proteins that are miscible with only one of the multiple phases of polyurethane when blended, or with multiple polyurethanes. For example, in some embodiments, the protein polyurethane blend may include proteins that are miscible with only the hard phase of polyurethane, or with multiple polyurethanes having both a hard phase and a soft phase. In specific embodiments, the protein polyurethane blend may include one or more proteins that are only dissolved in the hard phase of one or more polyurethanes. The protein polyurethane blends described herein may not contain or substantially contain proteins dispersed in the polyurethane in the form of particles. For example, in some embodiments, the protein polyurethane blend may not contain or substantially contain protein particles having an average diameter greater than 1 micron (µm).
蛋白質聚胺甲酸酯混摻物、其製造之方法、及此等混摻物之例示性性質係描述於US 2021/0355326中,其揭露內容係以引用方式併入本文中。Protein polyurethane blends, methods of making them, and exemplary properties of such blends are described in US 2021/0355326, the disclosure of which is incorporated herein by reference.
在一些實施例中,蛋白質聚胺甲酸酯混摻物可不含或實質上不含具有大於1微米(µm)之平均直徑之蛋白質粒子。在一些實施例中,蛋白質聚胺甲酸酯混摻物可不含或實質上不含具有大於1微米(µm)之平均直徑之大豆蛋白質粒子。在一些實施例中,蛋白質聚胺甲酸酯混摻物可不含或實質上不含具有大於1微米(µm)之平均直徑之膠原蛋白粒子。在一些實施例中,蛋白質聚胺甲酸酯混摻物可不含或實質上不含具有大於1微米(µm)之平均直徑之明膠粒子。在一些實施例中,蛋白質聚胺甲酸酯混摻物可不含或實質上不含具有大於1微米(µm)之平均直徑之牛血清白蛋白粒子。在一些實施例中,蛋白質聚胺甲酸酯混摻物可不含或實質上不含具有大於1微米(µm)之平均直徑之豌豆蛋白質粒子。在一些實施例中,蛋白質聚胺甲酸酯混摻物可不含或實質上不含具有大於1微米(µm)之平均直徑之卵白白蛋白粒子。在一些實施例中,蛋白質聚胺甲酸酯混摻物可不含或實質上不含具有大於1微米(µm)之平均直徑之酪蛋白蛋白質粒子。在一些實施例中,蛋白質聚胺甲酸酯混摻物可不含或實質上不含具有大於1微米(µm)之平均直徑之花生蛋白質粒子。在一些實施例中,蛋白質聚胺甲酸酯混摻物可不含或實質上不含具有大於1微米(µm)之平均直徑之麻仁蛋白蛋白質粒子。在一些實施例中,蛋白質聚胺甲酸酯混摻物可不含或實質上不含具有大於1微米(µm)之平均直徑之乳清蛋白質粒子。在一些實施例中,蛋白質聚胺甲酸酯混摻物可不含或實質上不含具有大於1微米(µm)之平均直徑之卡蘭賈(karanja)蛋白質粒子。在一些實施例中,蛋白質聚胺甲酸酯混摻物可不含或實質上不含具有大於1微米(µm)之平均直徑之纖維素酶粒子。在一些實施例中,蛋白質聚胺甲酸酯混摻物可不含或實質上不含具有大於1微米(µm)之平均直徑之重組膠原蛋白片段粒子。In some embodiments, the protein polyurethane blend may be free of or substantially free of protein particles having an average diameter greater than 1 micron (µm). In some embodiments, the protein polyurethane blend may be free of or substantially free of soy protein particles having an average diameter greater than 1 micron (µm). In some embodiments, the protein polyurethane blend may be free of or substantially free of collagen particles having an average diameter greater than 1 micron (µm). In some embodiments, the protein polyurethane blend may be free of or substantially free of gelatin particles having an average diameter greater than 1 micron (µm). In some embodiments, the protein polyurethane blend may be free of or substantially free of bovine serum albumin particles having an average diameter greater than 1 micron (µm). In some embodiments, the protein polyurethane blend may be free of or substantially free of pea protein particles having an average diameter greater than 1 micron (µm). In some embodiments, the protein polyurethane blend may be free of or substantially free of egg white albumin particles having an average diameter greater than 1 micron (µm). In some embodiments, the protein polyurethane blend may be free of or substantially free of casein protein particles having an average diameter greater than 1 micron (µm). In some embodiments, the protein polyurethane blend may be free of or substantially free of peanut protein particles having an average diameter greater than 1 micron (µm). In some embodiments, the protein polyurethane blend may be free of or substantially free of linseed protein particles having an average diameter greater than 1 micron (µm). In some embodiments, the protein polyurethane blend may be free of or substantially free of whey protein particles having an average diameter greater than 1 micron (µm). In some embodiments, the protein polyurethane blend may be free of or substantially free of karanja protein particles having an average diameter greater than 1 micron (µm). In some embodiments, the protein polyurethane blend may be free of or substantially free of cellulose enzyme particles having an average diameter greater than 1 micron (µm). In some embodiments, the protein polyurethane blend may be free of or substantially free of recombinant collagen fragment particles having an average diameter greater than 1 micron (µm).
適用於本文中所揭示之混摻物之蛋白質可係未經修飾或經化學修飾。在一些實施例中,蛋白質可經修飾以促進蛋白質與聚胺甲酸酯之硬相的混溶性。在一些實施例中,蛋白質可經化學修飾以增進水中溶解度。在此類實施例中,增進水中溶解度之化學修飾可促進蛋白質與聚胺甲酸酯之硬相的混溶性。在一些實施例中,經化學修飾之蛋白質可係部分水解之蛋白質。在一些實施例中,經化學修飾之蛋白質可係藉由親水性聚合物鏈(諸如聚乙二醇(PEG)鏈)與該蛋白質之共價附接來修飾的蛋白質。The proteins suitable for use in the blends disclosed herein may be unmodified or chemically modified. In some embodiments, the protein may be modified to promote miscibility of the protein with the hard phase of the polyurethane. In some embodiments, the protein may be chemically modified to enhance solubility in water. In such embodiments, chemical modifications that enhance solubility in water may enhance miscibility of the protein with the hard phase of the polyurethane. In some embodiments, the chemically modified protein may be a partially hydrolyzed protein. In some embodiments, the chemically modified protein may be a protein modified by covalent attachment of a hydrophilic polymer chain, such as a polyethylene glycol (PEG) chain, to the protein.
適用於本文中所述之蛋白質聚胺甲酸酯混摻物之聚胺甲酸酯包括包含至少兩個相(包括「軟相」及「硬相」)的聚胺甲酸酯。軟相係由在聚胺甲酸酯內之多元醇鏈段所形成,該多元醇鏈段由於極性差異而與含胺甲酸酯之相(urethane-containing phase)分離。含胺甲酸酯之相被稱為硬相。此相分離在所屬技術領域中係眾所周知的,且係聚胺甲酸酯之許多性質的基礎。Polyurethanes suitable for use in the protein polyurethane blends described herein include polyurethanes containing at least two phases, including a "soft phase" and a "hard phase". The soft phase is formed by polyol segments within the polyurethane that separate from the urethane-containing phase due to differences in polarity. The urethane-containing phase is referred to as the hard phase. This phase separation is well known in the art and is the basis of many of the properties of polyurethanes.
軟相在室溫下一般係彈性的,且一般具有低於室溫之軟化點或玻璃轉移溫度(Tg)。Tg可以藉由動力學分析(DMA)測量並藉由tan(δ)之峰值或儲存模數之起始下降來定量。替代地,Tg可藉由微差掃描熱量法(DSC)來測量。在一些情況下,軟相中可存在結晶度,可將其視為熔點,一般在0℃至約60℃之間。The soft phase is generally elastic at room temperature and generally has a softening point or glass transition temperature (Tg) below room temperature. Tg can be measured by dynamic analysis (DMA) and quantified by the peak value of tan (δ) or the onset of the decrease in storage modulus. Alternatively, Tg can be measured by differential scanning calorimetry (DSC). In some cases, there may be a degree of crystallinity in the soft phase, which can be regarded as a melting point, generally between 0°C and about 60°C.
硬相一般而言具有高於室溫、更一般而言高於約80℃之Tg或熔點。硬相之軟化可藉由測量如藉由DMA所測量之儲存模數(有時稱為剛度)之起始下降來測量。The hard phase generally has a Tg or melting point above room temperature, more generally above about 80° C. Softening of the hard phase can be measured by measuring the onset of the drop in storage modulus (sometimes referred to as stiffness) as measured by DMA.
聚胺甲酸酯或包括聚胺甲酸酯之蛋白質聚胺甲酸酯混摻物之「軟相」包含聚胺甲酸酯之多元醇組分。其功能係在高於其Tg之溫度下變得柔軟及可撓的,以賦予聚胺甲酸酯韌性、伸長率及可撓性。典型的軟鏈段可包含聚醚多元醇、聚酯多元醇、聚碳酸酯多元醇、及其混合物。彼等一般分子量在約250道耳頓至大於約5千道耳頓之範圍內。聚胺甲酸酯或包括聚胺甲酸酯之蛋白質聚胺甲酸酯混摻物之「硬相」包含聚合物之胺甲酸酯鏈段,該胺甲酸酯鏈段由用於連接多元醇以及短鏈二醇(諸如丁二醇、丙二醇、及類似者)之(多種)異氰酸酯所賦予。可用於本發明聚胺甲酸酯之典型異氰酸酯包括但不限於六亞甲基二異氰酸酯、異佛爾酮二異氰酸酯(isophorone diisocyanate)、亞甲基二異氰酸酯、苯基二異氰酸酯、及類似者。此等分子比用於製造軟鏈段之多元醇更具極性且更硬。因此,相較於軟鏈段,硬鏈段更硬且具有更高的軟化點。硬相之功能係為聚胺甲酸酯提供強度、耐溫性及耐磨性等性質。The "soft phase" of the polyurethane or protein polyurethane blend including polyurethane comprises the polyol component of the polyurethane. Its function is to become soft and flexible at a temperature above its Tg to impart toughness, elongation and flexibility to the polyurethane. Typical soft segments may comprise polyether polyols, polyester polyols, polycarbonate polyols, and mixtures thereof. Their general molecular weights range from about 250 Daltons to greater than about 5,000 Daltons. The "hard phase" of the polyurethane or protein polyurethane blend including polyurethane comprises the urethane segments of the polymer, which are imparted by isocyanate(s) used to link polyols and short chain diols (such as butanediol, propylene glycol, and the like). Typical isocyanates that can be used in the polyurethanes of the present invention include, but are not limited to, hexamethylene diisocyanate, isophorone diisocyanate, methylene diisocyanate, phenyl diisocyanate, and the like. These molecules are more polar and harder than the polyols used to make the soft segments. Therefore, the hard segments are harder and have a higher softening point than the soft segments. The function of the hard phase is to provide polyurethane with properties such as strength, temperature resistance and wear resistance.
本文中所述之蛋白質聚胺甲酸酯混摻物及膜可藉由將一或多種蛋白質與呈液體狀態之一或多種水性聚胺甲酸酯分散液摻合並乾燥該摻合物來形成。在一些實施例中,本文中所述之蛋白質聚胺甲酸酯混摻物及膜可藉由將溶解或分散於水溶液中之一或多種蛋白質與呈液體狀態之一或多種水性聚胺甲酸酯分散液摻合並乾燥該摻合物來形成。在一些實施例中,聚胺甲酸酯分散液可係離子型,且可係陰離子型或陽離子型。在一些實施例中,聚胺甲酸酯分散液可係非離子型。在一些實施例中,摻合之蛋白質及聚胺甲酸酯可形成一膜,且在某些實施例中可使用合適的附接程序(諸如直接塗佈、層壓程序、或熱模製程序)附接至一基材(例如一紡織物)。在某些實施例中,層壓程序可包括使用黏著劑將膜附接至基材。在一些實施例中,摻合之蛋白質及聚胺甲酸酯可經塗佈或以其他方式沉積在一基材上方,以將摻合的蛋白質及聚胺甲酸酯附接至該基材。在一些實施例中,將摻合之蛋白質及聚胺甲酸酯附接至基材可導致將該摻合之蛋白質及聚胺甲酸酯整合到該基材之一部分中。The protein polyurethane blends and films described herein can be formed by blending one or more proteins with one or more aqueous polyurethane dispersions in a liquid state and drying the blend. In some embodiments, the protein polyurethane blends and films described herein can be formed by blending one or more proteins dissolved or dispersed in an aqueous solution with one or more aqueous polyurethane dispersions in a liquid state and drying the blend. In some embodiments, the polyurethane dispersion can be ionic and can be anionic or cationic. In some embodiments, the polyurethane dispersion can be non-ionic. In some embodiments, the blended protein and polyurethane can form a film and in some embodiments can be attached to a substrate (e.g., a textile) using a suitable attachment process (e.g., direct coating, lamination process, or thermal molding process). In some embodiments, the lamination process can include using an adhesive to attach the film to the substrate. In some embodiments, the blended protein and polyurethane can be coated or otherwise deposited over a substrate to attach the blended protein and polyurethane to the substrate. In some embodiments, attaching the blended protein and polyurethane to the substrate can result in integrating the blended protein and polyurethane into a portion of the substrate.
溶解於一或多種聚胺甲酸酯之硬相中之一或多種蛋白質當摻合時可形成均質混合物。在一些實施例中,蛋白質聚胺甲酸酯混摻物可包括溶解於一或多種聚胺甲酸酯中之複數種蛋白質,使得該等蛋白質及(多種)聚胺甲酸酯當摻合及乾燥時形成均質混合物。一般而言,包括蛋白質及聚胺甲酸酯之均質混合物之蛋白質聚胺甲酸酯混摻物不包括未溶解於聚胺甲酸酯中之大量蛋白質。儘管如此,但在一些實施例中,蛋白質聚胺甲酸酯混摻物可包括一部分的分散在聚胺甲酸酯內之蛋白質。One or more proteins dissolved in the hard phase of one or more polyurethanes can form a homogeneous mixture when blended. In some embodiments, the protein polyurethane blend can include a plurality of proteins dissolved in one or more polyurethanes, so that the proteins and (multiple) polyurethanes form a homogeneous mixture when blended and dried. Generally speaking, the protein polyurethane blend comprising a homogeneous mixture of protein and polyurethane does not include a large amount of protein that is not dissolved in the polyurethane. Nevertheless, in some embodiments, the protein polyurethane blend can include a portion of the protein dispersed in the polyurethane.
在一些實施例中,蛋白質聚胺甲酸酯混摻物可包含一或多種著色劑。在一些實施例中,著色劑可係染料,例如纖維反應性染料、直接染料(direct dye)、或天然染料。例示性染料包括但不限於偶氮酸性染料、金屬錯合物結構酸性染料、蒽醌結構酸性染料、偶氮/重氮直接染料、硫化染料、及甕染染料(vat dye)。在一些實施例中,著色劑可係顏料,例如色澱顏料(lake pigment)。In some embodiments, the protein polyurethane blend may include one or more coloring agents. In some embodiments, the coloring agent may be a dye, such as a fiber-reactive dye, a direct dye, or a natural dye. Exemplary dyes include, but are not limited to, azo acid dyes, metal complex acid dyes, anthraquinone acid dyes, azo/diazo direct dyes, sulfur dyes, and vat dyes. In some embodiments, the coloring agent may be a pigment, such as a lake pigment.
適用於與根據本文中所述之實施例之一或多種蛋白質摻合之聚胺甲酸酯包括但不限於脂族聚胺甲酸酯、芳族聚胺甲酸酯、基於生物之聚胺甲酸酯、或經丙烯酸修飾之聚胺甲酸酯。合適的聚胺甲酸酯可商購自包括Lubrizol、Hauthaway、Stahl、及類似者之製造商。在一些實施例中,用於蛋白質聚胺甲酸酯混摻物之聚胺甲酸酯可係生物聚胺甲酸酯。在一些實施例中,聚胺甲酸酯可係聚酯聚胺甲酸酯。在一些實施例中,聚胺甲酸酯可係聚醚聚胺甲酸酯。在一些實施例中,聚胺甲酸酯可係基於聚碳酸酯之聚胺甲酸酯。在一些實施例中,聚胺甲酸酯可係脂族聚酯聚胺甲酸酯。在一些實施例中,聚胺甲酸酯可係脂族聚醚聚胺甲酸酯。在一些實施例中,聚胺甲酸酯可係脂族聚碳酸酯聚胺甲酸酯。在一些實施例中,聚胺甲酸酯可係芳族聚酯聚胺甲酸酯。在一些實施例中,聚胺甲酸酯可係芳族聚醚聚胺甲酸酯。在一些實施例中,聚胺甲酸酯可係芳族聚碳酸酯聚胺甲酸酯。在一些實施例中,聚胺甲酸酯可係脂族陰離子型聚酯聚胺甲酸酯。Polyurethanes suitable for blending with one or more proteins according to the embodiments described herein include, but are not limited to, aliphatic polyurethanes, aromatic polyurethanes, bio-based polyurethanes, or polyurethanes modified with acrylic acid. Suitable polyurethanes are commercially available from manufacturers including Lubrizol, Hauthaway, Stahl, and the like. In some embodiments, the polyurethanes used for protein polyurethane blends may be bio-polyurethanes. In some embodiments, the polyurethanes may be polyester polyurethanes. In some embodiments, the polyurethanes may be polyether polyurethanes. In some embodiments, the polyurethanes may be polycarbonate-based polyurethanes. In some embodiments, the polyurethanes may be aliphatic polyester polyurethanes. In some embodiments, the polyurethanes may be aliphatic polyether polyurethanes. In some embodiments, the polyurethane may be an aliphatic polycarbonate polyurethane. In some embodiments, the polyurethane may be an aromatic polyester polyurethane. In some embodiments, the polyurethane may be an aromatic polyether polyurethane. In some embodiments, the polyurethane may be an aromatic polycarbonate polyurethane. In some embodiments, the polyurethane may be an aliphatic anionic polyester polyurethane.
在一些實施例中,聚胺甲酸酯可具有選自由下列所組成之群組的軟鏈段:聚醚多元醇、聚酯多元醇、聚碳酸酯多元醇、及其混合物。在一些實施例中,聚胺甲酸酯可具有包含二異氰酸酯及視需要地短鏈二醇之硬鏈段。合適的二異氰酸酯可選自由下列所組成之群組:脂族二異氰酸酯,諸如六亞甲基二異氰酸酯、異佛爾酮二異氰酸酯;芳族二異氰酸酯,諸如4,4’二苯基亞甲基二異氰酸酯、甲苯二異氰酸酯、苯基二異氰酸酯、及其混合物。合適的短鏈二醇包括乙二醇、丙二醇、丁二醇、2,2甲基1,3丙二醇、戊二醇、己二醇、及其混合物。在一些實施例中,交聯劑諸如多官能醇,例如三羥甲基丙烷三醇(trimethylol propane triol),或二胺諸如乙二胺或4,4’二胺基,二苯二胺。In some embodiments, the polyurethane may have a soft segment selected from the group consisting of: polyether polyols, polyester polyols, polycarbonate polyols, and mixtures thereof. In some embodiments, the polyurethane may have a hard segment comprising a diisocyanate and, optionally, a short-chain diol. Suitable diisocyanates may be selected from the group consisting of: aliphatic diisocyanates, such as hexamethylene diisocyanate, isophorone diisocyanate; aromatic diisocyanates, such as 4,4' diphenylmethylene diisocyanate, toluene diisocyanate, phenyl diisocyanate, and mixtures thereof. Suitable short-chain diols include ethylene glycol, propylene glycol, butanediol, 2,2-methyl-1,3-propanediol, pentanediol, hexanediol, and mixtures thereof. In some embodiments, the crosslinking agent is a polyfunctional alcohol, such as trimethylol propane triol, or a diamine, such as ethylenediamine or 4,4'-diaminodiphenyldiamine.
例示性聚胺甲酸酯包括但不限於(i)具有約35%之固體含量及約1.02 g/mL之比重及160 mPa.s之布氏黏度之基於水性脂族聚醚之聚胺甲酸酯分散液、(ii)具有30%之固體含量、1.1 g/mL之比重、及<1000 mPa.s之黏度之非離子型脂族聚碳酸酯-聚醚聚胺甲酸酯分散液、(iii)具有約32%之固體含量、1.03 g/mL之比重、及約200 mPa.s之布氏黏度之水性脂族非離子型聚胺甲酸酯分散液、(iv)具有約50%之固體含量、1.1 g/mL之比重、小於或等於1200 mPa.s之布氏黏度、如根據ASTM D6866所測量之約50%之生物含量、30 MPa之拉伸強度、及1000%之斷裂伸長率之水性脂族陰離子型聚酯聚胺甲酸酯分散液、(v)具有約50%之固體含量、1.1 g/mL之比重、小於或等於1200 mPa.s之布氏黏度、如根據ASTM D6866所測量之約56%之生物含量、12 Mpa之拉伸強度、及800%之斷裂伸長率之水性脂族陰離子型聚酯聚胺甲酸酯分散液。Exemplary polyurethanes include, but are not limited to, (i) an aqueous aliphatic polyether-based polyurethane dispersion having a solids content of about 35% and a specific gravity of about 1.02 g/mL and a Brookfield viscosity of 160 mPa.s, (ii) a nonionic aliphatic polycarbonate-polyether polyurethane dispersion having a solids content of 30%, a specific gravity of 1.1 g/mL, and a viscosity of <1000 mPa.s, (iii) an aqueous aliphatic nonionic polyurethane dispersion having a solids content of about 32%, a specific gravity of 1.03 g/mL, and a Brookfield viscosity of about 200 mPa.s, (iv) an aqueous aliphatic nonionic polyurethane dispersion having a solids content of about 50%, a specific gravity of 1.1 g/mL, a Brookfield viscosity of less than or equal to 1200 mPa.s, a biocontent of about 50% as measured according to ASTM D6866, a specific gravity of 30 MPa, and an elongation at break of 1000%, (v) an aqueous aliphatic anionic polyester polyurethane dispersion having a solids content of about 50%, a specific gravity of 1.1 g/mL, a Brookfield viscosity less than or equal to 1200 mPa.s, a biocontent of about 56% as measured in accordance with ASTM D6866, a tensile strength of 12 MPa, and an elongation at break of 800%.
在一些實施例中,膜之聚胺甲酸酯可具有如根據ASTM D6866所測量之大於或等於約15%之生物含量。在一些實施例中,如根據ASTM D6866所測量,膜之聚胺甲酸酯可具有下列範圍內的生物含量:約15%至約80%、約20%至約80%、約30%至約80%、約40%至約80%、約50%至約80%、或約60%至約80%。In some embodiments, the polyurethane of the membrane can have a biocontent of greater than or equal to about 15% as measured according to ASTM D6866. In some embodiments, the polyurethane of the membrane can have a biocontent in the following ranges: about 15% to about 80%, about 20% to about 80%, about 30% to about 80%, about 40% to about 80%, about 50% to about 80%, or about 60% to about 80%, as measured according to ASTM D6866.
適用於與根據本文中所述之實施例之一或多種聚胺甲酸酯摻合之蛋白質包括但不限於膠原蛋白、明膠、牛血清白蛋白(BSA)、大豆蛋白質、豌豆蛋白質、卵白白蛋白、酪蛋白、花生蛋白質、麻仁蛋白蛋白質、乳清蛋白質、卡蘭賈蛋白質、大麥蛋白質、及纖維素酶。合適的膠原蛋白包括但不限於重組膠原蛋白(r-膠原蛋白)、重組膠原蛋白片段、及萃取之膠原蛋白。合適的大豆蛋白質包括但不限於大豆分離蛋白質(SPI)、豆粕蛋白質、及大豆蛋白質衍生物。在一些實施例中,大豆蛋白質可係部分水解之大豆分離蛋白質。合適的豌豆蛋白質包括但不限於豌豆分離蛋白質、及豌豆蛋白質衍生物。在一些實施例中,豌豆蛋白質可係部分水解之豌豆分離蛋白質。Proteins suitable for blending with one or more polyurethanes according to the embodiments described herein include, but are not limited to, collagen, gelatin, bovine serum albumin (BSA), soy protein, pea protein, egg white albumin, casein, peanut protein, hemp protein, whey protein, karanja protein, barley protein, and fibronectin. Suitable collagen includes, but is not limited to, recombinant collagen (r-collagen), recombinant collagen fragments, and extracted collagen. Suitable soy protein includes, but is not limited to, soy protein isolate (SPI), soybean meal protein, and soy protein derivatives. In some embodiments, soy protein can be partially hydrolyzed soy protein isolate. Suitable pea protein includes, but is not limited to, pea protein isolate, and pea protein derivatives. In some embodiments, the pea protein can be partially hydrolyzed pea protein isolate.
下表1列出一些例示性蛋白質及蛋白質之性質。明膠係來自豬皮之明膠,A型(Sigma Aldrich G2500)。膠原蛋白係購自Wuxi BIOT Biology-technology Company之萃取之牛膠原蛋白。牛血清白蛋白為Sigma Aldrich 5470牛血清白蛋白。r-膠原蛋白係來自Modern Meadow之重組膠原蛋白。大豆分離蛋白質係購自MP Medicals之大豆分離蛋白質(IC90545625)。豌豆蛋白質係購自Bobs Red Mills之豌豆蛋白粉(MTX5232)。卵白白蛋白蛋白質係來自雞蛋白之白蛋白(Sigma Aldrich A5253)。酪蛋白蛋白質係來自牛乳之酪蛋白(Sigma Aldrich C7078)。花生蛋白質係購自Tru-Nut之花生蛋白粉。乳清蛋白質係來自牛乳之乳清(Sigma Aldrich W1500)。其他合適的大豆分離蛋白質包括但不限於購自AMD (Clarisoy 100, 110, 150, 170, 180)、或DuPont(SUPRO ®XT 55、SUPRO ®XT 221D、及SOBIND ®Balance)之大豆分離蛋白質。其他合適的豌豆蛋白粉包括但不限於購自Puris之豌豆蛋白粉(870及870H)。 Table 1 below lists some exemplary proteins and the properties of the proteins. Gelatin is gelatin from pig skin, type A (Sigma Aldrich G2500). Collagen is extracted bovine collagen purchased from Wuxi BIOT Biology-technology Company. Bovine serum albumin is Sigma Aldrich 5470 bovine serum albumin. r-Collagen is recombinant collagen from Modern Meadow. Soy protein isolate is soy protein isolate purchased from MP Medicals (IC90545625). Pea protein is pea protein powder purchased from Bobs Red Mills (MTX5232). Ovalbumin protein is albumin from chicken protein (Sigma Aldrich A5253). Casein protein is casein from milk (Sigma Aldrich C7078). Peanut protein is peanut protein powder purchased from Tru-Nut. Whey protein is whey from cow's milk (Sigma Aldrich W1500). Other suitable soy protein isolates include, but are not limited to, soy protein isolates purchased from AMD (Clarisoy 100, 110, 150, 170, 180), or DuPont (SUPRO ® XT 55, SUPRO ® XT 221D, and SOBIND ® Balance). Other suitable pea protein powders include, but are not limited to, pea protein powders purchased from Puris (870 and 870H).
卡蘭賈蛋白質係從水黃皮番龍眼( Pongamia pinnata)樹(亦稱為無毛水黃皮( Pongamia glabra)樹)收穫之卡蘭賈種子中發現的蛋白質。可使用溶劑萃取程序自卡蘭賈種子中萃取該蛋白質。在一些實施例中,卡蘭賈蛋白質可係卡蘭賈分離蛋白質。在此類實施例中,卡蘭賈分離蛋白質可藉由脫脂之卡蘭賈種子餅之鹼性萃取及酸性沉澱來獲得。 Kalanja protein is a protein found in kalanja seeds harvested from the Pongamia pinnata tree (also known as the Pongamia glabra tree). The protein can be extracted from kalanja seeds using a solvent extraction procedure. In some embodiments, the kalanja protein can be an isolated kalanja protein. In such embodiments, the isolated kalanja protein can be obtained by alkaline extraction and acid precipitation of defatted kalanja seed cakes.
合適的纖維素酶蛋白質列於下表1中。「纖維素酶-RG」蛋白質係可購自Creative Enzymes ®之天然木黴菌屬纖維素酶。「纖維素酶-IG」蛋白質係可購自Carolina Biological Supply Company之實驗室級纖維素酶。 Suitable cellulase proteins are listed in Table 1 below. "Cellulase-RG" protein is a natural Trichoderma cellulase available from Creative Enzymes ® . "Cellulase-IG" protein is a laboratory grade cellulase available from Carolina Biological Supply Company.
表1中之50 Kda重組膠原蛋白片段(50 KDa r-膠原蛋白片段)係具有如SEQ ID NO: 1所示之胺基酸序列之膠原蛋白片段。The 50 KDa recombinant collagen fragment (50 KDa r-collagen fragment) in Table 1 is a collagen fragment having the amino acid sequence shown in SEQ ID NO: 1.
表1中列出之「溶解方法」係例示性水性溶劑,其中蛋白質可溶解於與如本文中所述之聚胺甲酸酯之硬相混溶的溶液中。可至少部分溶解於水溶液中之蛋白質適用於與聚胺甲酸酯分散液形成蛋白質聚胺甲酸酯混摻物。
表1 :例示蛋白質
在一些實施例中,蛋白質可具有下列性質中之一或多者:(i)在本文中所述之範圍內的分子量,(ii)在下述範圍內之等電點,(iii)在下述範圍內之以每100克蛋白質中離胺酸之克數計測量之胺基酸組成,及(iv)達200℃之蛋白質熱穩定性。 蛋白質分子量In some embodiments, the protein can have one or more of the following properties: (i) a molecular weight within the ranges described herein, (ii) an isoelectric point within the ranges described below, (iii) an amino acid composition measured as grams of lysine per 100 grams of protein within the ranges described below, and (iv) thermal stability of the protein up to 200°C. Protein Molecular Weight
在一些實施例中,蛋白質可具有約1 KDa(千道耳頓)至約700 KDa之範圍內(包括子範圍)的分子量。例如,蛋白質可具有下列範圍內的分子量:約1 KDa至約700 KDa、約10 KDa至約700 KDa、約20 KDa至約700 KDa、約50 KDa至約700 KDa、約100 KDa至約700 KDa、約200 KDa至約700 KDa、約300 KDa至約700 KDa、約400 KDa至約700 KDa、約500 KDa至約700 KDa、約600 KDa至約700 KDa、約1 KDa至約600 KDa、約1 KDa至約500 KDa、約1 KDa至約400 KDa、約1 KDa至約300 KDa、約1 KDA至約200 KDa、約1 KDa至約100 KDa、約1 KDa至約50 KDa、約1 KDa至約20 KDa、或約1 KDa至約10 KDa。 蛋白質等電點In some embodiments, the protein can have a molecular weight in the range of about 1 KDa (kilodaltons) to about 700 KDa, inclusive. For example, the protein can have a molecular weight in the range of about 1 KDa to about 700 KDa, about 10 KDa to about 700 KDa, about 20 KDa to about 700 KDa, about 50 KDa to about 700 KDa, about 100 KDa to about 700 KDa, about 200 KDa to about 700 KDa, about 300 KDa to about 700 KDa, about 400 KDa to about 700 KDa, about 500 KDa to about 700 KDa, about 600 KDa to about 700 KDa, about 1 KDa to about 600 KDa, about 1 KDa to about 500 KDa, about 1 KDa to about 400 KDa, about 1 KDa to about 300 KDa, about 1 KDa to about 200 KDa, about 1 KDa to about 100 KDa, about 1 KDa to about 50 KDa, about 1 KDa to about 20 KDa, or about 1 KDa to about 100 KDa. KDa to about 10 KDa. Protein isoelectric point
在一些實施例中,蛋白質可具有約4至約10之範圍內(包括子範圍)的等電點。例如,蛋白質可具有下列之範圍內的等電點:約4至約10、約4.5至約9.5、約5至約9、約5.5至約8.5、約6至約8、約6.5至約7.5、約6.5至約7。在一些實施例中,蛋白質可具有約4至約5之範圍內的等電點。 蛋白質胺基酸組成In some embodiments, the protein can have an isoelectric point in the range of about 4 to about 10 (including subranges). For example, the protein can have an isoelectric point in the range of about 4 to about 10, about 4.5 to about 9.5, about 5 to about 9, about 5.5 to about 8.5, about 6 to about 8, about 6.5 to about 7.5, about 6.5 to about 7. In some embodiments, the protein can have an isoelectric point in the range of about 4 to about 5. Protein Amino Acid Composition
在一些實施例中,蛋白質可具有以每100克蛋白質中離胺酸之克數計測量之約0.5 wt%至約100 wt%之範圍內(包括子範圍)的胺基酸組成(稱為「離胺酸重量百分比」)。例如,蛋白質可具有下列範圍內的離胺酸重量百分比:約0.5 wt%至約100 wt%、約1 wt%至約100 wt%、約5 wt%至約100 wt%、約10 wt%至約100 wt%、約20 wt%至約100 wt%、約30 wt%至約100 wt%、約40 wt%至約100 wt%、約50 wt%至約100 wt%、約60 wt%至約100 wt%、約70 wt%至約100 wt%、約80 wt%至約100 wt%、或約90 wt%至約100 wt%。在一些實施例中,蛋白質可係聚離胺酸。In some embodiments, the protein can have an amino acid composition in the range of about 0.5 wt % to about 100 wt %, inclusive, measured as grams of lysine per 100 grams of protein (referred to as the "lysine weight percent"). For example, the protein can have a lysine weight percentage in the following ranges: about 0.5 wt % to about 100 wt %, about 1 wt % to about 100 wt %, about 5 wt % to about 100 wt %, about 10 wt % to about 100 wt %, about 20 wt % to about 100 wt %, about 30 wt % to about 100 wt %, about 40 wt % to about 100 wt %, about 50 wt % to about 100 wt %, about 60 wt % to about 100 wt %, about 70 wt % to about 100 wt %, about 80 wt % to about 100 wt %, or about 90 wt % to about 100 wt %. In some embodiments, the protein can be polylysine.
在一些實施例中,蛋白質可具有約0.5 wt%至約20 wt%之範圍內(包括子範圍)的離胺酸重量百分比。例如,蛋白質可具有下列範圍內的離胺酸重量百分比:約0.5 wt%至約20 wt%、約1 wt%至約19 wt%、約2 wt%至約18 wt%、約3 wt%至約17 wt%、約4 wt%至約16 wt%、約5 wt%至約15 wt%、約6 wt%至約14 wt%、約7 wt%至約13 wt%、約8 wt%至約12 wt%、約9 wt%至約11 wt%、或約9 wt%至約10 wt%。在一些實施例中,蛋白質可具有約1 wt%至約20 wt%之範圍內的離胺酸重量百分比。在一些實施例中,蛋白質可具有約5 wt%至約20 wt%之範圍內的離胺酸重量百分比。在一些實施例中,蛋白質可具有約1 wt%至約12 wt%之範圍內的離胺酸重量百分比。在一些實施例中,蛋白質可具有約5 wt%至約12 wt%之範圍內的離胺酸重量百分比。在一些實施例中,蛋白質可具有約1 wt%至約15 wt%之範圍內的離胺酸重量百分比。在一些實施例中,蛋白質可具有約5 wt%至約15 wt%之範圍內的離胺酸重量百分比。In some embodiments, the protein can have a lysine weight percentage in the range of about 0.5 wt % to about 20 wt %, including sub-ranges. For example, the protein can have a lysine weight percentage in the following ranges: about 0.5 wt % to about 20 wt %, about 1 wt % to about 19 wt %, about 2 wt % to about 18 wt %, about 3 wt % to about 17 wt %, about 4 wt % to about 16 wt %, about 5 wt % to about 15 wt %, about 6 wt % to about 14 wt %, about 7 wt % to about 13 wt %, about 8 wt % to about 12 wt %, about 9 wt % to about 11 wt %, or about 9 wt % to about 10 wt %. In some embodiments, the protein can have a lysine weight percentage in the range of about 1 wt % to about 20 wt %. In some embodiments, the protein may have a weight percent of lysine in the range of about 5 wt % to about 20 wt %. In some embodiments, the protein may have a weight percent of lysine in the range of about 1 wt % to about 12 wt %. In some embodiments, the protein may have a weight percent of lysine in the range of about 5 wt % to about 12 wt %. In some embodiments, the protein may have a weight percent of lysine in the range of about 1 wt % to about 15 wt %. In some embodiments, the protein may have a weight percent of lysine in the range of about 5 wt % to about 15 wt %.
在一些實施例中,蛋白質可為熱穩定的。在一些實施例中,蛋白質可為非熱穩定的。如本文中所述,蛋白質熱穩定性係藉由微差掃描熱量法(DSC)測定,其中將預乾燥之蛋白粉(其中水分小於3%)自0℃掃描至200℃。在該蛋白質的DSC曲線中,大於10 mW/mg之吸熱峰經判定為「變性峰」,且對應於吸熱「變性峰」之溫度經定義為蛋白質之「變性溫度」。「熱穩定」的蛋白質意指該蛋白質具有200℃或更高之變性溫度。出於本揭露之目的,具有低於200℃之變性溫度的蛋白質被視為係「非熱穩定的」。例如,據發現,表1中所列之來自牛乳之乳清根據DSC在158℃下具有變性溫度,因此乳清被視為非熱穩定的。 蛋白質溶解In some embodiments, the protein may be thermostable. In some embodiments, the protein may be non-thermally stable. As described herein, protein thermostability is determined by differential scanning calorimetry (DSC), wherein a pre-dried protein powder (wherein the moisture is less than 3%) is scanned from 0°C to 200°C. In the DSC curve of the protein, an endothermic peak greater than 10 mW/mg is determined to be a "denaturation peak", and the temperature corresponding to the endothermic "denaturation peak" is defined as the "denaturation temperature" of the protein. A "thermally stable" protein means that the protein has a denaturation temperature of 200°C or higher. For the purposes of this disclosure, a protein with a denaturation temperature below 200°C is considered to be "non-thermally stable". For example, the whey from bovine milk listed in Table 1 was found to have a denaturation temperature of 158°C by DSC and therefore the whey is considered to be non-thermostable. Protein Solubilization
在一些實施例中,在與一或多種聚胺甲酸酯摻合之前,可將一或多種蛋白質溶解於水溶液中以形成水性蛋白質混合物。在一些實施例中,在將蛋白質與一或多種聚胺甲酸酯摻合之前將蛋白質溶解於水溶液中可促進蛋白質與一或多種聚胺甲酸酯之硬相的混溶性。例如,在將蛋白質與一或多種聚胺甲酸酯摻合之前將蛋白質溶解於水溶液中可促進蛋白質與(多種)聚胺甲酸酯之硬相的混溶性。並非所有蛋白質均能與聚胺甲酸酯之任何相自然地混溶。In some embodiments, one or more proteins may be dissolved in an aqueous solution to form an aqueous protein mixture prior to blending with one or more polyurethanes. In some embodiments, dissolving the protein in an aqueous solution prior to blending the protein with the one or more polyurethanes may promote miscibility of the protein with the hard phase of the one or more polyurethanes. For example, dissolving the protein in an aqueous solution prior to blending the protein with the one or more polyurethanes may promote miscibility of the protein with the hard phase of the polyurethane(s). Not all proteins are naturally miscible with any phase of the polyurethanes.
合適的水溶液包括但不限於水、鹼水溶液、酸水溶液、包括有機溶劑之水溶液、尿素溶液、及其混合物。在一些實施例中,鹼水溶液可係鹼性溶液,諸如氫氧化鈉、氨、或氫氧化銨溶液。在一些實施例中,酸性水溶液之實例可係乙酸或鹽酸(HCl)溶液。合適的有機溶劑包括但不限於乙醇、異丙醇、丙酮、乙酸乙酯、乙酸異丙酯、甘油、及類似者。在一些實施例中,水性蛋白質混合物中之蛋白質濃度可在約10 g/L至約300 g/L之範圍內,包括子範圍。例如,水性蛋白質混合物中之蛋白質濃度可係約10 g/L、約20 g/L、約30 g/L、約40 g/L、約50 g/L、約60 g/L、約70 g/L、約80 g/L、約90 g/L、約100 g/L、約150 g/L、約200 g/L、約250 g/L、或約300 g/L、或在具有此等值中任二者作為端點(包括端點)之範圍內。在一些實施例中,水性蛋白質混合物中之蛋白質濃度可在下列的範圍內:約10 g/L至約300 g/L、約20 g/L至約250 g/L、約30 g/L至約200 g/L、約40 g/L至約150 g/L,約50 g/L至約100 g/L,約60 g/L至約90 g/L,或約70 g/L至約80 g/L。Suitable aqueous solutions include, but are not limited to, water, alkaline aqueous solutions, acidic aqueous solutions, aqueous solutions including organic solvents, urea solutions, and mixtures thereof. In some embodiments, the alkaline aqueous solution may be an alkaline solution, such as sodium hydroxide, ammonia, or ammonium hydroxide solution. In some embodiments, examples of acidic aqueous solutions may be acetic acid or hydrochloric acid (HCl) solutions. Suitable organic solvents include, but are not limited to, ethanol, isopropanol, acetone, ethyl acetate, isopropyl acetate, glycerol, and the like. In some embodiments, the protein concentration in the aqueous protein mixture may be in the range of about 10 g/L to about 300 g/L, including subranges. For example, the protein concentration in the aqueous protein mixture can be about 10 g/L, about 20 g/L, about 30 g/L, about 40 g/L, about 50 g/L, about 60 g/L, about 70 g/L, about 80 g/L, about 90 g/L, about 100 g/L, about 150 g/L, about 200 g/L, about 250 g/L, or about 300 g/L, or in a range having any two of these values as endpoints (inclusive). In some embodiments, the protein concentration in the aqueous protein mixture can be in the range of about 10 g/L to about 300 g/L, about 20 g/L to about 250 g/L, about 30 g/L to about 200 g/L, about 40 g/L to about 150 g/L, about 50 g/L to about 100 g/L, about 60 g/L to about 90 g/L, or about 70 g/L to about 80 g/L.
在一些實施例中,蛋白質可經預處理及/或純化以改善水中溶解度。合適的預處理包括但不限於酸性處理、鹼性處理、酶水解、及鹽處理。例示性酸處理係用合適的酸(諸如乙酸或HCl)進行酸水解。例示性鹼處理係用合適的鹼(諸如氫氧化銨、NaOH、KOH、或其混合物)進行鹼性水解。用於水解之例示性酶包括但不限於木瓜酶、鳳梨酶、胰蛋白酶、鹼性蛋白酶、及類似者。合適的純化處理包括但不限於用鈣鹽移除植酸鹽(phytate)、透析過濾、超過濾、離心、及類似者。In some embodiments, the protein may be pretreated and/or purified to improve solubility in water. Suitable pretreatments include, but are not limited to, acid treatment, alkaline treatment, enzymatic hydrolysis, and salt treatment. Exemplary acid treatments are acid hydrolysis with a suitable acid (such as acetic acid or HCl). Exemplary alkaline treatments are alkaline hydrolysis with a suitable base (such as ammonium hydroxide, NaOH, KOH, or a mixture thereof). Exemplary enzymes for hydrolysis include, but are not limited to, papain, pineapple enzyme, trypsin, alkaline proteases, and the like. Suitable purification treatments include, but are not limited to, removal of phytate with calcium salts, diafiltration, superfiltration, centrifugation, and the like.
在一些實施例中,在與一或多種聚胺甲酸酯摻合之前向蛋白質中添加離胺酸或其他親水性胺基酸可促進該蛋白質與一或多種聚胺甲酸酯之硬相的混溶性。In some embodiments, the addition of lysine or other hydrophilic amino acids to the protein prior to blending with one or more polyurethanes can promote the miscibility of the protein with the hard phase of the one or more polyurethanes.
在一些實施例中,蛋白質可係部分水解的。蛋白質之部分水解可增進蛋白質在水中之溶解且/或促進蛋白質與聚胺甲酸酯之硬相的混溶性。蛋白質之部分水解可使用酶或強至中度的鹼來完成。In some embodiments, the protein may be partially hydrolyzed. Partial hydrolysis of the protein may enhance the solubility of the protein in water and/or promote the miscibility of the protein with the hard phase of the polyurethane. Partial hydrolysis of the protein may be accomplished using enzymes or strong to moderate bases.
在一些實施例中,蛋白質可藉由PEG聚乙二醇(PEG)與蛋白質之共價附接來化學修飾。蛋白質之PEG修飾可增進蛋白質在水中之溶解且/或促進蛋白質與聚胺甲酸酯之硬相的混溶性。蛋白質之PEG修飾可使用將親水性聚乙二醇(PEG)鏈共價附接至蛋白質之方法來完成。In some embodiments, the protein can be chemically modified by covalent attachment of PEG to the protein. PEG modification of the protein can enhance the solubility of the protein in water and/or promote the miscibility of the protein with the rigid phase of polyurethane. PEG modification of the protein can be accomplished using a method of covalently attaching a hydrophilic polyethylene glycol (PEG) chain to the protein.
根據本文中所述之一些實施例之膜及膜前驅物配方可包含(a)蛋白質聚胺甲酸酯混摻物,其包含溶解於由水性聚胺甲酸酯分散液製備之聚胺甲酸酯中之蛋白質、及(b)一或多種交聯劑。Membranes and membrane precursor formulations according to some embodiments described herein may include (a) a protein polyurethane blend comprising a protein dissolved in a polyurethane prepared from an aqueous polyurethane dispersion, and (b) one or more crosslinking agents.
適於併入膜及前驅物配方中之交聯劑包括但不限於環氧交聯劑、氮丙啶交聯劑、碳二亞胺交聯劑、異氰酸酯交聯劑、三聚氰胺交聯劑、及其組合。Crosslinkers suitable for incorporation into the film and precursor formulations include, but are not limited to, epoxy crosslinkers, aziridine crosslinkers, carbodiimide crosslinkers, isocyanate crosslinkers, melamine crosslinkers, and combinations thereof.
適於併入膜及前驅物配方中之環氧交聯劑包括但不限於二縮水甘油醚、或聚縮水甘油醚、及其組合。例示性二縮水甘油醚包括但不限於甘油二縮水甘油醚、聚甘油二縮水甘油醚、三羥甲基丙烷二縮水甘油醚、聚氧丙二醇二縮水甘油醚、間苯二酚二縮水甘油醚、異山梨醇二縮水甘油醚、聚(丙二醇)二縮水甘油醚、及乙二醇二縮水甘油醚。例示性的聚縮水甘油醚包括但不限於二甘油聚縮水甘油醚、聚甘油聚縮水甘油醚、甘油三縮水甘油醚、山梨醇聚縮水甘油醚、烷氧基化甘油聚縮水甘油醚、三羥甲基丙烷三縮水甘油醚、及新戊四醇四縮水甘油醚。Epoxy crosslinking agents suitable for incorporation into the film and propellant formulations include, but are not limited to, diglycidyl ethers, or polyglycidyl ethers, and combinations thereof. Exemplary diglycidyl ethers include, but are not limited to, glycerol diglycidyl ether, polyglycerol diglycidyl ether, trihydroxymethylpropane diglycidyl ether, polyoxypropylene glycol diglycidyl ether, resorcinol diglycidyl ether, isosorbide diglycidyl ether, poly(propylene glycol) diglycidyl ether, and ethylene glycol diglycidyl ether. Exemplary polyglycidyl ethers include, but are not limited to, diglycerol polyglycidyl ether, polyglycerol polyglycidyl ether, glycerol triglycidyl ether, sorbitol polyglycidyl ether, alkoxylated glycerol polyglycidyl ether, trihydroxymethylpropane triglycidyl ether, and pentaerythritol tetraglycidyl ether.
適於併入膜及前驅物配方中之氮丙啶交聯劑包括但不限於氮丙啶官能化支鏈聚酯交聯劑(aziridine functionalized branched polyester cross-linker)及多官能氮丙啶、及其組合。可購自An Fong Development Co., Ltd之WH-PZ5150係例示性氮丙啶官能化支鏈聚酯交聯劑。PZ-28多官能氮丙啶(基於丙烯亞胺之三官能聚氮丙啶)及PZ-33多官能氮丙啶(基於乙烯亞胺之三官能聚氮丙啶)(均可購自PolyAziridine LLC)係例示性多官能氮丙啶。Aziridine crosslinkers suitable for incorporation into the membrane and precursor formulations include, but are not limited to, aziridine functionalized branched polyester crosslinkers and polyfunctional aziridines, and combinations thereof. WH-PZ5150 available from An Fong Development Co., Ltd is an exemplary aziridine functionalized branched polyester crosslinker. PZ-28 polyfunctional aziridine (trifunctional polyaziridine based on propylene imine) and PZ-33 polyfunctional aziridine (trifunctional polyaziridine based on ethylene imine) (both available from PolyAziridine LLC) are exemplary polyfunctional aziridines.
適於併入膜及前驅物配方中之碳二亞胺交聯劑包括但不限於1-乙基-3-(3-二甲基胺基丙基)碳二亞胺(可購自Sigma-Aldrich)、及Permutex ®XR-5577(可購自Stahl)。 Carbodiimide crosslinking agents suitable for incorporation into the membrane and precursor formulations include, but are not limited to, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (available from Sigma-Aldrich), and Permutex® XR-5577 (available from Stahl).
適於併入膜及前驅物配方中之異氰酸酯交聯劑包括但不限於Permutex ®XR-5588(可購自Stahl)、XR-13-820(可購自Stahl)、AM-1506XL(可購自Quaker Color,McAdoo & Allen, Inc.之一部門)、Imprafix ®AH(基於水之無共溶劑封閉型脂族異氰酸酯,可購自Covestro LLC)、及Imprafix ®2794/1(基於水之脂族封閉型聚異氰酸酯,可購自Covestro LLC)。 Isocyanate crosslinkers suitable for incorporation into film and precursor formulations include, but are not limited to, Permutex® XR-5588 (available from Stahl), XR-13-820 (available from Stahl), AM-1506XL (available from Quaker Color, a division of McAdoo & Allen, Inc.), Imprafix® AH (a water-based, co-solvent-free, blocked aliphatic isocyanate available from Covestro LLC), and Imprafix® 2794/1 (a water-based, aliphatic blocked polyisocyanate available from Covestro LLC).
Permutex ®XR-9181(三聚氰胺交聯劑,可購自Stahl)係適於併入膜及前驅物配方中之例示性三聚氰胺交聯劑。 Permutex ® XR-9181 (melamine crosslinker, available from Stahl) is an exemplary melamine crosslinker suitable for incorporation into film and precursor formulations.
在一些實施例中,一或多種交聯劑可包含環氧交聯劑。在一些實施例中,一或多種交聯劑可包含氮丙啶交聯劑。在一些實施例中,一或多種交聯劑可包含異氰酸酯交聯劑。在一些實施例中,一或多種交聯劑可包含碳二亞胺交聯劑。在一些實施例中,一或多種交聯劑可包含三聚氰胺交聯劑。在一些實施例中,一或多種交聯劑可包含二或更多種交聯劑。In some embodiments, one or more crosslinking agents may include epoxy crosslinking agents. In some embodiments, one or more crosslinking agents may include aziridine crosslinking agents. In some embodiments, one or more crosslinking agents may include isocyanate crosslinking agents. In some embodiments, one or more crosslinking agents may include carbodiimide crosslinking agents. In some embodiments, one or more crosslinking agents may include melamine crosslinking agents. In some embodiments, one or more crosslinking agents may include two or more crosslinking agents.
在一些實施例中,一或多種交聯劑可包含至少三種交聯劑,其中各交聯劑係選自由下列所組成之群組的不同交聯劑:環氧交聯劑、氮丙啶交聯劑、碳二亞胺交聯劑、異氰酸酯交聯劑、及三聚氰胺交聯劑。In some embodiments, the one or more crosslinking agents may include at least three crosslinking agents, wherein each crosslinking agent is a different crosslinking agent selected from the group consisting of an epoxy crosslinking agent, an aziridine crosslinking agent, a carbodiimide crosslinking agent, an isocyanate crosslinking agent, and a melamine crosslinking agent.
在一些實施例中,一或多種交聯劑包含(a)第一交聯劑,其選自由下列所組成之群組:環氧交聯劑、氮丙啶交聯劑、異氰酸酯交聯劑、碳二亞胺交聯劑、及三聚氰胺交聯劑,及(b)第二交聯劑,其不同於第一交聯劑且係其選自由下列所組成之群組:環氧交聯劑、氮丙啶交聯劑、異氰酸酯交聯劑、碳二亞胺交聯劑、三聚氰胺交聯劑。在一些實施例中,一或多種交聯劑可包含至少三種交聯劑,其中各交聯劑係選自由下列所組成之群組的不同交聯劑:環氧交聯劑、氮丙啶交聯劑、異氰酸酯交聯劑、碳二亞胺交聯劑、及三聚氰胺交聯劑。In some embodiments, the one or more crosslinking agents include (a) a first crosslinking agent selected from the group consisting of epoxy crosslinking agents, aziridine crosslinking agents, isocyanate crosslinking agents, carbodiimide crosslinking agents, and melamine crosslinking agents, and (b) a second crosslinking agent that is different from the first crosslinking agent and is selected from the group consisting of epoxy crosslinking agents, aziridine crosslinking agents, isocyanate crosslinking agents, carbodiimide crosslinking agents, and melamine crosslinking agents. In some embodiments, the one or more crosslinking agents may include at least three crosslinking agents, wherein each crosslinking agent is a different crosslinking agent selected from the group consisting of an epoxy crosslinking agent, an aziridine crosslinking agent, an isocyanate crosslinking agent, a carbodiimide crosslinking agent, and a melamine crosslinking agent.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有約5微米至約200微米之範圍內(包括子範圍)的厚度(例如圖1A及圖1B中所示之厚度126)。例如,膜之蛋白質聚胺甲酸酯混摻物可具有下列範圍內的厚度:約5微米至約200微米、約10微米至約200微米、約15微米至約200微米、約20微米至約200微米、約25微米至約200微米、約30微米至約200微米、約35微米至約200微米、約40微米至約200微米、約45微米至約200微米、約50微米至約200微米、約75微米至約200微米、約100微米至約200微米、約125微米至約200微米、約150微米至約200微米、約5微米至約175微米、約5微米至約150微米、約5微米至約125微米、約5微米至約100微米、約5微米至約75微米、約5微米至約50微米、約5微米至約45微米、約5微米至約40微米、約5微米至約35微米、約5微米至約30微米、約5微米至約25微米、約5微米至約20微米、約5微米至約15微米、約5微米至約10微米、約10微米至約40微米、約10微米至約30微米、或約20微米至約40微米。In some embodiments, the protein polyurethane blend of the membrane can have a thickness in the range of about 5 microns to about 200 microns (including sub-ranges) (e.g., thickness 126 shown in Figures 1A and 1B). For example, the protein polyurethane blend of the membrane can have a thickness in the following ranges: about 5 microns to about 200 microns, about 10 microns to about 200 microns, about 15 microns to about 200 microns, about 20 microns to about 200 microns, about 25 microns to about 200 microns, about 30 microns to about 200 microns, about 35 microns to about 200 microns, about 40 microns to about 200 microns, about 45 microns to about 200 microns, about 50 microns to about 200 microns, about 75 microns to about 200 microns, about 100 microns to about 200 microns, about 125 microns to about 200 microns, about 150 microns to about 200 microns, about 160 microns to about 200 microns, about 180 microns to about 200 microns, about 190 microns to about 200 microns, about 210 microns to about 200 microns, about 230 microns to about 200 microns, about 240 microns to about 200 microns, about 250 microns to about 200 microns, about 260 microns to about 200 microns, about 270 microns to about 200 microns, about 280 microns to about 200 microns, about 260 microns to about 200 microns, about 280 microns to about 200 microns, about 2 In some embodiments, the present invention relates to a nanostructured carbon foam having a thickness of 400 nm to about 800 nm, about 5 nm to about 200 nm, about 5 nm to about 175 nm, about 5 nm to about 150 nm, about 5 nm to about 125 nm, about 5 nm to about 100 nm, about 5 nm to about 75 nm, about 5 nm to about 50 nm, about 5 nm to about 45 nm, about 5 nm to about 40 nm, about 5 nm to about 35 nm, about 5 nm to about 30 nm, about 5 nm to about 25 nm, about 5 nm to about 20 nm, about 5 nm to about 15 nm, about 5 nm to about 10 nm, about 10 nm to about 40 nm, about 10 nm to about 30 nm, or about 20 nm to about 40 nm.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有大於或等於約5 g/m 2之乾重。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可包含約5 g/m 2至約200 g/m 2之範圍內(包括子範圍)的乾重。例如,膜之蛋白質聚胺甲酸酯混摻物可具有下列範圍內的乾重:5 g/m 2至約200 g/m 2、約10 g/m 2至約200 g/m 2、約15 g/m 2至約200 g/m 2、約20 g/m 2至約200 g/m 2、約25 g/m 2至約200 g/m 2、約30 g/m 2至約200 g/m 2、約35 g/m 2至約200 g/m 2、約40 g/m 2至約200 g/m 2、約45 g/m 2至約200 g/m 2、約50 g/m 2至約200 g/m 2、約75 g/m 2至約200 g/m 2、約100 g/m 2至約200 g/m 2、約125 g/m 2至約200 g/m 2、約150 g/m 2至約200 g/m 2、約5 g/m 2至約175 g/m 2、約5 g/m 2至約150 g/m 2、約5 g/m 2至約125 g/m 2、約5 g/m 2至約100 g/m 2、約5 g/m 2至約75 g/m 2、約5 g/m 2至約50 g/m 2、約5 g/m 2至約45 g/m 2、約5 g/m 2至約40 g/m 2、約5 g/m 2至約35 g/m 2、約5 g/m 2至約30 g/m 2、約5 g/m 2至約25 g/m 2、約5 g/m 2至約20 g/m 2、約5 g/m 2至約15 g/m 2、約5 g/m 2至約10 g/m 2、約10 g/m 2至約40 g/m 2、約10 g/m 2至約30 g/m 2、或約20 g/m 2至約40 g/m 2。 In some embodiments, the protein polyurethane blend of the membrane may have a dry weight greater than or equal to about 5 g/m 2. In some embodiments, the protein polyurethane blend of the membrane may comprise a dry weight in the range of about 5 g/m 2 to about 200 g/m 2, including sub-ranges. For example, the protein polyurethane blend of the membrane can have a dry weight in the following ranges: 5 g/m 2 to about 200 g/m 2 , about 10 g/m 2 to about 200 g/m 2 , about 15 g/m 2 to about 200 g/m 2 , about 20 g/m 2 to about 200 g/m 2 , about 25 g/m 2 to about 200 g/m 2 , about 30 g/m 2 to about 200 g/m 2 , about 35 g/m 2 to about 200 g/m 2 , about 40 g/m 2 to about 200 g/m 2 , about 45 g/m 2 to about 200 g/m 2 , about 50 g/m 2 to about 200 g/m 2 , about 75 g/m 2 to about 200 g/m 2 , about 100 g/m 2 to about 200 g/m 2 , about 125 g/m 2 to about 200 g/m 2 , about 150 g/m 2 to about 200 g/m 2 , about 5 g/m 2 to about 175 g/m 2 , about 5 g/m 2 to about 150 g/m 2 , about 5 g/m 2 to about 125 g/m 2 , about 5 g/m 2 to about 100 g/m 2 , about 5 g/m 2 to about 75 g/m 2 , about 5 g/m 2 to about 50 g/m 2 , about 5 g/m 2 to about 45 g/m 2 , about 5 g/m 2 to about 40 g/m 2 , about 5 g/m 2 to about 35 g/m 2 , about 5 g/m 2 to about 30 g/m 2 2 , about 5 g/ m2 to about 25 g/ m2 , about 5 g/ m2 to about 20 g/ m2 , about 5 g/ m2 to about 15 g/ m2 , about 5 g/ m2 to about 10 g/ m2 , about 10 g/ m2 to about 40 g/ m2 , about 10 g/ m2 to about 30 g/ m2 , or about 20 g/ m2 to about 40 g/ m2 .
在一些實施例中,膜可包含複數種聚胺甲酸酯。在一些實施例中,一或多種蛋白質可僅溶解於複數種聚胺甲酸酯中之一者中。例如,在一些實施例中,膜可包含第一聚胺甲酸酯及第二聚胺甲酸酯,且一或多種蛋白質可僅溶解於第一聚胺甲酸酯中。在一些實施例中,一或多種蛋白質可溶解於複數種聚胺甲酸酯中。例如,在一些實施例中,膜可包含第一聚胺甲酸酯及第二聚胺甲酸酯,且一或多種蛋白質可溶解於第一聚胺甲酸酯及第二聚胺甲酸酯兩者中。In some embodiments, the membrane may comprise a plurality of polyurethanes. In some embodiments, one or more proteins may be soluble in only one of the plurality of polyurethanes. For example, in some embodiments, the membrane may comprise a first polyurethane and a second polyurethane, and one or more proteins may be soluble in only the first polyurethane. In some embodiments, one or more proteins may be soluble in a plurality of polyurethanes. For example, in some embodiments, the membrane may comprise a first polyurethane and a second polyurethane, and one or more proteins may be soluble in both the first polyurethane and the second polyurethane.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於10,000 mm的H 2O之防水性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於15,000 mm的H 2O之防水性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於20,000 mm的H 2O之防水性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於10,000 mm的H 2O且小於或等於30,000 mm的H 2O之防水性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於10,000 mm的H 2O且小於或等於20,000 mm的H 2O之防水性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於10,000 mm的H 2O且小於或等於15,000 mm的H 2O之防水性。 In some embodiments, the protein polyurethane blend of the membrane may have a water resistance of greater than 10,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, the protein polyurethane blend of the membrane may have a water resistance of greater than 15,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, the protein polyurethane blend of the membrane may have a water resistance of greater than 20,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, the protein polyurethane blend of the membrane may have a water resistance greater than 10,000 mm H2O and less than or equal to 30,000 mm H2O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, the protein polyurethane blend of the membrane may have a water resistance greater than 10,000 mm H2O and less than or equal to 20,000 mm H2O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, the protein polyurethane blend of the membrane can have a water resistance greater than 10,000 mm H 2 O and less than or equal to 15,000 mm H 2 O as measured according to the JIS L 1092 hydrostatic pressure test.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於3,000 mm的H 2O之防水性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於4,000 mm的H 2O之防水性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於5,000 mm的H 2O之防水性。 In some embodiments, the protein polyurethane blend of the membrane may have a water resistance of greater than 3,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, the protein polyurethane blend of the membrane may have a water resistance of greater than 4,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, the protein polyurethane blend of the membrane may have a water resistance of greater than 5,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於3,000 mm的H 2O且小於或等於30,000 mm的H 2O之防水性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於3,000 mm的H 2O且小於或等於20,000 mm的H 2O之防水性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於3,000 mm的H 2O且小於或等於15,000 mm的H 2O之防水性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於3,000 mm的H 2O且小於或等於10,000 mm的H 2O之防水性。 In some embodiments, the protein polyurethane blend of the membrane may have a water resistance greater than 3,000 mm H 2 O and less than or equal to 30,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, the protein polyurethane blend of the membrane may have a water resistance greater than 3,000 mm H 2 O and less than or equal to 20,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, the protein polyurethane blend of the membrane may have a water resistance greater than 3,000 mm H 2 O and less than or equal to 15,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, the protein polyurethane blend of the membrane can have a water resistance greater than 3,000 mm H2O and less than or equal to 10,000 mm H2O as measured according to the JIS L 1092 hydrostatic pressure test.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於4,000 mm的H 2O且小於或等於30,000 mm的H 2O之防水性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於4,000 mm的H 2O且小於或等於20,000 mm的H 2O之防水性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於4,000 mm的H 2O且小於或等於15,000 mm的H 2O之防水性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於4,000 mm的H 2O且小於或等於10,000 mm的H 2O之防水性。 In some embodiments, the protein polyurethane blend of the membrane may have a water resistance greater than 4,000 mm H 2 O and less than or equal to 30,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, the protein polyurethane blend of the membrane may have a water resistance greater than 4,000 mm H 2 O and less than or equal to 20,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, the protein polyurethane blend of the membrane may have a water resistance greater than 4,000 mm H 2 O and less than or equal to 15,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, the protein polyurethane blend of the membrane can have a water resistance greater than 4,000 mm H2O and less than or equal to 10,000 mm H2O as measured according to the JIS L 1092 hydrostatic pressure test.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於5,000 mm的H 2O且小於或等於30,000 mm的H 2O之防水性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於5,000 mm的H 2O且小於或等於20,000 mm的H 2O之防水性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於5,000 mm的H 2O且小於或等於15,000 mm的H 2O之防水性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於5,000 mm的H 2O且小於或等於10,000 mm的H 2O之防水性。 In some embodiments, the protein polyurethane blend of the membrane may have a water resistance greater than 5,000 mm H 2 O and less than or equal to 30,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, the protein polyurethane blend of the membrane may have a water resistance greater than 5,000 mm H 2 O and less than or equal to 20,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, the protein polyurethane blend of the membrane may have a water resistance greater than 5,000 mm H 2 O and less than or equal to 15,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, the protein polyurethane blend of the membrane can have a water resistance greater than 5,000 mm H 2 O and less than or equal to 10,000 mm H 2 O as measured according to the JIS L 1092 hydrostatic pressure test.
在一些實施例中,該蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於10,000 mm的H 2O之防水性。在一些實施例中,包含:包含蛋白質聚胺甲酸酯混摻物之膜之物品可具有根據JIS L 1092靜水壓法測試所測量之大於15,000 mm的H 2O之防水性。在一些實施例中,包含:包含蛋白質聚胺甲酸酯混摻物之膜之物品可具有根據JIS L 1092靜水壓法測試所測量之大於20,000 mm的H 2O之防水性。在一些實施例中,包含:包含蛋白質聚胺甲酸酯混摻物之膜之物品可具有根據JIS L 1092靜水壓法測試所測量之大於10,000 mm的H 2O且小於或等於30,000 mm的H 2O之防水性。在一些實施例中,包含:包含蛋白質聚胺甲酸酯混摻物之膜之物品可具有根據JIS L 1092靜水壓法測試所測量之大於10,000 mm的H 2O且小於或等於20,000 mm的H 2O之防水性。在一些實施例中,包含:包含蛋白質聚胺甲酸酯混摻物之膜之物品可具有根據JIS L 1092靜水壓法測試所測量之大於10,000 mm的H 2O且小於或等於15,000 mm的H 2O之防水性。 In some embodiments, the protein polyurethane blend may have a water resistance of greater than 10,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, an article comprising a film comprising a protein polyurethane blend may have a water resistance of greater than 15,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, an article comprising a film comprising a protein polyurethane blend may have a water resistance of greater than 20,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, an article comprising: a film comprising a protein polyurethane blend may have a water resistance greater than 10,000 mm H2O and less than or equal to 30,000 mm H2O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, an article comprising: a film comprising a protein polyurethane blend may have a water resistance greater than 10,000 mm H2O and less than or equal to 20,000 mm H2O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, an article comprising a film comprising a protein polyurethane blend may have a water resistance greater than 10,000 mm H 2 O and less than or equal to 15,000 mm H 2 O as measured according to the JIS L 1092 hydrostatic pressure test.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於5,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於10,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於20,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於30,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於40,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於50,000 g/m 2/24hr之透氣性。 In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 5,000 g/m 2 /24hr measured according to JIS L 1099 B1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 10,000 g/m 2 /24hr measured according to JIS L 1099 B1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 20,000 g/m 2 /24hr measured according to JIS L 1099 B1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 30,000 g/m 2 /24hr measured according to JIS L 1099 B1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 40,000 g/ m2 /24hr as measured according to JIS L 1099 B1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 50,000 g/ m2 /24hr as measured according to JIS L 1099 B1.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於5,000 g/m 2/24hr且小於或等於100,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於5,000 g/m 2/24hr且小於或等於90,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於5,000 g/m 2/24hr且小於或等於80,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於5,000 g/m 2/24hr且小於或等於60,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於5,000 g/m 2/24hr且小於或等於50,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於10,000 g/m 2/24hr且小於或等於50,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於15,000 g/m 2/24hr且小於或等於50,000 g/m 2/24hr之透氣性。 In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 5,000 g/m 2 /24hr and less than or equal to 100,000 g/m 2 /24hr as measured according to JIS L 1099 B1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 5,000 g/m 2 /24hr and less than or equal to 90,000 g/m 2 /24hr as measured according to JIS L 1099 B1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 5,000 g/m 2 /24hr and less than or equal to 80,000 g/m 2 /24hr as measured according to JIS L 1099 B1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 5,000 g/m 2 /24hr and less than or equal to 60,000 g/m 2 /24hr as measured according to JIS L 1099 B1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 5,000 g/m 2 /24hr and less than or equal to 50,000 g/m 2 /24hr as measured according to JIS L 1099 B1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 10,000 g/m 2 /24hr and less than or equal to 50,000 g/m 2 /24hr as measured according to JIS L 1099 B1. In some embodiments, the protein polyurethane blend of the membrane can have an air permeability greater than 15,000 g/m 2 /24 hr and less than or equal to 50,000 g/m 2 /24 hr as measured according to JIS L 1099 B1.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於3,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於4,000 g/m 2/24hr之透氣性。 In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 3,000 g/ m2 /24hr measured according to JIS L 1099 B1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 4,000 g/ m2 /24hr measured according to JIS L 1099 B1.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於3,000 g/m 2/24hr且小於或等於100,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於3,000 g/m 2/24hr且小於或等於90,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於3,000 g/m 2/24hr且小於或等於80,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於3,000 g/m 2/24hr且小於或等於60,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於3,000 g/m 2/24hr且小於或等於50,000 g/m 2/24hr之透氣性。 In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 3,000 g/m 2 /24hr and less than or equal to 100,000 g/m 2 /24hr as measured according to JIS L 1099 B1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 3,000 g/m 2 /24hr and less than or equal to 90,000 g/m 2 /24hr as measured according to JIS L 1099 B1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 3,000 g/m 2 /24hr and less than or equal to 80,000 g/m 2 /24hr as measured according to JIS L 1099 B1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 3,000 g/ m2 /24hr and less than or equal to 60,000 g/ m2 /24hr as measured according to JIS L 1099 B1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 3,000 g/ m2 /24hr and less than or equal to 50,000 g/ m2 /24hr as measured according to JIS L 1099 B1.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於4,000 g/m 2/24hr且小於或等於100,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於4,000 g/m 2/24hr且小於或等於90,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於4,000 g/m 2/24hr且小於或等於80,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於4,000 g/m 2/24hr且小於或等於60,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 B1所測量之大於4,000 g/m 2/24hr且小於或等於50,000 g/m 2/24hr之透氣性。 In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 4,000 g/m 2 /24hr and less than or equal to 100,000 g/m 2 /24hr as measured according to JIS L 1099 B1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 4,000 g/m 2 /24hr and less than or equal to 90,000 g/m 2 /24hr as measured according to JIS L 1099 B1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 4,000 g/m 2 /24hr and less than or equal to 80,000 g/m 2 /24hr as measured according to JIS L 1099 B1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 4,000 g/ m2 /24hr and less than or equal to 60,000 g/ m2 /24hr as measured according to JIS L 1099 B1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 4,000 g/ m2 /24hr and less than or equal to 50,000 g/ m2 /24hr as measured according to JIS L 1099 B1.
在一些實施例中,包含:包含蛋白質聚胺甲酸酯混摻物之膜之物品可具有根據JIS L 1099 B1所測量之大於3,000 g/m 2/24hr之透氣性。在一些實施例中,包含:包含蛋白質聚胺甲酸酯混摻物之膜之物品可具有根據JIS L 1099 B1所測量之大於4,000 g/m 2/24hr之透氣性。在一些實施例中,包含:包含蛋白質聚胺甲酸酯混摻物之膜之物品可具有根據JIS L 1099 B1所測量之大於5,000 g/m 2/24hr之透氣性。在一些實施例中,包含:包含蛋白質聚胺甲酸酯混摻物之膜之物品可具有根據JIS L 1099 B1所測量之大於10,000 g/m 2/24hr之透氣性。在一些實施例中,包含:包含蛋白質聚胺甲酸酯混摻物之膜之物品可具有根據JIS L 1099 B1所測量之大於15,000 g/m 2/24hr之透氣性。 In some embodiments, an article comprising a film comprising a protein polyurethane blend may have an air permeability greater than 3,000 g/m 2 /24hr measured according to JIS L 1099 B1. In some embodiments, an article comprising a film comprising a protein polyurethane blend may have an air permeability greater than 4,000 g/m 2 /24hr measured according to JIS L 1099 B1. In some embodiments, an article comprising a film comprising a protein polyurethane blend may have an air permeability greater than 5,000 g/m 2 /24hr measured according to JIS L 1099 B1. In some embodiments, an article comprising a film comprising a protein polyurethane blend may have an air permeability greater than 10,000 g/ m2 /24hr measured according to JIS L 1099 B1. In some embodiments, an article comprising a film comprising a protein polyurethane blend may have an air permeability greater than 15,000 g/ m2 /24hr measured according to JIS L 1099 B1.
在一些實施例中,包含:包含蛋白質聚胺甲酸酯混摻物之膜之物品可具有根據JIS L 1099 B1所測量之大於3,000 g/m 2/24hr且小於或等於115,000 g/m 2/24hr之透氣性。在一些實施例中,包含含有蛋白質聚胺甲酸酯混摻物之膜之物品可具有根據JIS L 1099 B1所測量之大於4,000 g/m 2/24hr且小於或等於115,000 g/m 2/24hr之透氣性。在一些實施例中,包含含有蛋白質聚胺甲酸酯混摻物之膜之物品可具有根據JIS L 1099 B1所測量之大於5,000 g/m 2/24hr且小於或等於115,000 g/m 2/24hr之透氣性。在一些實施例中,包含含有蛋白質聚胺甲酸酯混摻物之膜之物品可具有根據JIS L 1099 B1所測量之大於10,000 g/m 2/24hr且小於或等於115,000 g/m 2/24hr之透氣性。在一些實施例中,包含含有蛋白質聚胺甲酸酯混摻物之膜之物品可具有根據JIS L 1099 B1所測量之大於15,000 g/m 2/24hr且小於或等於115,000 g/m 2/24hr之透氣性。 In some embodiments, an article comprising a film comprising a protein polyurethane blend may have an air permeability greater than 3,000 g/m 2 /24hr and less than or equal to 115,000 g/m 2 /24hr measured according to JIS L 1099 B1. In some embodiments, an article comprising a film comprising a protein polyurethane blend may have an air permeability greater than 4,000 g/m 2 /24hr and less than or equal to 115,000 g/m 2 /24hr measured according to JIS L 1099 B1. In some embodiments, an article including a film containing a protein polyurethane blend may have an air permeability of greater than 5,000 g/m 2 /24hr and less than or equal to 115,000 g/m 2 /24hr measured according to JIS L 1099 B1. In some embodiments, an article including a film containing a protein polyurethane blend may have an air permeability of greater than 10,000 g/m 2 /24hr and less than or equal to 115,000 g/m 2 /24hr measured according to JIS L 1099 B1. In some embodiments, an article including a film containing a protein polyurethane blend may have an air permeability of greater than 15,000 g/m 2 /24 hr and less than or equal to 115,000 g/m 2 /24 hr as measured according to JIS L 1099 B1.
在一些實施例中,包含含有蛋白質聚胺甲酸酯混摻物之膜之物品可具有根據JIS L 1092靜水壓法測試所測量之大於10,000 mm的H 2O之防水性及根據JIS L 1099 B1所測量之大於3,000 g/m 2/24hr之透氣性。在一些實施例中,包含含有蛋白質聚胺甲酸酯混摻物之膜之物品可具有根據JIS L 1092靜水壓法測試所測量之大於10,000 mm的H 2O之防水性及根據JIS L 1099 B1所測量之大於5,000 g/m 2/24hr之透氣性。在一些實施例中,包含含有蛋白質聚胺甲酸酯混摻物之膜之物品可具有根據JIS L 1092靜水壓法測試所測量之大於10,000 mm的H 2O之防水性及根據JIS L 1099 B1所測量之大於10,000 g/m 2/24hr之透氣性。 In some embodiments, an article comprising a film containing a protein polyurethane blend may have a water resistance of greater than 10,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test and an air permeability of greater than 3,000 g/m 2 /24 hr as measured by JIS L 1099 B1. In some embodiments, an article comprising a film containing a protein polyurethane blend may have a water resistance of greater than 10,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test and an air permeability of greater than 5,000 g/m 2 /24 hr as measured by JIS L 1099 B1. In some embodiments, an article including a film containing a protein polyurethane blend can have a water resistance greater than 10,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test and an air permeability greater than 10,000 g/m 2 /24 hr as measured by JIS L 1099 B1.
在一些實施例中,包含含有蛋白質聚胺甲酸酯混摻物之膜之物品可具有根據JIS L 1092靜水壓法測試所測量之大於10,000 mm的H 2O且小於或等於30,000 mm的H 2O之防水性及根據JIS L 1099 B1所測量之大於3,000 g/m 2/24hr且小於或等於115,000 g/m 2/24h之透氣性。在一些實施例中,包含含有蛋白質聚胺甲酸酯混摻物之膜之物品可具有根據JIS L 1092靜水壓法測試所測量之大於10,000 mm的H 2O且小於或等於30,000 mm的H 2O之防水性及根據JIS L 1099 B1所測量之大於10,000 g/m 2/24hr且小於或等於115,000 g/m 2/24h之透氣性。 In some embodiments, an article including a film containing a protein polyurethane blend can have a water resistance greater than 10,000 mm H2O and less than or equal to 30,000 mm H2O measured according to JIS L 1092 hydrostatic pressure test and an air permeability greater than 3,000 g/ m2 /24hr and less than or equal to 115,000 g/ m2 /24h measured according to JIS L 1099 B1. In some embodiments, an article including a film containing a protein polyurethane blend can have a water resistance greater than 10,000 mm H2O and less than or equal to 30,000 mm H2O measured according to JIS L 1092 hydrostatic pressure test and an air permeability greater than 10,000 g/ m2 /24hr and less than or equal to 115,000 g/ m2 /24h measured according to JIS L 1099 B1.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 A1所測量之大於3,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 A1所測量之大於4,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 A1所測量之大於5,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 A1所測量之大於3,000 g/m 2/24hr且小於或等於10,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 A1所測量之大於4,000 g/m 2/24hr至小於或等於10,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1099 A1所測量之大於5,000 g/m 2/24hr至小於或等於10,000 g/m 2/24hr之透氣性。 In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 3,000 g/ m2 /24hr as measured according to JIS L 1099 A1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 4,000 g/ m2 /24hr as measured according to JIS L 1099 A1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 5,000 g/ m2 /24hr as measured according to JIS L 1099 A1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 3,000 g/m 2 /24hr and less than or equal to 10,000 g/m 2 /24hr as measured according to JIS L 1099 A1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 4,000 g/m 2 /24hr to less than or equal to 10,000 g/m 2 /24hr as measured according to JIS L 1099 A1. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 5,000 g/m 2 /24hr to less than or equal to 10,000 g/m 2 /24hr as measured according to JIS L 1099 A1.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據ASTM E 96 B所測量之大於250 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據ASTM E 96 B所測量之大於500 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據ASTM E 96 B所測量之大於700 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據ASTM E 96 B所測量之大於1,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據ASTM E 96 B所測量之大於250 g/m 2/24hr至小於或等於1,200 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據ASTM E 96 B所測量之大於250 g/m 2/24hr至小於或等於1,000 g/m 2/24hr之透氣性。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據ASTM E 96 B所測量之大於700 g/m 2/24hr至小於或等於1,000 g/m 2/24hr之透氣性。 In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 250 g/m 2 /24hr measured according to ASTM E 96 B. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 500 g/m 2 /24hr measured according to ASTM E 96 B. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 700 g/m 2 /24hr measured according to ASTM E 96 B. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability greater than 1,000 g/m 2 /24hr measured according to ASTM E 96 B. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability of greater than 250 g/m 2 /24hr to less than or equal to 1,200 g/m 2 /24hr as measured according to ASTM E 96 B. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability of greater than 250 g/m 2 /24hr to less than or equal to 1,000 g/m 2 /24hr as measured according to ASTM E 96 B. In some embodiments, the protein polyurethane blend of the membrane may have an air permeability of greater than 700 g/m 2 /24hr to less than or equal to 1,000 g/m 2 /24hr as measured according to ASTM E 96 B.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有下列中之二或更多者:(i)根據如本文中所揭示之JIS L 1092靜水壓法測試所測量之防水性值,(ii)根據如本文中所揭示之JIS L 1099 B1所測量之透氣性值,(iii)根據如本文中所揭示之JIS L 1099 A1所測量之透氣性值,及(iv)根據如本文中所揭示之ASTM E 96 B所測量之透氣性值。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有(i)至(iv)中之三或更多者。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有(i)至(iv)中之所有四者。In some embodiments, the protein polyurethane blend of the membrane may have two or more of the following: (i) a water resistance value measured according to the JIS L 1092 hydrostatic pressure test as disclosed herein, (ii) a breathability value measured according to the JIS L 1099 B1 as disclosed herein, (iii) a breathability value measured according to the JIS L 1099 A1 as disclosed herein, and (iv) a breathability value measured according to the ASTM E 96 B as disclosed herein. In some embodiments, the protein polyurethane blend of the membrane may have three or more of (i) to (iv). In some embodiments, the protein polyurethane blend of the membrane may have all four of (i) to (iv).
例如,在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於10,000 mm的H 2O之防水性及根據JIS L 1099 B1所測量之大於5,000 g/m 2/24hr之透氣性。 For example, in some embodiments, the protein polyurethane blend of the membrane can have a water resistance greater than 10,000 mm H2O as measured according to the JIS L 1092 hydrostatic pressure test and an air permeability greater than 5,000 g/ m2 /24hr as measured according to JIS L 1099 B1.
作為另一實例,在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於10,000 mm的H 2O且小於或等於30,000 mm的H 2O之防水性及根據JIS L 1099 B1所測量之大於5,000 g/m 2/24hr且小於或等於100,000 g/m 2/24hr之透氣性。 As another example, in some embodiments, the protein polyurethane blend of the membrane can have a water resistance greater than 10,000 mm H2O and less than or equal to 30,000 mm H2O as measured according to the JIS L 1092 hydrostatic pressure test and an air permeability greater than 5,000 g/ m2 /24hr and less than or equal to 100,000 g/ m2 /24hr as measured according to JIS L 1099 B1.
作為另一實例,在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於3,000 mm的H2O之防水性及根據JIS L 1099 B1所測量之大於3,000 g/m2/24h之透氣性。As another example, in some embodiments, the protein polyurethane blend of the membrane can have a water resistance greater than 3,000 mm H2O as measured by the JIS L 1092 hydrostatic pressure test and an air permeability greater than 3,000 g/m2/24h as measured by JIS L 1099 B1.
作為另一實例,在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於3,000 mm的H 2O且小於或等於30,000 mm的H 2O之防水性及根據JIS L 1099 B1所測量之大於3,000 g/m 2/24hr且小於或等於100,000 g/m 2/24hr之透氣性。 As another example, in some embodiments, the protein polyurethane blend of the membrane can have a water resistance greater than 3,000 mm H2O and less than or equal to 30,000 mm H2O as measured according to the JIS L 1092 hydrostatic pressure test and an air permeability greater than 3,000 g/ m2 /24hr and less than or equal to 100,000 g/ m2 /24hr as measured according to JIS L 1099 B1.
另一實例,在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於4,000 mm的H 2O之防水性及根據JIS L 1099 B1所測量之大於4,000 g/m 2/24hr之透氣性。 As another example, in some embodiments, the protein polyurethane blend of the membrane can have a water resistance greater than 4,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test and an air permeability greater than 4,000 g/m 2 /24 hr as measured by JIS L 1099 B1.
作為另一實例,在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於4,000 mm的H 2O且小於或等於30,000 mm的H 2O之防水性及根據JIS L 1099 B1所測量之大於4,000 g/m 2/24hr且小於或等於100,000 g/m 2/24hr之透氣性。 As another example, in some embodiments, the protein polyurethane blend of the membrane can have a water resistance greater than 4,000 mm H2O and less than or equal to 30,000 mm H2O as measured according to the JIS L 1092 hydrostatic pressure test and an air permeability greater than 4,000 g/ m2 /24hr and less than or equal to 100,000 g/ m2 /24hr as measured according to JIS L 1099 B1.
作為另一實例,在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有根據JIS L 1092靜水壓法測試所測量之大於10,000 mm的H 2O且小於或等於15,000 mm的H 2O之防水性及根據JIS L 1099 B1所測量之大於20,000 g/m 2/24hr且小於或等於40,000 g/m 2/24hr之透氣性。 As another example, in some embodiments, the protein polyurethane blend of the membrane can have a water resistance greater than 10,000 mm H2O and less than or equal to 15,000 mm H2O as measured by the JIS L 1092 hydrostatic pressure test and an air permeability greater than 20,000 g/ m2 /24hr and less than or equal to 40,000 g/ m2 /24hr as measured by JIS L 1099 B1.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有如根據ASTM D6866所測量之大於或等於約15%之生物含量。在一些實施例中,如根據ASTM D6866所測量,膜之蛋白質聚胺甲酸酯混摻物可具有下列範圍內的生物含量:約15%至約80%、約20%至約80%、約30%至約80%、約40%至約80%、約50%至約80%、或約60%至約80%。In some embodiments, the protein polyurethane blend of the membrane can have a biocontent greater than or equal to about 15% as measured according to ASTM D6866. In some embodiments, the protein polyurethane blend of the membrane can have a biocontent in the following ranges: about 15% to about 80%, about 20% to about 80%, about 30% to about 80%, about 40% to about 80%, about 50% to about 80%, or about 60% to about 80% as measured according to ASTM D6866.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有如根據ASTM D6866所測量之大於或等於約35%之生物含量。在一些實施例中,如根據ASTM D6866所測量,膜之蛋白質聚胺甲酸酯混摻物可具有約35%至約80%之範圍內的生物含量。In some embodiments, the protein polyurethane blend of the membrane can have a biocontent greater than or equal to about 35% as measured according to ASTM D6866. In some embodiments, the protein polyurethane blend of the membrane can have a biocontent in the range of about 35% to about 80% as measured according to ASTM D6866.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有如根據用9 kPa荷重之馬丁代爾磨耗測試所測量之大於或等於約20,000次循環的馬丁代爾乾磨耗。In some embodiments, the protein polyurethane blend of the membrane can have a Martindale Dry Abrasion of greater than or equal to about 20,000 cycles as measured according to the Martindale Abrasion Test with a 9 kPa load.
在一些實施例中,當在蛋白質及交聯劑不存在之情況下固化時,用於膜及前驅物配方之水性聚胺甲酸酯分散液可具有如藉由JIS L 1092靜水壓法測試所測量之大於10,000 mm的H 2O之防水性。在一些實施例中,當在蛋白質及交聯劑不存在之情況下固化時,水性聚胺甲酸酯分散液可包含根據JIS L 1092靜水壓法測試所測量之大於10,000 mm的H 2O且小於或等於20,000 mm的H 2O之防水性。在一些實施例中,當在蛋白質及交聯劑不存在之情況下固化時,水性聚胺甲酸酯分散液可包含根據JIS L 1092靜水壓法測試所測量之大於10,000 mm的H 2O且小於或等於15,000 mm的H 2O之防水性。 In some embodiments, when cured in the absence of protein and crosslinking agent, the aqueous polyurethane dispersion used for film and precursor formulations can have a water resistance greater than 10,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, when cured in the absence of protein and crosslinking agent, the aqueous polyurethane dispersion can comprise a water resistance greater than 10,000 mm H 2 O and less than or equal to 20,000 mm H 2 O as measured by the JIS L 1092 hydrostatic pressure test. In some embodiments, the aqueous polyurethane dispersion can comprise a water resistance greater than 10,000 mm H2O and less than or equal to 15,000 mm H2O as measured according to the JIS L 1092 hydrostatic pressure test when cured in the absence of a protein and a crosslinking agent.
在一些實施例中,用於膜及前驅物配方之水性聚胺甲酸酯分散液可包含具有約35%之固體含量及約1.02 g/mL之比重之基於水性脂族聚醚之聚胺甲酸酯。在一些實施例中,用於膜及前驅物配方之水性聚胺甲酸酯分散液可包含具有約30%之固體含量及約1.1 g/mL之比重之非離子型脂族聚碳酸酯-聚醚聚胺甲酸酯。在一些實施例中,用於膜及前驅物配方之水性聚胺甲酸酯分散液可包含具有約50%之固體含量、1.1 g/mL之比重、小於或等於1200 mPa.s之布氏黏度、如根據ASTM D6866所測量之約50%之生物含量、30 MPa之拉伸強度、及1000%之斷裂伸長率之水性脂族陰離子型聚酯聚胺甲酸酯分散液。在一些實施例中,用於膜及前驅物配方之水性聚胺甲酸酯分散液可包含具有約50%之固體含量、1.1 g/mL之比重、小於或等於1200 mPa.s之布氏黏度、如根據ASTM D6866所測量之約56%之生物含量、12 MPa之拉伸強度、及800%之斷裂伸長率之水性脂族陰離子型聚酯聚胺甲酸酯分散液。In some embodiments, the aqueous polyurethane dispersion for membrane and precursor formulations may include an aqueous aliphatic polyether-based polyurethane having a solid content of about 35% and a specific gravity of about 1.02 g/mL. In some embodiments, the aqueous polyurethane dispersion for membrane and precursor formulations may include a nonionic aliphatic polycarbonate-polyether polyurethane having a solid content of about 30% and a specific gravity of about 1.1 g/mL. In some embodiments, the aqueous polyurethane dispersion used in the membrane and precursor formulations may include an aqueous aliphatic anionic polyester polyurethane dispersion having a solids content of about 50%, a specific gravity of 1.1 g/mL, a Brookfield viscosity of less than or equal to 1200 mPa.s, a biocontent of about 50% as measured according to ASTM D6866, a tensile strength of 30 MPa, and an elongation at break of 1000%. In some embodiments, the aqueous polyurethane dispersion used in the membrane and precursor formulations may include an aqueous aliphatic anionic polyester polyurethane dispersion having a solids content of about 50%, a specific gravity of 1.1 g/mL, a Brookfield viscosity of less than or equal to 1200 mPa.s, a biocontent of about 56% as measured according to ASTM D6866, a tensile strength of 12 MPa, and an elongation at break of 800%.
在一些實施例中,用於膜及前驅物配方之水性聚胺甲酸酯分散液可包含下列中之二或更多者:(i)具有約35%之固體含量及約1.02 g/mL之比重之基於水性脂族聚醚之聚胺甲酸酯;(ii)具有約30%之固體含量及約1.1 g/mL之比重之非離子型脂族聚碳酸酯-聚醚聚胺甲酸酯分散液;(iii)具有約32%之固體含量、1.03 g/mL之比重、及約200 mPa.s之布氏黏度之水性脂族非離子型聚胺甲酸酯分散液;(iv)具有約50%之固體含量、1.1 g/mL之比重、小於或等於1200 mPa.s之布氏黏度、如根據ASTM D6866所測量之約50%之生物含量、30 MPa之拉伸強度、及1000%之斷裂伸長率之水性脂族陰離子型聚酯聚胺甲酸酯分散液;及(vi)具有約50%之固體含量、1.1 g/mL之比重、小於或等於1200 mPa.s之布氏黏度、如根據ASTM D6866所測量之約56%之生物含量、12 Mpa之拉伸強度、及800%之斷裂伸長率之水性脂族陰離子型聚酯聚胺甲酸酯分散液。In some embodiments, the aqueous polyurethane dispersion used in the membrane and precursor formulations may include two or more of the following: (i) an aqueous aliphatic polyether-based polyurethane having a solids content of about 35% and a specific gravity of about 1.02 g/mL; (ii) a nonionic aliphatic polycarbonate-polyether polyurethane dispersion having a solids content of about 30% and a specific gravity of about 1.1 g/mL; (iii) an aqueous aliphatic nonionic polyurethane dispersion having a solids content of about 32%, a specific gravity of 1.03 g/mL, and a Brookfield viscosity of about 200 mPa.s; (iv) an aqueous aliphatic nonionic polyurethane dispersion having a solids content of about 50%, a specific gravity of 1.1 g/mL, a Brookfield viscosity of less than or equal to 1200 mPa.s, a biocontent of about 50% as measured according to ASTM D6866, a specific gravity of 30 MPa, and an elongation at break of 1000%; and (vi) an aqueous aliphatic anionic polyester polyurethane dispersion having a solids content of about 50%, a specific gravity of 1.1 g/mL, a Brookfield viscosity less than or equal to 1200 mPa.s, a biocontent of about 56% as measured in accordance with ASTM D6866, a tensile strength of 12 MPa, and an elongation at break of 800%.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可具有大於或等於5 wt%蛋白質。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物中蛋白質之量可在約5 wt%至約50 wt%的蛋白質之範圍內,包括子範圍。例如,在一些實施例中,蛋白質聚胺甲酸酯混摻物中蛋白質之量可在下列之範圍內:約10 wt%至約50 wt%、約15 wt%至約50 wt%、約20 wt%至約50 wt%、約25 wt%至約50 wt%、約30 wt%至約50 wt%、約35 wt%至約50 wt%、約40 wt%至約50 wt%、約45 wt%至約50 wt%、約5 wt%至約45 wt%、約5 wt%至約40 wt%、約5 wt%至約35 wt%、約5 wt%至約30 wt%、約5 wt%至約25 wt%、約5 wt%至約20、或約5 wt%至約15 wt%。In some embodiments, the protein polyurethane blend of the membrane can have greater than or equal to 5 wt % protein. In some embodiments, the amount of protein in the protein polyurethane blend of the membrane can be in the range of about 5 wt % to about 50 wt % protein, including subranges. For example, in some embodiments, the amount of protein in the protein polyurethane blend can be in the range of about 10 wt % to about 50 wt %, about 15 wt % to about 50 wt %, about 20 wt % to about 50 wt %, about 25 wt % to about 50 wt %, about 30 wt % to about 50 wt %, about 35 wt % to about 50 wt %, about 40 wt % to about 50 wt %, about 45 wt % to about 50 wt %, about 5 wt % to about 45 wt %, about 5 wt % to about 40 wt %, about 5 wt % to about 35 wt %, about 5 wt % to about 30 wt %, about 5 wt % to about 25 wt %, about 5 wt % to about 20, or about 5 wt % to about 15 wt %.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物中蛋白質之量可在約50 wt%至約95 wt%之範圍內,包括子範圍。例如,在一些實施例中,蛋白質聚胺甲酸酯混摻物中聚胺甲酸酯之量可在下列之範圍內:約55 wt%至約95 wt%、約60 wt%至約95 wt%、約65 wt%至約95 wt%、約70 wt%至約95 wt%、約75 wt%至約95 wt%、約80 wt%至約95 wt%、約85 wt%至約95 wt%、約50 wt%至約90 wt%、約50 wt%至約85 wt%、約50 wt%至約80 wt%、約50 wt%至約75 wt%、約50 wt%至約70 wt%、約50 wt%至約65 wt%、約50 wt%至約60 wt%、或約50 wt%至約55 wt%。In some embodiments, the amount of protein in the protein polyurethane blend of the membrane can be in the range of about 50 wt % to about 95 wt %, including subranges. For example, in some embodiments, the amount of polyurethane in the protein polyurethane blend can be in the range of about 55 wt % to about 95 wt %, about 60 wt % to about 95 wt %, about 65 wt % to about 95 wt %, about 70 wt % to about 95 wt %, about 75 wt % to about 95 wt %, about 80 wt % to about 95 wt %, about 85 wt % to about 95 wt %, about 50 wt % to about 90 wt %, about 50 wt % to about 85 wt %, about 50 wt % to about 80 wt %, about 50 wt % to about 75 wt %, about 50 wt % to about 70 wt %, about 50 wt % to about 65 wt %, about 50 wt % to about 60 wt %, or about 50 wt % to about 55 wt %.
在一些實施例中,上文列出之重量百分比值及範圍可基於蛋白質聚胺甲酸酯混摻物之總重量計。在一些實施例中,上文列出之重量百分比值及範圍可基於蛋白質聚胺甲酸酯混摻物中僅蛋白質及聚胺甲酸酯之總重量計。除非另有說明,否則聚胺甲酸酯及蛋白質之重量百分比值或範圍係基於蛋白質聚胺甲酸酯混摻物中僅蛋白質及聚胺甲酸酯之總重量計。In some embodiments, the weight percentage values and ranges listed above can be based on the total weight of the protein polyurethane blend. In some embodiments, the weight percentage values and ranges listed above can be based on the total weight of only the protein and polyurethane in the protein polyurethane blend. Unless otherwise specified, the weight percentage values or ranges of polyurethane and protein are based on the total weight of only the protein and polyurethane in the protein polyurethane blend.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物中蛋白質之量加上聚胺甲酸酯之量的總和可係約80 wt%或更多。例如,在一些實施例中,蛋白質聚胺甲酸酯混摻物中蛋白質之量加上聚胺甲酸酯之量的總和可在下列之範圍內:約80 wt%至100 wt%、約82 wt%至100 wt%、約84 wt%至100 wt%、約86 wt%至100 wt%、約88 wt%至100 wt%、約90 wt%至100 wt%、約92 wt%至100 wt%、約94 wt%至100 wt%、約96 wt%至100 wt%、或約98 wt%至100 wt%。In some embodiments, the sum of the amount of protein plus the amount of polyurethane in the protein polyurethane blend of the membrane may be about 80 wt% or more. For example, in some embodiments, the sum of the amount of protein plus the amount of polyurethane in the protein polyurethane blend may be in the range of about 80 wt% to 100 wt%, about 82 wt% to 100 wt%, about 84 wt% to 100 wt%, about 86 wt% to 100 wt%, about 88 wt% to 100 wt%, about 90 wt% to 100 wt%, about 92 wt% to 100 wt%, about 94 wt% to 100 wt%, about 96 wt% to 100 wt%, or about 98 wt% to 100 wt%.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可用有色染料染色。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可用酸性染料染色。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可用反應性染料染色。例示性纖維反應性染料包括但不限於硫酸根合乙基碸(sulphatoethylsulphone) (Remazol)、三𠯤、乙烯基碸、及丙烯醯胺染料。例示性酸性染料包括但不限於偶氮結構酸性染料、金屬錯合物結構酸性染料、苯胺結構染料、及蒽醌結構酸性染料。In some embodiments, the protein polyurethane blend of the membrane can be dyed with a colored dye. In some embodiments, the protein polyurethane blend of the membrane can be dyed with an acid dye. In some embodiments, the protein polyurethane blend of the membrane can be dyed with a reactive dye. Exemplary fiber reactive dyes include, but are not limited to, sulphatoethylsulphone (Remazol), tris(thiazole), vinyl sulphone, and acrylamide dyes. Exemplary acid dyes include, but are not limited to, azo structured acid dyes, metal complex structured acid dyes, aniline structured dyes, and anthraquinone structured acid dyes.
在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可係無孔的。在一些實施例中,膜之蛋白質聚胺甲酸酯混摻物可係微孔的。In some embodiments, the protein polyurethane blend of the membrane can be nonporous. In some embodiments, the protein polyurethane blend of the membrane can be microporous.
根據本文中所述之一些實施例之膜前驅物配方包含水、蛋白質、水性聚胺甲酸酯分散液、及一或多種交聯劑。該一或多種交聯劑可以相對於該配方中之水、蛋白質、及水性聚胺甲酸酯分散液之總重量之約0.1 wt%至約5 wt%之範圍內的重量百分比存在。在一些實施例中,蛋白質可以溶解於配方之聚胺甲酸酯分散液之聚胺甲酸酯中。The film precursor formulation according to some embodiments described herein comprises water, protein, aqueous polyurethane dispersion, and one or more crosslinking agents. The one or more crosslinking agents may be present in a weight percentage in the range of about 0.1 wt % to about 5 wt % relative to the total weight of the water, protein, and aqueous polyurethane dispersion in the formulation. In some embodiments, the protein may be dissolved in the polyurethane of the polyurethane dispersion of the formulation.
在一些實施例中,膜前驅物配方可包含以相對於配方中之水、蛋白質、及水性聚胺甲酸酯分散液之總重量之下列範圍的重量百分比存在一或多種交聯劑:約0.2 wt%至約5 wt%、約0.5 wt%至約5 wt%、約0.75 wt%至約5 wt%、約1 wt%至約5 wt%、約1.5 wt%至約5 wt%、約2 wt%至約5 wt%、約3 wt%至約5 wt%、約0.1 wt%至約4 wt%、約0.1 wt%至約3 wt%、約0.1 wt%至約2 wt%、或約0.1 wt%至約1 wt%。In some embodiments, the membrane prodrug formulation may include one or more crosslinking agents in the following weight percentage ranges relative to the total weight of water, protein, and aqueous polyurethane dispersion in the formulation: about 0.2 wt% to about 5 wt%, about 0.5 wt% to about 5 wt%, about 0.75 wt% to about 5 wt%, about 1 wt% to about 5 wt%, about 1.5 wt% to about 5 wt%, about 2 wt% to about 5 wt%, about 3 wt% to about 5 wt%, about 0.1 wt% to about 4 wt%, about 0.1 wt% to about 3 wt%, about 0.1 wt% to about 2 wt%, or about 0.1 wt% to about 1 wt%.
在一些實施例中,膜前驅物配方可包含消泡劑。在一些實施例中,消泡劑可包括基於礦物油之消泡劑。在一些實施例中,膜前驅物配方可包含防沫劑。In some embodiments, the membrane pre-drive formulation may include a defoamer. In some embodiments, the defoamer may include a mineral oil-based defoamer. In some embodiments, the membrane pre-drive formulation may include an antifoamer.
在一些實施例中,膜前驅物配方可包含大於或等於5 wt%蛋白質。在一些實施例中,膜前驅物配方中蛋白質之量可在約5 wt%至約50 wt%的蛋白質之範圍內,包括子範圍。例如,在一些實施例中,膜前驅物配方中蛋白質之量可在下列之範圍內:約10 wt%至約50 wt%、約15 wt%至約50 wt%、約20 wt%至約50 wt%、約25 wt%至約50 wt%、約30 wt%至約50 wt%、約35 wt%至約50 wt%、約40 wt%至約50 wt%、約45 wt%至約50 wt%、約5 wt%至約45 wt%、約5 wt%至約40 wt%、約5 wt%至約35 wt%、約5 wt%至約30 wt%、約5 wt%至約25 wt%、約5 wt%至約20、或約5 wt%至約15 wt%。In some embodiments, the membrane prodrug formulation may include greater than or equal to 5 wt % protein. In some embodiments, the amount of protein in the membrane prodrug formulation may be in the range of about 5 wt % to about 50 wt % protein, including subranges. For example, in some embodiments, the amount of protein in the membrane propellant formulation can be in the range of about 10 wt % to about 50 wt %, about 15 wt % to about 50 wt %, about 20 wt % to about 50 wt %, about 25 wt % to about 50 wt %, about 30 wt % to about 50 wt %, about 35 wt % to about 50 wt %, about 40 wt % to about 50 wt %, about 45 wt % to about 50 wt %, about 5 wt % to about 45 wt %, about 5 wt % to about 40 wt %, about 5 wt % to about 35 wt %, about 5 wt % to about 30 wt %, about 5 wt % to about 25 wt %, about 5 wt % to about 20, or about 5 wt % to about 15 wt %.
在一些實施例中,膜前驅物配方中聚胺甲酸酯之量可在約50 wt%至約95 wt%之範圍內,包括子範圍。例如,在一些實施例中,膜前驅物配方中聚胺甲酸酯之量可在下列之範圍內:約55 wt%至約95 wt%、約60 wt%至約95 wt%、約65 wt%至約95 wt%、約70 wt%至約95 wt%、約75 wt%至約95 wt%、約80 wt%至約95 wt%、約85 wt%至約95 wt%、約50 wt%至約90 wt%、約50 wt%至約85 wt%、約50 wt%至約80 wt%、約50 wt%至約75 wt%、約50 wt%至約70 wt%、約50 wt%至約65 wt%、約50 wt%至約60 wt%、或約50 wt%至約55 wt%。In some embodiments, the amount of polyurethane in the membrane prodrive formulation may be in the range of about 50 wt % to about 95 wt %, including subranges. For example, in some embodiments, the amount of polyurethane in the membrane pre-drive formulation can be in the range of about 55 wt% to about 95 wt%, about 60 wt% to about 95 wt%, about 65 wt% to about 95 wt%, about 70 wt% to about 95 wt%, about 75 wt% to about 95 wt%, about 80 wt% to about 95 wt%, about 85 wt% to about 95 wt%, about 50 wt% to about 90 wt%, about 50 wt% to about 85 wt%, about 50 wt% to about 80 wt%, about 50 wt% to about 75 wt%, about 50 wt% to about 70 wt%, about 50 wt% to about 65 wt%, about 50 wt% to about 60 wt%, or about 50 wt% to about 55 wt%.
除非另有說明,否則膜前驅物配方中聚胺甲酸酯及蛋白質之重量百分比值或範圍係基於配方中僅蛋白質及聚胺甲酸酯固體之總重量計。Unless otherwise stated, the weight percentage values or ranges of polyurethane and protein in the membrane pre-driver formulation are based on the total weight of only protein and polyurethane solids in the formulation.
在一些實施例中,膜前驅物配方可包含一或多種有色染料。在一些實施例中,膜前驅物配方可包含一或多種酸性染料。在一些實施例中,膜前驅物配方可包含一或多種反應性染料。例示性纖維反應性染料包括但不限於硫酸根合乙基碸(sulphatoethylsulphone) (Remazol)、三𠯤、乙烯基碸、及丙烯醯胺染料。例示性酸性染料包括但不限於偶氮結構酸性染料、金屬錯合物結構酸性染料、苯胺結構染料、及蒽醌結構酸性染料。In some embodiments, the membrane prodrug formulation may include one or more colored dyes. In some embodiments, the membrane prodrug formulation may include one or more acid dyes. In some embodiments, the membrane prodrug formulation may include one or more reactive dyes. Exemplary fiber reactive dyes include, but are not limited to, sulphatoethylsulphone (Remazol), tris(thionine), vinyl sulphone, and acrylamide dyes. Exemplary acid dyes include, but are not limited to, azo structure acid dyes, metal complex structure acid dyes, aniline structure dyes, and anthraquinone structure acid dyes.
在一些實施例中,蛋白質聚胺甲酸酯混摻物膜可應用於一紡織物。在一些實施例中,可將蛋白質聚胺甲酸酯混摻物膜附接至一紡織物。In some embodiments, the protein polyurethane blend film can be applied to a textile. In some embodiments, the protein polyurethane blend film can be attached to a textile.
圖1A及圖1B顯示根據一些實施例之材料100。材料100包含一紡織物110及一蛋白質聚胺甲酸酯混摻物膜120。蛋白質聚胺甲酸酯混摻物膜120包括一底表面122、一頂表面124、及在底表面122與頂表面124之間測得之厚度126。底表面122及頂表面124可為紡織物110之外部表面。在一些實施例中,材料100可包含複數個蛋白質聚胺甲酸酯混摻物膜120。1A and 1B show a material 100 according to some embodiments. The material 100 includes a textile 110 and a protein polyurethane blend film 120. The protein polyurethane blend film 120 includes a bottom surface 122, a top surface 124, and a thickness 126 measured between the bottom surface 122 and the top surface 124. The bottom surface 122 and the top surface 124 can be the exterior surfaces of the textile 110. In some embodiments, the material 100 can include a plurality of protein polyurethane blend films 120.
蛋白質聚胺甲酸酯混摻物膜120可經塗佈或以其他方式沉積在紡織物110上方。在一些實施例中,蛋白質聚胺甲酸酯混摻物膜120可設置在紡織物110上方。在一些實施例中,蛋白質聚胺甲酸酯混摻物膜120可設置在紡織物110之頂表面114上方,如圖1A所示。在一些實施例中,蛋白質聚胺甲酸酯混摻物膜120可設置在紡織物110之底表面112上,如圖1B所示。在一些實施例中,蛋白質聚胺甲酸酯混摻物膜120可設置在織物110之頂表面114上。在一些實施例中,蛋白質聚胺甲酸酯混摻物膜120可設置在紡織物110之底表面112上。The protein polyurethane blend film 120 may be coated or otherwise deposited on the textile 110. In some embodiments, the protein polyurethane blend film 120 may be disposed on the textile 110. In some embodiments, the protein polyurethane blend film 120 may be disposed on the top surface 114 of the textile 110, as shown in FIG. 1A. In some embodiments, the protein polyurethane blend film 120 may be disposed on the bottom surface 112 of the textile 110, as shown in FIG. 1B. In some embodiments, the protein polyurethane blend film 120 may be disposed on the top surface 114 of the textile 110. In some embodiments, the protein polyurethane blend film 120 may be disposed on the bottom surface 112 of the textile 110.
在一些實施例中,紡織物110之頂表面114可係紡織物110之一正面表面。在此類實施例中,當包含物品100之服裝物品被使用者穿著時,紡織物110之頂表面114可係紡織物110之一面向外部之表面。在一些實施例中,紡織物之底表面112可係紡織物100之背面表面。在此類實施例中,當包含物品100之服裝物品被使用者穿著時,底表面112可係紡織物110之一內部面向皮膚之表面。In some embodiments, top surface 114 of textile 110 may be a front surface of textile 110. In such embodiments, when an article of clothing containing article 100 is worn by a user, top surface 114 of textile 110 may be an exterior-facing surface of textile 110. In some embodiments, bottom surface 112 of textile may be a rear surface of textile 100. In such embodiments, when an article of clothing containing article 100 is worn by a user, bottom surface 112 may be an interior, skin-facing surface of textile 110.
紡織物110可包含一或多個紡織物層。一或多個紡織物層可係例如織造物層、非織造物層、針織物層、網格織物層、或皮革層。在一些實施例中,紡織物110可包括一第一紡織物層及一第二紡織物層,且膜120可設置在第一紡織物層及第二紡織物層之間。The textile 110 may include one or more textile layers. The one or more textile layers may be, for example, a woven layer, a nonwoven layer, a knitted layer, a mesh fabric layer, or a leather layer. In some embodiments, the textile 110 may include a first textile layer and a second textile layer, and the film 120 may be disposed between the first textile layer and the second textile layer.
一或多層紡織物層可由回收或原生纖維、長絲、或紗線所構成。在一些實施例中,紡織物110可係或可包含一聚酯針織物層、一聚酯棉混紡、一聚酯棉氨綸混紡針織物層、或一絨面革層。One or more textile layers may be made of recycled or virgin fibers, filaments, or yarns. In some embodiments, the textile 110 may be or may include a polyester knitted fabric layer, a polyester-cotton blended fabric layer, a polyester-cotton-spandex blended knitted fabric layer, or a suede leather layer.
在一些實施例中,紡織物110可由一或多種天然纖維製造,例如由棉、亞麻布、絲、羊毛、洋麻、亞麻、羊絨、安哥拉山羊毛、竹子、韌皮、麻類植物、大豆、海藻纖維(seacell)、乳或乳蛋白、蜘蛛絲、幾丁聚醣、菌絲體、纖維素(包括細菌纖維素)、或木材製造之纖維。In some embodiments, the textile 110 may be made from one or more natural fibers, such as fibers made from cotton, linen, silk, wool, kenaf, flax, cashmere, angora, bamboo, leather, hemp, soy, seacell, milk or milk protein, spider silk, chitosan, mycelium, cellulose (including bacterial cellulose), or wood.
在一些實施例中,紡織物110可由一或多種合成纖維製造,例如由聚酯、尼龍、芳族聚醯胺、聚烯烴纖維(諸如聚乙烯、聚丙烯)、人造絲、萊賽爾(lyocell)、黏液纖維(viscose)、抗微生物紗線(A.M.Y.)、Sorbtek,尼龍、彈性體(諸如Lycra ®、氨綸、或Elastane ®)、聚酯-聚胺甲酸酯共聚物、聚芳醯胺、碳(包括碳纖維及富勒烯(fullerene))、玻璃、矽、礦物、金屬或金屬混摻物(包括含鐵、鋼、鉛、金、銀、鉑、銅、鋅、及鈦者),或其混合物製造之纖維。 In some embodiments, the textile 110 may be made of one or more synthetic fibers, such as polyester, nylon, aramid, polyolefin fibers (such as polyethylene, polypropylene), rayon, lyocell, viscose, antimicrobial yarn (AMY), Sorbtek, nylon, elastomer (such as Lycra® , spandex, or Elastane® ), polyester-polyurethane copolymers, polyaramid, carbon (including carbon fibers and fullerene), glass, silicon, minerals, metals or metal blends (including those containing iron, steel, lead, gold, silver, platinum, copper, zinc, and titanium), or a mixture thereof.
在一些實施例中,非織造紡織物110可係短纖維(staple)非織造物、熔噴(melt-blown)非織造物、紡成(spunlaid)非織造物、閃紡(flashspun)非織造物、或其組合。In some embodiments, the nonwoven textile 110 may be a staple nonwoven, a melt-blown nonwoven, a spun nonwoven, a flashspun nonwoven, or a combination thereof.
在一些實施例中,紡織物110可用著色劑著色。在一些實施例中,著色劑可係有色染料,例如酸性染料、纖維反應性染料、直接染料、硫染料、鹼性染料、反應性染料、或甕染染料。在一些實施例中,著色劑可係顏料,例如色澱顏料。In some embodiments, the textile 110 can be colored with a colorant. In some embodiments, the colorant can be a colored dye, such as an acid dye, a fiber reactive dye, a direct dye, a sulfur dye, an alkaline dye, a reactive dye, or a vat dye. In some embodiments, the colorant can be a pigment, such as a color pigment.
在一些實施例中,如例如圖2A中所示,材料100可包含一蛋白質聚胺甲酸酯混摻物膜120,其係用黏著劑附接至紡織物110之一表面。在一些實施例中,材料100可包含一蛋白質聚胺甲酸酯混摻物膜120,其係用黏著劑附接至紡織物110之頂表面114。在一些實施例中,材料100可包含一蛋白質聚胺甲酸酯混摻物膜120,其係用黏著劑附接至紡織物110之底表面112。在一些實施例中,材料100可包括用黏著劑附接至紡織物110表面之底表面112之一第一蛋白質聚胺甲酸酯混摻物膜120及附接至紡織物110表面之頂表面114之一第二蛋白質聚胺甲酸酯混摻物膜120。In some embodiments, as shown in, for example, FIG. 2A , material 100 may include a protein polyurethane blend film 120 attached to one surface of textile 110 with an adhesive. In some embodiments, material 100 may include a protein polyurethane blend film 120 attached to a top surface 114 of textile 110 with an adhesive. In some embodiments, material 100 may include a protein polyurethane blend film 120 attached to a bottom surface 112 of textile 110 with an adhesive. In some embodiments, the material 100 may include a first protein polyurethane blend film 120 attached to a bottom surface 112 of a textile surface 110 with an adhesive and a second protein polyurethane blend film 120 attached to a top surface 114 of the textile surface 110.
在此類實施例中,黏著劑可包含一黏著劑層150,該黏著劑層包括一底表面152、一頂表面154,及在底表面152及頂表面154之間測得之厚度156。在一些實施例中,厚度156可在約5微米至約50微米之範圍內,包括子範圍。例如,厚度156可在下列之範圍內:約5微米至約50微米、約10微米至約50微米、約20微米至約50微米、約30微米至約50微米、或約20微米至約40微米。在一些實施例中,黏著劑層150可具有約5 g/m 2至約50 g/m 2之範圍內(包括子範圍)的乾重。例如,黏著劑層150可具有下列範圍內的乾重:約5 g/m 2至約50 g/m 2、約10 g/m 2至約50 g/m 2、約20 g/m 2至約50 g/m 2、約30 g/m 2至約50 g/m 2、或約20 g/m 2至約40 g/m 2。 In such embodiments, the adhesive may include an adhesive layer 150, which includes a bottom surface 152, a top surface 154, and a thickness 156 measured between the bottom surface 152 and the top surface 154. In some embodiments, the thickness 156 may be in the range of about 5 microns to about 50 microns, including sub-ranges. For example, the thickness 156 may be in the range of: about 5 microns to about 50 microns, about 10 microns to about 50 microns, about 20 microns to about 50 microns, about 30 microns to about 50 microns, or about 20 microns to about 40 microns. In some embodiments, the adhesive layer 150 may have a dry weight in the range of about 5 g/ m2 to about 50 g/ m2 (including sub-ranges). For example, the adhesive layer 150 may have a dry weight in the range of about 5 g/ m2 to about 50 g/ m2 , about 10 g/ m2 to about 50 g/ m2 , about 20 g/ m2 to about 50 g/ m2 , about 30 g/ m2 to about 50 g/ m2 , or about 20 g/m2 to about 40 g/ m2 .
適用於黏著劑層150之黏著劑包括但不限於聚胺甲酸酯黏著劑、熱熔融黏著劑、乳液聚合物黏著劑、乾帶材(dry web)黏著劑、乾層壓黏著劑、或濕層壓黏著劑。可購自C.L. Hauthaway & Sons Corporation之Hauthane Hd-2001係適用於黏著劑層150之例示性層壓黏著劑。例示性聚胺甲酸酯黏著劑包括但不限於來自Hauthaway之L-2183、L-2245、L-2255及來自Covestro之Impranil ®DAH、DAA。例示性乾帶材黏著劑包括但不限於來自Protechnic之9D8D20。在一些實施例中,聚胺甲酸酯黏著劑可係聚胺甲酸酯反應性黏著劑(亦稱為反應性熱熔融黏著劑)。 Adhesives suitable for adhesive layer 150 include, but are not limited to, polyurethane adhesives, hot melt adhesives, emulsion polymer adhesives, dry web adhesives, dry lamination adhesives, or wet lamination adhesives. Hauthane HD-2001 available from CL Hauthaway & Sons Corporation is an exemplary lamination adhesive suitable for adhesive layer 150. Exemplary polyurethane adhesives include, but are not limited to, L-2183, L-2245, L-2255 from Hauthaway and Impranil® DAH, DAA from Covestro. Exemplary dry web adhesives include, but are not limited to, 9D8D20 from Protechnic. In some embodiments, the polyurethane adhesive may be a polyurethane reactive adhesive (also known as a reactive hot melt adhesive).
在一些實施例中,黏著劑層150可係一連續層。在一些實施例中,黏著劑層150可係一不連續層,其包含以一規則或不規則圖案沉積之黏著劑。可以使用例如轉輪凹版印刷程序(rotogravure process)來沉積不連續黏著劑層。在一些實施例中,一不連續黏著劑層可包含黏著劑島(例如,點或方形)、黏著劑線、或其組合之一圖案。In some embodiments, the adhesive layer 150 can be a continuous layer. In some embodiments, the adhesive layer 150 can be a discontinuous layer comprising adhesive deposited in a regular or irregular pattern. The discontinuous adhesive layer can be deposited using, for example, a rotogravure process. In some embodiments, a discontinuous adhesive layer can include a pattern of adhesive islands (e.g., dots or squares), adhesive lines, or a combination thereof.
在一些實施例中,膜120可用防潑水整理劑170處理。在一些實施例中,防潑水整理劑170可包含如根據AATCC 22所測量之大於或等於約70之防潑水性噴霧等級。在一些實施例中,膜120可用無氟防潑水整理劑170處理。在一些實施例中,無氟防潑水整理劑170可包含如根據AATCC 22所測量之大於或等於約70之防潑水性噴霧等級。在一些實施例中,防潑水整理劑170可包含聚胺甲酸酯整理劑,其包含如根據AATCC 22所測量之大於或等於約70之防潑水性噴霧等級。在一些實施例中,防潑水整理劑170可包含無氟聚胺甲酸酯整理劑,其包含如根據AATCC 22所測量之大於或等於約70之防潑水性噴霧等級。In some embodiments, the film 120 may be treated with a water repellent finish 170. In some embodiments, the water repellent finish 170 may include a water repellent spray rating of greater than or equal to about 70 as measured according to AATCC 22. In some embodiments, the film 120 may be treated with a fluorine-free water repellent finish 170. In some embodiments, the fluorine-free water repellent finish 170 may include a water repellent spray rating of greater than or equal to about 70 as measured according to AATCC 22. In some embodiments, the water repellent finish 170 may include a polyurethane finish including a water repellent spray rating of greater than or equal to about 70 as measured according to AATCC 22. In some embodiments, the water repellent finish 170 may include a fluorine-free polyurethane finish comprising a water repellent spray rating of greater than or equal to about 70 as measured according to AATCC 22.
在一些實施例中,防潑水整理劑170可包含聚碳酸酯聚胺甲酸酯。在一些實施例中,防潑水整理劑170可包含脂族聚碳酸酯聚胺甲酸酯。在一些實施例中,用於防潑水整理劑170之聚胺甲酸酯可包含水性脂族聚碳酸酯聚胺甲酸酯分散液。在一些實施例中,水性脂肪族聚碳酸酯聚胺甲酸酯分散液可具有約34%之固體含量及5至1000 mPa.s之黏度。In some embodiments, the water-repellent finish 170 may include polycarbonate polyurethane. In some embodiments, the water-repellent finish 170 may include aliphatic polycarbonate polyurethane. In some embodiments, the polyurethane used for the water-repellent finish 170 may include an aqueous aliphatic polycarbonate polyurethane dispersion. In some embodiments, the aqueous aliphatic polycarbonate polyurethane dispersion may have a solid content of about 34% and a viscosity of 5 to 1000 mPa.s.
在一些實施例中,如例如圖2B中所示,材料100可包含一第一紡織物110、一第二紡織物110、及設置在第一紡織物110及第二紡織物110之間的一蛋白質聚胺甲酸酯混摻物膜120。在此類實施例中,蛋白質聚胺甲酸酯混摻物膜120可用一第一黏著劑層150附接至第一紡織物110之一底表面且用一第二黏著劑層150附接至第二紡織物110之一頂表面。In some embodiments, as shown in, for example, FIG. 2B , the material 100 may include a first textile 110, a second textile 110, and a protein polyurethane blend film 120 disposed between the first textile 110 and the second textile 110. In such embodiments, the protein polyurethane blend film 120 may be attached to a bottom surface of the first textile 110 with a first adhesive layer 150 and to a top surface of the second textile 110 with a second adhesive layer 150.
在一些實施例中,如例如圖2B中所示,紡織物110可用防潑水整理劑170處理。在一些實施例中,材料100可包含設置在一第一紡織物110及一第二紡織物110之間的一蛋白質聚胺甲酸酯混摻物膜120,且第一紡織物110、第二紡織物110、或兩者可用防潑水整理劑170處理。In some embodiments, as shown in, for example, FIG2B , the textile 110 may be treated with a water-repellent finish 170. In some embodiments, the material 100 may include a protein polyurethane blend film 120 disposed between a first textile 110 and a second textile 110, and the first textile 110, the second textile 110, or both may be treated with a water-repellent finish 170.
材料100可藉由將一或多種蛋白質聚胺甲酸酯混摻物膜120附接至紡織物110來製造。在一些實施例中,(多個)蛋白質聚胺甲酸酯混摻物膜可層疊在一犧牲層上方,該犧牲層在層疊之後且在將一或多個膜120附接至紡織物110之前或之後被移除。蛋白質聚胺甲酸酯混摻物膜120可使用任何合適的塗佈技術來沉積,包括但不限於輥襯刮刀塗佈(knife over roll)、凹版塗佈、狹縫式模具塗佈(slot die coating)、多層狹縫式模具塗佈、或簾幕式塗佈(curtain coating)。多層狹縫式模具塗佈可允許同時塗佈多個相鄰的膜或層。The material 100 can be made by attaching one or more protein polyurethane blend films 120 to a textile 110. In some embodiments, the protein polyurethane blend film(s) can be laminated over a sacrificial layer that is removed after lamination and before or after attaching the one or more films 120 to the textile 110. The protein polyurethane blend film 120 may be deposited using any suitable coating technique, including but not limited to knife over roll, gravure coating, slot die coating, multi-layer slot die coating, or curtain coating. Multi-layer slot die coating may allow for the simultaneous coating of multiple adjacent films or layers.
在一些實施例中,紡織物110可用一黏著劑層150塗佈,且可在黏著劑層150上方形成一或多個膜120。在此類實施例中,(多個)膜120可以與下文所述用於方法300相同之方式形成在黏著劑層150上方,其中該等膜120係形成在黏著劑層150上方而不是在一犧牲層上方。In some embodiments, the textile 110 may be coated with an adhesive layer 150, and one or more films 120 may be formed over the adhesive layer 150. In such embodiments, the film(s) 120 may be formed over the adhesive layer 150 in the same manner as described below for method 300, wherein the films 120 are formed over the adhesive layer 150 rather than over a sacrificial layer.
為製造蛋白質聚胺甲酸酯前驅物配方,可將一或多種水性聚胺甲酸酯分散液與一或多種蛋白質摻合以形成摻合混合物。合適的摻合設備包括但不限於摻合機、立式攪拌機、在線攪拌機、或高剪切攪拌機。To prepare the protein polyurethane precursor formulation, one or more aqueous polyurethane dispersions may be blended with one or more proteins to form a blended mixture. Suitable blending equipment includes, but is not limited to, a blender, a stand mixer, an inline mixer, or a high shear mixer.
在一些實施例中,在與一或多種水性聚胺甲酸酯分散液摻合之前,可將(多種)蛋白質分散或溶解於水溶液中。合適的水溶液包括但不限於水、鹼水溶液、酸水溶液、包括有機溶劑之水溶液、尿素溶液、及其混合物。在一些實施例中,鹼水溶液可係鹼性溶液,諸如氫氧化鈉、氨、或氫氧化銨溶液。在一些實施例中,酸性水溶液之實例可係乙酸或鹽酸(HCl)溶液。合適的有機溶劑包括但不限於乙醇、異丙醇、丙酮、乙酸乙酯、乙酸異丙酯、甘油、及類似者。In some embodiments, the protein(s) may be dispersed or dissolved in an aqueous solution prior to blending with one or more aqueous polyurethane dispersions. Suitable aqueous solutions include, but are not limited to, water, alkaline aqueous solutions, acidic aqueous solutions, aqueous solutions including organic solvents, urea solutions, and mixtures thereof. In some embodiments, the alkaline aqueous solution may be an alkaline solution, such as sodium hydroxide, ammonia, or ammonium hydroxide solution. In some embodiments, an example of an acidic aqueous solution may be an acetic acid or hydrochloric acid (HCl) solution. Suitable organic solvents include, but are not limited to, ethanol, isopropanol, acetone, ethyl acetate, isopropyl acetate, glycerol, and the like.
在一些實施例中,蛋白質聚胺甲酸酯前驅物配方可包含一或多種添加劑。合適的添加劑包括但不限於填料、顏料、塑化劑、蠟、流變改質劑、阻燃劑、抗微生物劑、抗真菌劑、抗氧化劑、UV穩定劑、手感改質劑(hand modifier)、整平劑、及類似者。合適的抗微生物/抗真菌劑包括Ultra-Fresh DW-56。合適的阻燃劑包括Cetaflam ®DB9(含有C−PO(OH) 2或C−PO(OR) 2基團之具有含碳鏈之聚合物之有機磷化合物)、Cetaflam ®PD3300(含有C−PO(OH) 2或C−PO(OR) 2基團之具有含碳鏈之聚合物之有機磷化合物)、或用於塗佈紡織物之其他阻燃劑。合適的填料包括但不限於熱塑性微球,例如Expancel ®微球。合適的流變改質劑包括但不限於鹼可溶脹之流變改質劑、疏水改質之基於環氧乙烷之胺甲酸酯(hydrophobically-modified ethylene oxide-based urethane, HEUR)流變改質劑、及體積排除(volume exclusion)增稠劑。例示性鹼可溶脹之流變改質劑包括但不限於來自Dow Chemicals之Acrysol ™DR-106、Acrysol ™ASE-60及來自Scott-Bader之Texicryl ®13-3131、及Texicryl ®13-308。例示性HEUR改質劑包括但不限於來自Stahl之RM-4410及來自HeiQ之Chemtex 2241-A。例示性體積排除增稠劑包括但不限於來自Dow Chemicals之Walocel ™XM 20000 PV及來自Sigma- Aldrich之甲基-羥乙基纖維素。HM-13-843(水性改質之聚矽氧溶液手感改質劑,可獲自Stahl Holdings B.V.)係例示性手感改質劑。 In some embodiments, the protein polyurethane precursor formulation may include one or more additives. Suitable additives include, but are not limited to, fillers, pigments, plasticizers, waxes, rheology modifiers, flame retardants, antimicrobial agents, antifungal agents, antioxidants, UV stabilizers, hand modifiers, levelers, and the like. Suitable antimicrobial/antifungal agents include Ultra-Fresh DW-56. Suitable flame retardants include Cetaflam ® DB9 (organophosphorus compound of a polymer with a carbon chain containing C-PO(OH) 2 or C-PO(OR) 2 groups), Cetaflam ® PD3300 (organophosphorus compound of a polymer with a carbon chain containing C-PO(OH) 2 or C-PO(OR) 2 groups), or other flame retardants used for coating textiles. Suitable fillers include, but are not limited to, thermoplastic microspheres, such as Expancel ® microspheres. Suitable rheology modifiers include, but are not limited to, alkali-swellable rheology modifiers, hydrophobically-modified ethylene oxide-based urethane (HEUR) rheology modifiers, and volume exclusion thickeners. Exemplary alkali-swellable rheology modifiers include, but are not limited to, Acrysol ™ DR-106, Acrysol ™ ASE-60 from Dow Chemicals, and Texicryl® 13-3131, and Texicryl® 13-308 from Scott-Bader. Exemplary HEUR modifiers include, but are not limited to, RM-4410 from Stahl and Chemtex 2241-A from HeiQ. Exemplary volume exclusion thickeners include, but are not limited to, Walocel ™ XM 20000 PV from Dow Chemicals and methyl-hydroxyethyl cellulose from Sigma-Aldrich. HM-13-843 (a water-based modified polysilicone solution feel modifier, available from Stahl Holdings BV) is an exemplary feel modifier.
在一些實施例中,蛋白質聚胺甲酸酯混摻物膜可在一犧牲層上方形成並在形成之後附接至基材層(例如紡織物)。圖3顯示根據一些實施例之用於製造材料之方法300。方法300可用於將一或多個膜120附接至一紡織物110之一或多個表面。除非另有說明,否則方法300之步驟不需以本文中所闡述之順序來進行。此外,除非另有說明,否則方法300之步驟不需依序進行。In some embodiments, the protein polyurethane blend film can be formed on a sacrificial layer and attached to a substrate layer (e.g., textile) after formation. FIG. 3 shows a method 300 for making a material according to some embodiments. The method 300 can be used to attach one or more membranes 120 to one or more surfaces of a textile 110. Unless otherwise specified, the steps of the method 300 do not need to be performed in the order described herein. In addition, unless otherwise specified, the steps of the method 300 do not need to be performed in sequence.
在步驟302中,本文中所述之前驅物配方可藉由將一或多種水性聚胺甲酸酯分散液、一或多種蛋白質、及一或多種交聯劑摻合以形成摻合混合物來產生。在一些實施例中,在步驟302中與聚胺甲酸酯摻合之前,可將(多種)蛋白質在分散或溶解於水溶液中。合適的水溶液包括但不限於水、鹼水溶液、酸水溶液、包括有機溶劑之水溶液、尿素溶液、及其混合物。在一些實施例中,鹼水溶液可係鹼性溶液,諸如氫氧化鈉、氨、或氫氧化銨溶液。在一些實施例中,酸性水溶液之實例可係乙酸或鹽酸(HCl)溶液。合適的有機溶劑包括但不限於乙醇、異丙醇、丙酮、乙酸乙酯、乙酸異丙酯、甘油、及類似者。In step 302, the above-described driver formulations may be produced by blending one or more aqueous polyurethane dispersions, one or more proteins, and one or more crosslinking agents to form a blended mixture. In some embodiments, the protein(s) may be dispersed or dissolved in an aqueous solution prior to blending with the polyurethane in step 302. Suitable aqueous solutions include, but are not limited to, water, alkaline aqueous solutions, acidic aqueous solutions, aqueous solutions including organic solvents, urea solutions, and mixtures thereof. In some embodiments, the alkaline aqueous solution may be an alkaline solution, such as sodium hydroxide, ammonia, or ammonium hydroxide solution. In some embodiments, an example of an acidic aqueous solution may be an acetic acid or hydrochloric acid (HCl) solution. Suitable organic solvents include, but are not limited to, ethanol, isopropyl alcohol, acetone, ethyl acetate, isopropyl acetate, glycerol, and the like.
在一些實施例中,在步驟302中可將一或多種有色染料添加到混摻物中。在一些實施例中,在步驟302中可將一或多種添加劑添加到混摻物中。合適的添加劑包括但不限於填料、顏料、塑化劑、蠟、流變改質劑、阻燃劑、抗微生物劑、抗真菌劑、抗氧化劑、UV穩定劑、及手感改質劑,如本文中所述。In some embodiments, one or more colored dyes may be added to the mixture in step 302. In some embodiments, one or more additives may be added to the mixture in step 302. Suitable additives include, but are not limited to, fillers, pigments, plasticizers, waxes, rheology modifiers, flame retardants, antimicrobials, antifungals, antioxidants, UV stabilizers, and feel modifiers, as described herein.
在步驟304中,將一或多層的摻合混合物設置在犧牲層之一表面上方。在步驟304中,可將一或多層的摻合混合物塗佈在犧牲層之表面上。在一些實施例中,可將一層的摻合混合物直接塗佈在犧牲層之表面上。塗佈可包括澆注、擠出、鑄造等。在一些實施例中,可使用例如葉片、刮刀、輥、輥襯刮刀、簾幕式塗佈、及狹縫式模具塗佈將混合物鋪展至所欲厚度。In step 304, one or more layers of the blended mixture are disposed over a surface of the sacrificial layer. In step 304, one or more layers of the blended mixture may be coated on the surface of the sacrificial layer. In some embodiments, a layer of the blended mixture may be coated directly on the surface of the sacrificial layer. Coating may include pouring, extrusion, casting, etc. In some embodiments, the mixture may be spread to a desired thickness using, for example, a blade, a scraper, a roller, a roller-lined scraper, curtain coating, and slot die coating.
犧牲層係不定義為一層材料100之一材料層。相反,犧牲層在材料100之製造期間被移除。犧牲層可以機械方式(例如藉由剝離)、或以化學方式(例如藉由溶解犧牲層)移除。在一些實施例中,犧牲層可係一離型紙。The sacrificial layer is not defined as a material layer of the material 100. Instead, the sacrificial layer is removed during the manufacturing of the material 100. The sacrificial layer can be removed mechanically (e.g., by peeling) or chemically (e.g., by dissolving the sacrificial layer). In some embodiments, the sacrificial layer can be a release paper.
在步驟306中,可將該一或多層中之溶劑(例如水)移除,以形成蛋白質聚胺甲酸酯混摻物膜120。合適的溶劑移除方法包括但不限於隧道乾燥、真空乾燥、用熱空氣之烘箱乾燥、濕度箱乾燥、用熱空氣之浮選乾燥(flotation drying)、及具有用於預熱之中程IR(紅外線)及之後用於後續乾燥之熱空氣之組合的烘箱。In step 306, the solvent (e.g., water) in the one or more layers may be removed to form the protein polyurethane blend film 120. Suitable solvent removal methods include, but are not limited to, tunnel drying, vacuum drying, oven drying with hot air, humidity chamber drying, flotation drying with hot air, and an oven with a combination of mid-range IR (infrared) for preheating and then hot air for post drying.
在一些實施例中,可重複步驟304及306以將混合物之各層塗佈在犧牲層上方。例如,在一些實施例中,可將摻合混合物之一第一層塗佈在犧牲層上,然後完全地或部分地乾燥。然後,在完全地或部分地乾燥第一層之後,可將摻合混合物之一第二層塗佈在第一層上。在此類實施例中,在塗佈兩層之後,可以將該等層乾燥以形成膜120。In some embodiments, steps 304 and 306 may be repeated to apply layers of the mixture over the sacrificial layer. For example, in some embodiments, a first layer of the blended mixture may be applied over the sacrificial layer and then completely or partially dried. Then, after completely or partially drying the first layer, a second layer of the blended mixture may be applied over the first layer. In such embodiments, after applying the two layers, the layers may be dried to form the membrane 120.
在步驟308中,移除犧牲層。犧牲層可藉由機械程序或化學程序來移除。例如,犧牲層可藉由將犧牲層自膜120剝離來移除。作為另一實例,犧牲層可藉由溶解該犧牲層來移除。In step 308, the sacrificial layer is removed. The sacrificial layer may be removed by a mechanical process or a chemical process. For example, the sacrificial layer may be removed by peeling the sacrificial layer from the film 120. As another example, the sacrificial layer may be removed by dissolving the sacrificial layer.
在步驟310中,將膜120附接至一基材層(例如紡織物110)。在一些實施例中,在步驟310中附接膜120可包括熱壓程序。在此類實施例中,膜120可以與紡織物110直接接觸。另外,在此類實施例中,膜120可部分地熔融到紡織物110中,且在冷卻時,兩個層會牢固地附接。在一些實施例中,在步驟310中將膜120附接至紡織物110可包括層壓程序。在此類實施例中,層壓可用一黏著劑層150來完成。在此類實施例中,紡織物110及/或膜120可用黏著劑藉由已知技術(諸如狹縫式模具鑄造、吻合塗佈(kiss coating)、下拉技術(drawdown technique)、或反向轉印塗佈(reverse transfer coating))塗佈。在一些實施例中,層壓程序可包括使紡織物110及膜120在加熱下通過輥。In step 310, film 120 is attached to a substrate layer (e.g., textile 110). In some embodiments, attaching film 120 in step 310 may include a heat press process. In such embodiments, film 120 may be in direct contact with textile 110. Additionally, in such embodiments, film 120 may be partially melted into textile 110, and upon cooling, the two layers may be firmly attached. In some embodiments, attaching film 120 to textile 110 in step 310 may include a lamination process. In such embodiments, lamination may be accomplished with an adhesive layer 150. In such embodiments, the textile 110 and/or film 120 may be coated with an adhesive by known techniques such as slot die casting, kiss coating, drawdown technique, or reverse transfer coating. In some embodiments, the lamination process may include passing the textile 110 and film 120 through a roller under heat.
在一些實施例中,步驟310可自方法300中省略。在此類實施例中,膜120可不附接至一基材層。例如,在此類實施例中,膜120可不附接至紡織物110。In some embodiments, step 310 may be omitted from method 300. In such embodiments, film 120 may not be attached to a substrate layer. For example, in such embodiments, film 120 may not be attached to textile 110.
本文中所述之材料可用於各種應用中。例如,材料可用於鞋類、衣服、手套、家俱、車輛內飾、及其他商品及產品,諸如大衣、外套、夾克、襯衫、長褲、褲子、短褲、泳裝、內衣、制服、徽章或字母、服裝、領帶、裙子、洋裝、罩衫、緊身褲、手套、合指手套、鞋子、鞋子組件(諸如鞋底、鞋腰(quarter)、鞋舌、鞋領口、沿條、及後幫(counter))、禮服鞋、運動鞋、跑步鞋、休閒鞋、運動鞋、跑步鞋或休閒鞋組件(諸如腳趾套(toe cap)、鞋頭(toe box)、外底、中底、鞋面、鞋帶、鞋眼片(eyelet)、鞋領、襯裡、跟腱凹口(Achilles notch)、後跟、及後幫)、時裝鞋或女鞋及其等的鞋組件(諸如鞋面、外底、翹頭翹度、鞋頭、裝飾、鞋前幫(vamp)、襯裡、鞋墊、中墊、厚底、後幫、及鞋跟或高跟)、長靴、涼鞋、鈕扣、涼鞋、帽子、面罩、安全帽、頭帶、頭巾、及腰帶;珠寶諸如手鐲、錶帶、及項鍊;手套、雨傘、手杖、皮夾、手機或穿戴式電腦遮蓋物、錢包、背包、手提箱、手提包、對開本、文件夾、盒子、及其他個人物品;運動、體育、狩獵、或休閒裝備,諸如馬具、繫帶、韁繩、馬銜、皮帶、連指手套、網球拍、高爾夫球桿、馬球、曲棍球、或長曲棍球裝備、棋盤及遊戲板、藥球、足壘球(kick ball)、棒球、及其他種類的球、及玩具;書籍裝訂、書皮、相框、或藝術品;家俱及家居、辦公室或其他室內或室外陳設品包括椅子、沙發、門、座椅、長軟椅、房間隔板、杯墊、滑鼠墊、辦公桌記事本或其他墊、桌子、床、地板、牆壁或天花板覆蓋物、地板材料、汽車、船舶、飛機及其他車輛產品,包括座椅、頭枕、內飾、鑲板、方向盤、操縱桿或控制器覆蓋物、及其他包裹物或覆蓋物。The materials described herein can be used in a variety of applications. For example, the materials can be used in footwear, clothing, gloves, furniture, vehicle interiors, and other goods and products, such as coats, jackets, jackets, shirts, trousers, pants, shorts, swimwear, underwear, uniforms, badges or letters, clothing, ties, skirts, dresses, blouses, leggings, gloves, mittens, shoes, shoe components (such as soles, quarters, tongues, collars, welts, and counters), dress shoes, athletic shoes, running shoes, casual shoes, athletic shoes, running shoes or casual shoe components (such as toe caps, toe boxes, outsoles, midsoles, uppers, laces, eyelets, collars, linings, Achilles tendon notches, etc.) notch), heel, and back), fashion shoes or women's shoes and their components (such as uppers, outer soles, toe caps, toes, decorations, vamps, linings, insoles, midsoles, platforms, backs, and heels or high heels), boots, sandals, buckles, sandals, hats, masks, helmets, headbands, scarves, and belts; jewelry such as bracelets, watchbands, and necklaces; gloves, umbrellas , canes, wallets, cell phone or wearable computer covers, wallets, backpacks, briefcases, handbags, folios, folders, boxes, and other personal items; sports, athletic, hunting, or recreational equipment such as harnesses, leashes, reins, harnesses, belts, mittens, tennis rackets, golf clubs, polo, hockey, or lacrosse equipment, chess and game boards, medicine balls, softballs (kick ball), baseballs, and other types of balls, and toys; book bindings, book covers, picture frames, or artwork; furniture and home, office, or other indoor or outdoor furnishings including chairs, sofas, doors, seats, ottomans, room dividers, coasters, mouse pads, desk organizers or other pads, tables, beds, floor, wall or ceiling coverings, flooring materials, automotive, marine, aircraft, and other vehicular products including seats, headrests, interior trim, trim, steering wheels, joystick or controller covers, and other wrappings or coverings.
本文中所討論之實施例將在下列實施例中進一步闡明。應理解,此等實例不限於上述之實施例。 實例1The embodiments discussed herein will be further illustrated in the following embodiments. It should be understood that these embodiments are not limited to the above-mentioned embodiments.
將100 g的基於水性脂族聚醚之聚胺甲酸酯分散液(具有35%之固體含量、1.02 g/mL之比重及160 mPa.s之布氏黏度)(「WPD1」)、0.3 g的AF-715(可購自Quaker Color之防沫劑)、及5 g的Permutex ®XR-5577(聚碳二亞胺交聯劑,可購自Stahl Holdings B.V.)添加至150 mL燒杯中以製備聚胺甲酸酯配方。使用Caframo葉輪攪拌器在室溫下將配方在燒杯中混合5分鐘。在混合之後,將2 g的Permutex ®EVO-EX-RM-2956(流變改質劑,可購自Stahl Holdings B.V.)添加至燒杯中並將該組合再混合5至10分鐘。然後將聚胺甲酸酯配方通過190微米尼龍網濾紙過濾器過濾,並在真空烘箱中在室溫下除氣至多1小時以移除氣泡。 100 g of a waterborne aliphatic polyether-based polyurethane dispersion having a solids content of 35%, a specific gravity of 1.02 g/mL, and a Brookfield viscosity of 160 mPa.s ("WPD1"), 0.3 g of AF-715 (antifoam available from Quaker Color), and 5 g of Permutex ® XR-5577 (polycarbodiimide crosslinker available from Stahl Holdings BV) were added to a 150 mL beaker to prepare the polyurethane formulation. The formulation was mixed in the beaker for 5 minutes at room temperature using a Caframo impeller stirrer. After mixing, 2 g of Permutex ® EVO-EX-RM-2956 (rheology modifier available from Stahl Holdings BV) was added to the beaker and the combination was mixed for another 5 to 10 minutes. The polyurethane formulation was then filtered through a 190 micron nylon mesh paper filter and degassed in a vacuum oven at room temperature for up to 1 hour to remove air bubbles.
在除氣之後,多層聚胺甲酸酯膜係藉由使用具有刮刀施加器之Sintex實驗室塗佈機將兩層的聚胺甲酸酯配方各自塗佈到一離型紙上來製造。當塗佈時,施加第一層,然後在70℃下乾燥90秒。在施加並乾燥第一層之後,將第二層施加在該第一層之頂部,然後將兩層在70℃下乾燥90秒、在90℃下乾燥90秒、及在150℃下乾燥90秒。在乾燥之後,將膜自離型紙剝離。膜具有在20與40微米之間的厚度。然後將膜在溫濕度控制箱(Forma ™環境箱,可購自Thermo Scientific)中在23℃及50%相對濕度下條件處理至多24小時。 After degassing, a multi-layer polyurethane film was made by coating two layers of the polyurethane formulation each onto a release paper using a Sintex laboratory coater with a doctor blade applicator. When coating, the first layer was applied and then dried at 70°C for 90 seconds. After applying and drying the first layer, the second layer was applied on top of the first layer, and then both layers were dried at 70°C for 90 seconds, at 90°C for 90 seconds, and at 150°C for 90 seconds. After drying, the film was peeled off the release paper. The film had a thickness between 20 and 40 microns. The membranes were then conditioned in a temperature and humidity controlled chamber (Forma ™ Environmental Chamber, available from Thermo Scientific) at 23°C and 50% relative humidity for up to 24 hours.
根據JIS L 1092,使用靜水壓頭測試儀(Hydro Tester MK4,可購自Ardmel)測量自膜切下之不同樣本的防水性。使用定製之測試夾具根據JIS L 1099 B1靜水壓法測試來測量自膜切下之不同樣品的透氣性。The waterproofness of different samples cut from the film was measured using a hydrostatic head tester (Hydro Tester MK4, available from Ardmel) according to JIS L 1092. The air permeability of different samples cut from the film was measured using a custom-made test fixture according to the JIS L 1099 B1 hydrostatic pressure test.
定製之測試夾具係根據JIS L 1099 B1測試方法建造。該夾具具有一個可裝水的底座、一個中心具有直徑為89-mm之孔的蓋子、及一個具有89 mm外徑、80 mm內徑、及50 mm長的圓柱管。將管固定至蓋子,並使用橡皮筋將樣本膜安裝到管上。將蓋子放置在底座上,將樣品膜浸入水位線以下10 mm處。將具有75-mm管長及56 mm直徑之乾燥劑杯的一端用一丙烯酸片材密封。然後將該杯用乙酸鉀乾燥劑溶液填充至2/3體積並用一PTFE微孔膜密封並且進一步用膠帶固定。測試夾具之所有部件均使用丙烯酸塑膠片材及丙烯酸管製造。The custom test fixture was constructed according to the JIS L 1099 B1 test method. The fixture has a base that can hold water, a lid with a hole of 89-mm diameter in the center, and a cylindrical tube with an outer diameter of 89 mm, an inner diameter of 80 mm, and a length of 50 mm. The tube was fixed to the lid, and the sample membrane was mounted on the tube using a rubber band. The lid was placed on the base, and the sample membrane was immersed 10 mm below the water line. One end of the desiccant cup with a 75-mm tube length and a diameter of 56 mm was sealed with an acrylic sheet. The cup was then filled to 2/3 of its volume with potassium acetate desiccant solution and sealed with a PTFE microporous membrane and further secured with tape. All parts of the test fixture are made of acrylic plastic sheets and acrylic tubes.
在防水性測試及透氣性測試期間,使用Espec BTL-433溫濕度箱控制膜樣本之溫度及相對濕度。膜樣本(樣本1A、1B、1C、及1D)之透氣性及防水性測量值顯示於下表4中。 實例2至12During the waterproofness test and air permeability test, the temperature and relative humidity of the membrane samples were controlled using an Espec BTL-433 temperature and humidity chamber. The air permeability and waterproofness measurements of the membrane samples (Samples 1A, 1B, 1C, and 1D) are shown in Table 4 below. Examples 2 to 12
大豆分離蛋白質(SPI)溶液係藉由將176.47 g的大豆分離蛋白質(SUPRO ®XT 221D,由DuPont製造,可購自Solae LLC)添加至預熱至50℃之1 L的0.05 mol/L氫氧化鈉水溶液中來製備。在添加之後,使用Caframo葉輪攪拌器將該溶液在50℃及250 rpm下混合30分鐘,以完全溶解SPI。然後使SPI溶液冷卻至室溫。在冷卻之後,添加24 g的Ultra-Fresh Dw-56(水性抗微生物分散液)並將溶液在室溫下以250 rpm混合5至10分鐘。 A soy protein isolate (SPI) solution was prepared by adding 176.47 g of soy protein isolate (SUPRO ® XT 221D, manufactured by DuPont, available from Solae LLC) to 1 L of a 0.05 mol/L aqueous sodium hydroxide solution preheated to 50°C. After addition, the solution was mixed at 50°C and 250 rpm for 30 minutes using a Caframo impeller stirrer to completely dissolve the SPI. The SPI solution was then cooled to room temperature. After cooling, 24 g of Ultra-Fresh Dw-56 (aqueous antimicrobial dispersion) was added and the solution was mixed at 250 rpm for 5 to 10 minutes at room temperature.
蛋白質聚胺甲酸酯混摻物膜係藉由將下列物質添加至150 mL燒杯中來製備:(a) SPI溶液,其質量如下表2至3中所詳述、(b)水性聚胺甲酸酯分散液(waterborne polyurethane dispersion, WPD),其質量如下表2至3中所詳述、(c) 0.3 g的消泡劑(AF-715,可購自Quaker Color)、及(d)交聯劑,其量如下表2至3中所詳述。使用Caframo葉輪攪拌機在室溫下將各配方在其各自的燒杯中混合5分鐘。該等水性聚胺甲酸酯分散液係WPD1、非離子型脂族聚碳酸酯-聚醚聚胺甲酸酯分散液(具有30%之固體含量、1.1 g/mL之比重、及<1000 mPa.s之黏度)(「WPD2」),或兩者。交聯劑係WH-PZ5150(氮丙啶官能化支鏈聚酯交聯劑,可購自An Fong Development Co., Ltd.)、Permutex ®XR-5577、或XR-13-820(可購自Stahl Holdings B.V.之異氰酸酯交聯劑)。 The protein polyurethane blend films were prepared by adding the following to a 150 mL beaker: (a) SPI solution, the mass of which is detailed in Tables 2 to 3, (b) waterborne polyurethane dispersion (WPD), the mass of which is detailed in Tables 2 to 3, (c) 0.3 g of defoamer (AF-715, available from Quaker Color), and (d) crosslinker, the amount of which is detailed in Tables 2 to 3. Each formulation was mixed in its respective beaker at room temperature for 5 minutes using a Caframo impeller mixer. The aqueous polyurethane dispersions are WPD1, nonionic aliphatic polycarbonate-polyether polyurethane dispersion (having a solid content of 30%, a specific gravity of 1.1 g/mL, and a viscosity of <1000 mPa.s) ("WPD2"), or both. The crosslinking agent is WH-PZ5150 (aziridine functionalized branched polyester crosslinker, available from An Fong Development Co., Ltd.), Permutex ® XR-5577, or XR-13-820 (isocyanate crosslinker available from Stahl Holdings BV).
在混合之後,將2 g的Permutex ®EVO-EX-RM-2956 (Stahl Holdings B.V.)添加至燒杯中並將該組合再混合5至10分鐘。將各配方通過190微米尼龍網濾紙過濾器過濾,並在真空烘箱中在室溫下除氣至多1小時以移除氣泡。 After mixing, 2 g of Permutex® EVO-EX-RM-2956 (Stahl Holdings BV) was added to the beaker and the combination was mixed for an additional 5 to 10 minutes. Each formulation was filtered through a 190 micron nylon mesh filter paper filter and degassed in a vacuum oven at room temperature for up to 1 hour to remove air bubbles.
在除氣之後,多層聚胺甲酸酯膜係由各配方藉由使用具有刮刀施加器之Sintex實驗室塗佈機將兩層的配方塗佈到一離型紙上來製造。當塗佈時,施加第一層,然後在70℃下乾燥90秒。在施加並乾燥第一層之後,將第二層施加在該第一層之頂部,然後將兩層在70℃下乾燥90秒、在90℃下乾燥90秒、及在150℃下乾燥90秒。在乾燥之後,將膜自離型紙剝離。各膜具有在20與40微米之間的厚度。在測試之前,將膜在溫濕度控制箱(Forma ™環境箱,可購自Thermo Scientific)中在23℃及50%相對濕度下條件處理至多24小時。 After degassing, multi-layer polyurethane films were made from each formulation by coating two layers of the formulation onto a release paper using a Sintex laboratory coater with a doctor blade applicator. When coating, the first layer was applied and then dried at 70°C for 90 seconds. After applying and drying the first layer, the second layer was applied on top of the first layer, and then both layers were dried at 70°C for 90 seconds, at 90°C for 90 seconds, and at 150°C for 90 seconds. After drying, the film was peeled off the release paper. Each film had a thickness between 20 and 40 microns. Prior to testing, the membranes were conditioned in a temperature and humidity controlled chamber (Forma ™ Environmental Chamber, available from Thermo Scientific) at 23°C and 50% relative humidity for up to 24 hours.
實例11及12係使用與實例2至10相同之方法製造,不同之處在於不包括交聯劑,如下表3中所詳述。Examples 11 and 12 were prepared using the same method as Examples 2 to 10, except that no crosslinking agent was included, as detailed in Table 3 below.
使用實例1中所述之方法測量自膜切下之不同樣本的透氣性及防水性。各膜類型之不同膜樣本(樣品2A、2B、2C等)之透氣性及防水性值顯示於下表4中。 實例13The air permeability and water resistance of different samples cut from the membrane were measured using the method described in Example 1. The air permeability and water resistance values of different membrane samples (samples 2A, 2B, 2C, etc.) of each membrane type are shown in Table 4 below. Example 13
將100 g的WPD1及0.3 g的AF-715添加至150 mL燒杯中以製備聚胺甲酸酯配方。使用Caframo葉輪攪拌器在室溫下將配方在燒杯中混合5分鐘。在混合之後,將1 g的Permutex ®EVO-EX-RM-2956添加至燒杯中並將該組合再混合5至10分鐘。然後將聚胺甲酸酯配方通過190微米尼龍網濾紙過濾器過濾,並在真空烘箱中在室溫下除氣至多1小時以移除氣泡。 100 g of WPD1 and 0.3 g of AF-715 were added to a 150 mL beaker to prepare the polyurethane formulation. The formulation was mixed in the beaker using a Caframo impeller stirrer at room temperature for 5 minutes. After mixing, 1 g of Permutex ® EVO-EX-RM-2956 was added to the beaker and the combination was mixed for another 5 to 10 minutes. The polyurethane formulation was then filtered through a 190 micron nylon mesh filter paper filter and degassed in a vacuum oven at room temperature for up to 1 hour to remove air bubbles.
在除氣之後,多層聚胺甲酸酯膜係藉由使用具有刮刀施加器之Sintex實驗室塗佈機及與上文實例1中所述相同之程序將兩層的聚胺甲酸酯配方各自塗佈到一離型紙上來製造。使用實例1中所述之方法測量自膜切下之樣本的透氣性及防水性。膜樣本之透氣性及防水性測量值顯示於下表4中。 實例14After degassing, a multi-layer polyurethane film was made by coating two layers of the polyurethane formulation each onto a release paper using a Sintex laboratory coater with a doctor blade applicator and the same procedure as described in Example 1 above. The air permeability and water resistance of samples cut from the film were measured using the methods described in Example 1. The air permeability and water resistance measurements of the film samples are shown in Table 4 below. Example 14
將100 g的WPD2及0.3 g的AF-715添加至150 mL燒杯中以製備聚胺甲酸酯配方。使用Caframo葉輪攪拌器在室溫下將配方在燒杯中混合5分鐘。在混合之後,將1 g的HM-13-843(水性改質之聚矽氧溶液手感改質劑,可購自Stahl Holdings B.V.)添加至燒杯中並將該組合再混合5至10分鐘。然後將聚胺甲酸酯配方通過190微米尼龍網濾紙過濾器過濾,並在真空烘箱中在室溫下除氣至多1小時以移除氣泡。100 g of WPD2 and 0.3 g of AF-715 were added to a 150 mL beaker to prepare a polyurethane formulation. The formulation was mixed in the beaker using a Caframo impeller stirrer at room temperature for 5 minutes. After mixing, 1 g of HM-13-843 (a water-based modified polysilicone solution feel modifier, available from Stahl Holdings B.V.) was added to the beaker and the combination was mixed for another 5 to 10 minutes. The polyurethane formulation was then filtered through a 190 micron nylon mesh filter paper filter and degassed in a vacuum oven at room temperature for up to 1 hour to remove air bubbles.
在除氣之後,多層聚胺甲酸酯膜係藉由使用具有刮刀施加器之Sintex實驗室塗佈機及與上文實例1中所述相同之程序將兩層的聚胺甲酸酯配方各自塗佈到一離型紙上來製造。使用實例1中所述之方法測量自膜切下之樣本的透氣性及防水性。膜樣本之透氣性及防水性測量值顯示於下表4中。 實例15After degassing, a multi-layer polyurethane film was made by coating two layers of the polyurethane formulation each onto a release paper using a Sintex laboratory coater with a doctor blade applicator and the same procedure as described in Example 1 above. The air permeability and water resistance of samples cut from the film were measured using the methods described in Example 1. The air permeability and water resistance measurements of the film samples are shown in Table 4 below. Example 15
製備三種不同的物品(物品A、B、及C),其在不同紡織物基材上包含一蛋白質聚胺甲酸酯混摻物膜。物品A係藉由將實例3之配方直接塗佈到一100%聚酯紡織物基材上來製造。物品B係藉由將實例3之配方直接塗佈到一100%棉紡織物基材上來製造。物品C係藉由將下表3中所示之實例15之配方塗佈在一100%聚酯紡織物基材上來製造。實施例15之配方係使用與實施例2至12相同之程序製造。所使用之另外的水性聚胺甲酸酯分散液係水性脂族非離子型聚胺甲酸酯分散液,其具有約32%之固體含量、1.03 g/mL之比重、及約200 mPa.s之布氏黏度(「WPD3」)。Three different articles (articles A, B, and C) were prepared, which included a protein polyurethane blend film on different textile substrates. Article A was made by applying the formulation of Example 3 directly to a 100% polyester textile substrate. Article B was made by applying the formulation of Example 3 directly to a 100% cotton textile substrate. Article C was made by applying the formulation of Example 15 shown in Table 3 below to a 100% polyester textile substrate. The formulation of Example 15 was made using the same procedure as Examples 2 to 12. The other aqueous polyurethane dispersion used was an aqueous aliphatic nonionic polyurethane dispersion having a solid content of about 32%, a specific gravity of 1.03 g/mL, and a Brookfield viscosity of about 200 mPa.s ("WPD3").
使用下列程序將配方塗佈在物品A至C上。在將配方除氣之後,使用具有刮刀施加器之Sintex實驗室塗佈機將各物品A至C之紡織物基材用一層對應的配方塗佈。在塗佈之後,將層在70℃下乾燥90秒,接著在90℃下乾燥90秒,且最後在150℃下乾燥90秒。在乾燥之後,如用掃描電子顯微鏡(Phenom Pro X, NanoScience Instruments)在物品之一橫截面上進行測量,所有三個物品上之塗層具有在17與50微米之間的厚度。然後在測試前將塗佈之物品在溫濕度控制箱(FORMA ™環境箱,Thermo Scientific)中在23℃及50%相對濕度下條件處理至多24小時。 The formulations were coated on articles A to C using the following procedure. After degassing the formulations, the textile substrate of each article A to C was coated with a layer of the corresponding formulation using a Sintex laboratory coater with a doctor blade applicator. After coating, the layers were dried at 70° C. for 90 seconds, then at 90° C. for 90 seconds, and finally at 150° C. for 90 seconds. After drying, the coatings on all three articles had a thickness between 17 and 50 microns as measured on one of the cross sections of the articles using a scanning electron microscope (Phenom Pro X, NanoScience Instruments). The coated articles were then conditioned in a temperature and humidity controlled chamber (FORMA ™ Environmental Chamber, Thermo Scientific) at 23°C and 50% relative humidity for up to 24 hours before testing.
使用實例1中所述之方法測量自物品A至C切下之不同樣本的透氣性及防水性。物品之不同膜樣本(A1、A2、A3等)之透氣性及防水性測量值顯示於下表5中。 實例16The air permeability and water resistance of different samples cut from articles A to C were measured using the method described in Example 1. The air permeability and water resistance measurements of different film samples (A1, A2, A3, etc.) of the article are shown in Table 5 below. Example 16
將來自實例15之物品A之樣品用0.5%至5% (w/w)反應性染料(Reactive Navy 1143 – cas 86024-59-1乙烯基碸、氯-三𠯤、與銅之金屬錯合物)於水染浴中以1:10紡織物與染浴的重量比染色。該染浴亦包括蘇打灰,其濃度為10 mg/mL染浴溶液。在將樣本放入染浴之後,使用氫氧化鈉將染浴溶液之pH提高至10以上。在提高pH之後,將樣品在紅外線染色機(Pyrotec 4染色機,Roaches International)中在60℃下染色四小時。在染色之後,將樣本在60℃下於DI水中洗滌15分鐘。使用分光測色儀(Ultra Scan Pro, HunterLab)在反射(包含鏡面反射)模式下測量物品A之樣本及未染色樣本之顏色性質。下表6顯示兩個樣本之顏色性質。染色樣本之顏色性質顯示塗佈配方中顯著之染料吸收。 實例17 A sample of Item A from Example 15 was dyed with 0.5% to 5% (w/w) reactive dye (Reactive Navy 1143 - cas 86024-59-1 vinyl sulfide, chloro-triphosphine, and copper metal complex) in an aqueous dye bath at a weight ratio of 1:10 textile to dye bath. The dye bath also included soda ash at a concentration of 10 mg/mL dye bath solution. After placing the sample in the dye bath, the pH of the dye bath solution was raised to above 10 using sodium hydroxide. After raising the pH, the sample was dyed in an infrared dyer (Pyrotec 4 dyer, Roaches International) at 60°C for four hours. After dyeing, the sample was washed in DI water at 60°C for 15 minutes. The color properties of the sample of Article A and the undyed sample were measured using a spectrophotometer (Ultra Scan Pro, HunterLab) in reflectance (including specular reflectance) mode. Table 6 below shows the color properties of the two samples. The color properties of the dyed sample show significant dye absorption in the coating formulation. Example 17
將包含用實例3之配方製造之一蛋白質聚胺甲酸酯混摻物膜之一物品用聚胺甲酸酯反應性黏著劑層壓至一針織紡織物上。在層壓之後,將物品在溫濕度控制箱(FORMA ™環境箱,Thermo Scientific)中在23℃及50%相對濕度下條件處理至多24小時。在條件處理之後,然後使用馬丁代爾磨耗試驗機(Martindale Abrader)(James Heal Martindale Abrasion And Pilling Tester,型號1605-181114)在9千帕斯卡(kPa)壓力下在乾燥條件下測試物品之磨耗性能。對物品之多個樣本進行測試直至失效,且每20,000次循環檢查一次是否失效。樣本在200,000次循環時失效。 實例18 An article comprising a protein polyurethane blend film made with the recipe of Example 3 was laminated onto a knitted textile with a polyurethane reactive adhesive. After lamination, the article was conditioned in a temperature and humidity controlled box (FORMA ™ environmental box, Thermo Scientific) at 23°C and 50% relative humidity for up to 24 hours. After conditioning, the abrasion performance of the article was then tested under dry conditions at 9 kPa pressure using a Martindale Abrader (James Heal Martindale Abrasion And Pilling Tester, Model 1605-181114). Multiple samples of the article were tested until failure, and failure was checked every 20,000 cycles. The sample failed at 200,000 cycles. Example 18
製備根據實例3之蛋白質聚胺甲酸酯配方。然後根據實例1來製備用作整理劑之聚胺甲酸酯配方,不同之處在於水性脂族聚碳酸酯聚胺甲酸酯分散液具有約34%之固體含量及5至1000 mPa.s之黏度。使用(「WPD4」)代替WPD1並使用1 g的WH-PZ5150代替XR-5577(參見表3,實例18)。A protein polyurethane formulation according to Example 3 was prepared. A polyurethane formulation for use as a finishing agent was then prepared according to Example 1, except that the aqueous aliphatic polycarbonate polyurethane dispersion had a solid content of about 34% and a viscosity of 5 to 1000 mPa.s. ("WPD4") was used instead of WPD1 and 1 g of WH-PZ5150 was used instead of XR-5577 (see Table 3, Example 18).
在除氣之後,使用具有刮刀施加器之Sintex實驗室塗佈機將聚胺甲酸酯配方及蛋白質聚胺甲酸酯配方施加到一離型紙上。首先,使用與實例2至12相同之程序,用蛋白質聚胺甲酸酯配方來製備基線樣本18A。其次,藉由將聚胺甲酸酯配方以兩層方式沉積在一離型紙上來製備樣本18B。施加第一層的聚胺甲酸酯配方以得到小於20微米之濕厚度。藉由刮塗離型紙以達到盡可能低的厚度或定位在離型紙表面之上方的刮刀高度以給出所欲之濕塗層厚度來達成所欲之塗層厚度。然後將聚胺甲酸酯配方之第一層在70℃下乾燥90秒。在第一層之施加及乾燥之後,使用相同方法將聚胺甲酸酯配方之第二層施加在該第一層之頂部上。然後將兩層在70℃下乾燥90秒,在90℃下乾燥90秒,在150℃下乾燥90秒。在聚胺甲酸酯層乾燥之後,使用相同之程序施加兩層的蛋白質聚胺甲酸酯配方並乾燥。在將蛋白質聚胺甲酸酯配方層乾燥之後,將四層樣本自離型紙剝離。After degassing, the polyurethane formulation and the protein polyurethane formulation were applied to a release paper using a Sintex laboratory coater with a doctor blade applicator. First, a baseline sample 18A was prepared using the protein polyurethane formulation using the same procedure as Examples 2 to 12. Second, sample 18B was prepared by depositing the polyurethane formulation in two layers on a release paper. The first layer of the polyurethane formulation was applied to give a wet thickness of less than 20 microns. The desired coating thickness was achieved by doctoring the release paper to achieve the lowest possible thickness or positioning the doctor blade height above the surface of the release paper to give the desired wet coating thickness. The first layer of the polyurethane formulation was then dried at 70°C for 90 seconds. After the first layer was applied and dried, a second layer of the polyurethane formulation was applied on top of the first layer using the same method. Both layers were then dried at 70°C for 90 seconds, 90°C for 90 seconds, and 150°C for 90 seconds. After the polyurethane layer was dried, two layers of the protein polyurethane formulation were applied and dried using the same procedure. After the protein polyurethane formulation layer was dried, the four-layer sample was peeled off the release paper.
樣本18A及18B皆具有在20與40微米之間的厚度。在測試之前,將樣本在溫濕度控制箱(FORMA ™環境箱,可購自Thermo Scientific)中在23℃及50%相對濕度下條件處理至多24小時。使用實例1中所述之方法測量來自兩個樣本之試樣的透氣性及防水性。試樣之透氣性及防水性測量值顯示於下表7中。兩個樣本之試樣的噴霧等級亦根據AATCC 22測量。噴霧等級結果亦顯示在表7中。樣本18A具有0之噴霧等級。樣本18B具有≥80之噴霧等級。 實例19至22 Samples 18A and 18B both have a thickness between 20 and 40 microns. Prior to testing, the samples were conditioned at 23°C and 50% relative humidity for up to 24 hours in a temperature and humidity controlled chamber (FORMA ™ Environmental Chamber, available from Thermo Scientific). The air permeability and water resistance of the samples from the two samples were measured using the method described in Example 1. The air permeability and water resistance measurements of the samples are shown in Table 7 below. The spray rating of the samples of the two samples was also measured according to AATCC 22. The spray rating results are also shown in Table 7. Sample 18A has a spray rating of 0. Sample 18B has a spray rating of ≥80. Examples 19 to 22
使用與實例2至12相同之方法製造大豆分離蛋白質(SPI)溶液。The same method as in Examples 2 to 12 was used to prepare a soy protein isolate (SPI) solution.
蛋白質聚胺甲酸酯混摻物膜係藉由將下列物質添加至150 mL燒杯中來製備:(a) SPI溶液,其質量如下表8中所詳述、(b)水性聚胺甲酸酯分散液(WPD),其質量如下表8中所詳述、(c) 0.3 g的消泡劑(AF-715,可購自Quaker Color)、及(d) 4 g的Imprafix ®AH(基於水之無共溶劑封閉型脂族異氰酸酯交聯劑)。使用Caframo葉輪攪拌機在室溫下將各配方在其各自的燒杯中混合5分鐘。水性聚胺甲酸酯分散液係WPD2、WPD3、水性脂族陰離子型聚酯聚胺甲酸酯分散液(具有約50%之固體含量,1.1 g/mL之比重、小於或等於1200 mPa.s之布氏黏度、如根據ASTM D6866所測量之約50%之生物含量、30 MPa之拉伸強度、及1000%之斷裂伸長率)(「WPD5」)、及水性脂族陰離子型聚酯聚胺甲酸酯分散液(具有約50%之固體含量,1.1 g/mL之比重、小於或等於1200 mPa.s之布氏黏度、如根據ASTM D6866所測量之約56%之生物含量、12 MPa之拉伸強度、及800%之斷裂伸長率)(「WPD6」)。 The protein polyurethane blend film was prepared by adding the following to a 150 mL beaker: (a) SPI solution, the mass of which is detailed in Table 8 below, (b) waterborne polyurethane dispersion (WPD), the mass of which is detailed in Table 8 below, (c) 0.3 g of defoamer (AF-715, available from Quaker Color), and (d) 4 g of Imprafix ® AH (a water-based, co-solvent-free, blocked aliphatic isocyanate crosslinker). Each formulation was mixed in its own beaker at room temperature for 5 minutes using a Caframo impeller mixer. The aqueous polyurethane dispersions are WPD2, WPD3, an aqueous aliphatic anionic polyester polyurethane dispersion having a solid content of about 50%, a specific gravity of 1.1 g/mL, a Brookfield viscosity of less than or equal to 1200 mPa.s, a biocontent of about 50% as measured according to ASTM D6866, a tensile strength of 30 MPa, and an elongation at break of 1000% ("WPD5"), and an aqueous aliphatic anionic polyester polyurethane dispersion having a solid content of about 50%, a specific gravity of 1.1 g/mL, a Brookfield viscosity of less than or equal to 1200 mPa.s, a biocontent of about 56% as measured according to ASTM D6866, a tensile strength of 12 MPa, and an elongation at break of 800% ("WPD6").
在混合之後,將0.3 g的不含溶劑,基於聚胺甲酸酯寡聚物之流變改質劑(具有約50%之固體含量)添加至燒杯中並將該組合再混合5至10分鐘。將各配方通過190微米尼龍網濾紙過濾器過濾,並在真空烘箱中在室溫下除氣至多1小時以移除氣泡。After mixing, 0.3 g of a solvent-free, polyurethane oligomer-based rheology modifier (having approximately 50% solids content) was added to the beaker and the combination was mixed for an additional 5 to 10 minutes. Each formulation was filtered through a 190 micron nylon mesh filter paper filter and degassed in a vacuum oven at room temperature for up to 1 hour to remove air bubbles.
在除氣之後,使用與實例2至12相同之方法由各配方製造多個蛋白質聚胺甲酸酯膜。After degassing, multiple protein polyurethane membranes were made from each formulation using the same method as Examples 2 to 12.
使用實例1中所述之方法測量自膜切下之不同樣本的透氣性及防水性。各膜類型之不同膜樣本(樣品19A、19B、19C等)之透氣性及防水性值顯示於下表9中。 實例表
表2
雖然本文中已描述各種實施例,但是它們係以實例而非限制之方式來呈現。顯而易見,基於在本文中所呈現之教示及指引,調整及修改係意欲落入所揭示之實施例之等效物的含義及範圍內。因此,所屬技術領域中具有通常知識者將明顯看出,在不脫離本揭露之精神及範疇之情況下,可對本文中所揭示之實施例進行形式及細節上之各種改變。在本文中所呈現之實施例的元件不一定是互相排斥的,而是可互換的,藉以滿足所屬技術領域中具有通常知識者將會理解之各種情況。Although various embodiments have been described herein, they are presented by way of example and not limitation. It is apparent that, based on the teachings and guidance presented herein, adjustments and modifications are intended to fall within the meaning and range of equivalents of the disclosed embodiments. Therefore, it will be apparent to those of ordinary skill in the art that various changes in form and detail may be made to the embodiments disclosed herein without departing from the spirit and scope of the present disclosure. The elements of the embodiments presented herein are not necessarily mutually exclusive, but are interchangeable to satisfy various circumstances that will be understood by those of ordinary skill in the art.
本揭露之實施例在本文中係參照其如附圖中所繪示之實施例來詳細描述,其中像是參考編號係用於指示相同或功能相似之元件。提及「一個實施例(one embodiment)」、「一實施例(an embodiment)」、「一些實施例(some embodiments)」、「在某些實施例中(in certain embodiments)」係表明所描述之實施例可包括一具體的特徵、結構、或特性,但每個實施例可不必然包括該具體的特徵、結構、或特性。此外,此類片語不一定是指相同的實施例。此外,當結合一實施例來描述一具體特徵、結構、或特性時,無論是否有明確描述,據認為所屬技術領域中具有通常知識者能夠結合其他實施例來實現此類特徵、結構或特性。The embodiments of the present disclosure are described in detail herein with reference to the embodiments thereof as illustrated in the accompanying drawings, where reference numbers are used to indicate identical or functionally similar elements. Reference to "one embodiment," "an embodiment," "some embodiments," and "in certain embodiments" indicates that the described embodiments may include a specific feature, structure, or characteristic, but each embodiment may not necessarily include the specific feature, structure, or characteristic. In addition, such phrases do not necessarily refer to the same embodiment. In addition, when a specific feature, structure, or characteristic is described in conjunction with an embodiment, it is believed that a person of ordinary skill in the art will be able to implement such feature, structure, or characteristic in conjunction with other embodiments, whether or not explicitly described.
此等實例係對本揭露之說明而非限制。對於所屬技術領域中具有通常知識者而言,在本領域中通常所遇到的各種條件及參數的其他合適的修改及調整將會是顯而易見的,且係在本揭露的精神及範疇內。These examples are illustrative rather than limiting of the present disclosure. Other suitable modifications and adjustments of the various conditions and parameters normally encountered in the art will be obvious to those skilled in the art and are within the spirit and scope of the present disclosure.
應理解,本文中所使用之措詞或術語係出於描述而非限制之目的。本揭露之廣度及範疇不應受限於上述例示性實施例中之任一者,而應僅根據以下申請專利範圍及其等效物定義。 序列 SEQ ID NO: 1:膠原蛋白片段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t should be understood that the phraseology or terminology used herein is for the purpose of description and not limitation. The breadth and scope of the present disclosure should not be limited to any of the above exemplary embodiments, but should only be defined in accordance with the following claims and their equivalents. Sequence SEQ ID NO: 1: Collagen fragment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
無without
併入本文中之附圖形成本說明書之一部分且繪示本發明之實施例。該等圖式與說明書一起進一步用於解釋所揭示之實施例之原理並使相關技術領域中具有通常知識者能夠製造及使用所揭示之實施例。此等圖式意欲說明而非限制。儘管在此等實施例之上下文中大致描述本揭露,但是應理解,其並不意欲將本揭露之範疇限於此等特定實施例。在該等圖式中,相似的參考編號指示相同或功能上類似之元件。 [圖1A]顯示根據一些實施例之包含一蛋白質聚胺甲酸酯混摻物膜之材料。 [圖1B]顯示根據一些實施例之包含一蛋白質聚胺甲酸酯混摻物膜之材料。 [圖2A]顯示根據一些實施例之包含附接至一紡織物之一蛋白質聚胺甲酸酯混摻物膜之材料。 [圖2B]顯示根據一些實施例之包含在兩個紡織物之間設置一蛋白質聚胺甲酸酯混摻物膜之材料。 [圖3]顯示根據一些實施例之用於製造材料之方法的方塊圖。The accompanying drawings incorporated herein form a part of this specification and illustrate embodiments of the present invention. These drawings, together with the specification, are further used to explain the principles of the disclosed embodiments and enable those with ordinary knowledge in the relevant technical field to make and use the disclosed embodiments. These drawings are intended to illustrate rather than limit. Although the disclosure is generally described in the context of these embodiments, it should be understood that it is not intended to limit the scope of the disclosure to these specific embodiments. In these drawings, similar reference numbers indicate identical or functionally similar elements. [Figure 1A] shows a material comprising a protein polyurethane blend membrane according to some embodiments. [Figure 1B] shows a material comprising a protein polyurethane blend membrane according to some embodiments. [FIG. 2A] shows a material comprising a protein polyurethane blend film attached to a textile according to some embodiments. [FIG. 2B] shows a material comprising a protein polyurethane blend film disposed between two textiles according to some embodiments. [FIG. 3] shows a block diagram of a method for making a material according to some embodiments.
TW202500672A_113122885_SEQL.xmlTW202500672A_113122885_SEQL.xml
Claims (39)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363509213P | 2023-06-20 | 2023-06-20 | |
| US63/509,213 | 2023-06-20 | ||
| US202463657519P | 2024-06-07 | 2024-06-07 | |
| US63/657,519 | 2024-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202500672A true TW202500672A (en) | 2025-01-01 |
Family
ID=93936291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW113122885A TW202500672A (en) | 2023-06-20 | 2024-06-20 | Protein polyurethane alloy membranes |
Country Status (2)
| Country | Link |
|---|---|
| TW (1) | TW202500672A (en) |
| WO (1) | WO2024263676A1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI573838B (en) * | 2016-01-22 | 2017-03-11 | 國立臺北科技大學 | Waterborne polyurethane composition, polyurethane hybrid film and preparation method thereof |
| EP4143258A4 (en) * | 2020-05-01 | 2024-05-22 | Modern Meadow, Inc. | PROTEIN-POLYURETHANE ALLOYS AND LAYERED MATERIALS INCLUDING THE SAME |
-
2024
- 2024-06-20 TW TW113122885A patent/TW202500672A/en unknown
- 2024-06-20 WO PCT/US2024/034667 patent/WO2024263676A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2024263676A1 (en) | 2024-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230033725A1 (en) | Protein polyurethane alloys and layered materials including the same | |
| CN107028256B (en) | Garment belt comprising polymer composition | |
| US11352497B2 (en) | Layered collagen materials and methods of making the same | |
| WO2019017987A1 (en) | Biofabricated leather articles, and methods thereof | |
| EP3824030B1 (en) | Biofabricated leather articles, and methods thereof | |
| JP2014040109A (en) | Laminated fiber cloth structure | |
| JP7732983B2 (en) | Leather-like material comprising melt-blended collagen and thermoplastic polymer | |
| TW202500672A (en) | Protein polyurethane alloy membranes | |
| US20250361675A1 (en) | Protein polyurethane alloy materials | |
| US20250019540A1 (en) | Protein polyurethane alloys comprising a succinylated protein and methods of making the same | |
| HK40117992A (en) | Protein polyurethane alloy materials | |
| WO2025259940A1 (en) | Thermoformed protein polyurethane alloy materials | |
| US20250376594A1 (en) | Melt-blended thermoplastic protein elastomer composites | |
| HK40117605A (en) | Melt-blended thermoplastic protein elastomer composites | |
| TW202507120A (en) | Cross-linked and dyed textile materials | |
| CN118696095A (en) | Protein polyurethane alloy containing succinylated protein and preparation method thereof | |
| HK40077522A (en) | Protein polyurethane alloys and layered materials including the same | |
| HK40110488A (en) | Protein polyurethane alloys comprising a succinylated protein and methods of making the same | |
| HK40129898A (en) | Cross-linked and dyed textile materials |